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Abstract 
Glia express a variety of ion channels, but the precise subtypes expressed by 
astrocytes and oligodendrocytes has not been fully elucidated. The Kir7.1 subtype of 
inwardly rectifying potassium channels (Kir) is highly expressed in retinal pigment 
epithelium and has been demonstrated in Purkinje neurons of the adult rat cerebellum 
and pyramidal neurons of the hippocampus, but it has not previously been identified in 
glia. Using quantitative real time PCR, an ion channel profile for the developing mouse 
optic nerve was constructed and Kir7.1 was identified as one of the major ion channels 
present. Immunostaining revealed widespread expression of Kir7.1 in glia and neurons 
in the mouse brain with the highest expression found in optic nerve oligodendrocytes. 
A major function of Kir is to maintain the membrane potential of glia in the face of 
large ionic shifts associated with normal neuronal function and pathology. 
Oligodendrocytes are particularly susceptible to ischemia so the role of Kir7.1 in 
maintaining oligodendrocyte integrity during oxygen and glucose deprivation (ODG) in 
the isolated intact mouse optic nerve was examined, using the Kir7.1 channel blocker 
VU590. Blockade of Kir7.1 resulted in increased cell death of optic nerve 
oligodendrocytes in normoxic conditions by activating caspase -dependent apoptotic 
pathways and significantly augmented cell death induced by OGD. Moreover, 
intracellular calcium fluctuations dependent on store operated calcium entry in optic 
nerve glia were identified as a potential mechanism for the cellular stress induced by 
Kir7.1 inhibition. The results presented within this thesis demonstrate functional 
expression of Kir7.1 in glial cells, and indicate they are important in maintaining 
oligodendrocytic integrity in both physiological and pathological conditions. 
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Chapter 1 - General Introduction 
 
 
 
1 
 
1.1. Cells of the central nervous system 
The two main cell types of the central nervous system (CNS) are neurones and glia. 
Neurones are electrically excitable cells and are responsible for transmitting electrical 
and chemical signals, thus receiving, processing and conveying information throughout 
the nervous system (Levitan et al., 2001).  Glia are electrically inexcitable and are made 
up of astrocytes, myelinating oligodendrocytes, oligodendrocyte progenitor cells 
(OPCs) and microglial cells. Glial cells were previously considered to be the connective 
tissue of the brain, but it is now known that their functions are vital to the normal 
physiology and function of the nervous system (Verkhratsky and Butt, 2013). Neurones 
and glia are neural cells that originate from a common multipotent neural progenitor 
cell of the neuroepithelium, under the control of multiple signals. In contrast, 
microglial cells are mesodermal cells derived from foetal macrophages that enter the 
CNS during embryonic development to give rise to microglia (Kessaris et al., 2001; 
Colognato and Ffrench-Constant, 2004). It was also believed that neuronal precursor 
cells disappear around birth so that there would be no development of new neurones 
in the mature brain. This notion changed as evidence started accumulating on the 
presence of populations of neural stem cells in the subventricular zone (SVZ) and the 
dentate gyrus of the hippocampus, that give rise to neurones throughout life (Kernie 
and Parent, 2010). 
 
1.1.1. Astrocytes 
Astrocytes are multi-functional glial cells and are the main homeostatic element of 
the CNS. A defining characteristic of astrocytes is the expression of the glial fibrillary 
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acidic protein (GFAP; Figure 1.1), an intermediate filament that forms the astrocytic 
cytoskeleton and is used as a marker for mature astrocytes (Kimelberg, 2004). 
Astrocytes have a very heterogeneous morphological phenotype in the various brain 
regions which include protoplasmic astrocytes of grey matter of the brain and the 
spinal cord, which have a number of thick processes that are often found to be in 
contact with blood vessels and they are associated with neuronal cell somata and 
synapses, fibrous astrocytes localised in the white matter which usually display the 
“traditional” stellate morphology with longer and thinner processes and are associated 
with the nodes of Ranvier, classical radial glia that act as pluripotent neural precursor 
cells during development, radial Müller glia of the retina, cerebellar Bergmann glia and 
velate astrocytes, tanycytes that connect ventricular walls with parts of hypothalamus 
and spinal cord, pituicytes in the neuro-hypophysis, and perivascular and marginal 
astrocytes. In addition, astroglia cover several types of specialised cells such as 
ependymocytes, choroid plexus cells and retinal pigment epithelial cells (Parpura and 
Verkhratsky, 2012). 
 
Astrocytes support neuronal functions in many ways: 
• they provide structural support by organization of the CNS in domains; the 
distribution of astrocytes throughout the adult CNS is highly organized and 
parcellates the gray matter of the entire brain and spinal cord into small astrocyte-
delimited domains that form the basis for a neuro-vascular unit, which is central 
for neurovascular coupling and the metabolic support of neurons. The parcelling 
process starts during the later stages of embryogenesis and has been termed 
3 
 
"tiling" (Nedergaard et al., 2003; Verkhratsky and Butt, 2013). The astrocytic 
domains are very well-defined and the elements within each domain, i.e. neurons, 
synaptic terminals and blood vessels are integrated and surrounded by 
protoplasmic astrocyte processes that express all receptors necessary for synaptic 
support and local signalling, while distal signalling and coupling of neighbouring 
astrocytes occurs through the most distal astrocytic processes which are rich in 
gap junctions (Bushong et al., 2002; Verkhratsky and Butt, 2013). 
 
• they contribute to the formation of the blood-brain barrier; The physical 
substrate of the BBB are the endothelial cells of the brain capillaries which are 
sealed by tight junctions that inhibit the paracellular transport of molecules even 
as small as ions. The barrier function is not fixed, but can be modulated and 
regulated, both in health and in pathology and the role of astrocytes is to 
completely ensheath the CNS capillaries in order to regulate and maintain the 
properties of the BBB. In vitro studies have provided ample evidence that 
astrocytes can regulate the BBB by adjusting the physical barrier (inducing tighter 
tight junctions), controlling the transport barrier (via the expression and polarized 
localisation of transporters on the astrocytic endfeet), and regulating the 
metabolic barrier thus ensuring an adequate supply of essential water-soluble 
nutrients and metabolites required by nervous tissue, and for which the BBB has 
low passive permeability (Dupport et al., 1998; Hasseloff et al., 2005; Abbott et al., 
2006; Abbott et al., 2010; Verkhratsky and Butt, 2013). More recently, pericytes 
have been also shown to contribute to BBB induction (Dohgu et al., 2005). 
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• they are responsible for the formation of glial scar tissue (reactive gliosis) in case 
of brain injury; Astrogliosis is triggered by signals (represented by 
neurotransmitters such as ATP and glutamate, cytokines, growth factors and blood 
factors) derived from damaged cells at the core of any insult regardless of 
aetiology. Generally, astrocytic transformation into reactive astrocytes begins with 
the upregulation of GFAP and vimentin, and hypertrophy of the astrocytic cell 
body and processes. Two morphological types of reactive astrogliosis have been 
identified to date: i) isomorphic gliosis in which the normal architecture of CNS 
tissue is not altered, astroglial microdomain organisation is preserved and the 
remodelling of neuronal networks is facilitated, and ii) anisomorphic gliosis during 
which the reactive astrocytes proliferate and lose their domain organisation. In 
anisomorphic gliosis, astrocytes also produce keratin and chondroitin thus 
inhibiting axonal regeneration and resulting in the formation of a permanent glial 
scar (Sofroniew, 2009; Robel et al., 2011; Verkhratsky and Butt, 2013).  
 
• they provide metabolic support through the “astrocyte-neurone lactate shuttle”; 
The brain has very high energy requirements mainly due to the need for 
maintenance and restoration of ion gradients following signalling processes such 
as postsynaptic and action potentials, as well as uptake and recycling of 
neurotransmitters (Attwell and Laughlin, 2001; Alle et al., 2009). It is now 
generally accepted that the metabolic needs of active neural tissue are met, at 
least partially, by non-oxidative glucose metabolism (i.e., glycolysis) (Figley and 
Stroman, 2011; Bélanger et al., 2011). Experimental evidence has demonstrated 
that the amount of glucose taken up by astrocytes is disproportionally high 
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compared to their energy requirements (Barros et al., 2009; Chuquet et al., 2010) 
and the reason for this is explained by the astrocyte-neuron lactate shuttle (ANLS) 
model proposed by Pellerin and Magistretti (Pellerin and Magistretti, 1994). 
Perivascular astroglial processes possess GLUT1 transporters via which they 
uptake glucose and through the process of aerobic glycolysis they convert it into 
pyruvate and subsequently into lactate by lactate dehydrogenase type 5 (LDH5), 
an enzyme exclusive to astrocytes. Lactate is released into the ECS and is taken up 
by neurons via the monocarboxylase transporters (MCT-1 and 2), where it is 
converted back into pyruvate by LDH1 and is utilised to produce energy. 
Glutamate released during synaptic transmission and uptaken by astrocytes acts 
as a signal for astrocytes to increase their delivery of energy supply to active 
neurones. This coupling of high synaptic activity and energy delivery from 
astrocytes to neurons is critical for higher cognitive brain functions (Suzuki et al., 
2011; Verkhratsky and Butt, 2013). 
 
• they provide developmental support with neurone migration and the formation 
of new synapses; Following the generation of neural stem cells from 
neuroectodermal cells, the first cells to develop are radial glia, an important 
function of which is to provide a scaffold along which the neural precursor cell can 
migrate (Kriegstein and Alvarez-Buylla, 2009). This is particularly important where 
neurones will be organised in layers e.g. cerebral cortex and cerebellum (Rakic, 
2003 a and b). When neurones have reached their final sites, they will start 
extending axons and forming synapses. The biggest wave of synaptogenesis starts 
shortly after birth in the mammalian brain and lasts for several weeks, while 
6 
 
synapses continuously strengthen, weaken, die or are formed throughout life 
(Kelsch et al., 2010). Experimentally, increased synaptogenesis has been observed 
when neurons are cultured together with astrocytes due to the production of 
cholesterol by astrocytes, as this lipid is essential for new membranes that are 
formed during synaptogenesis (Mauch et al., 2001). Moreover, glia produce 
signals by which they can influence the expression of proteins that are essential 
for synapse formation. Following the formation of new synapses, astrocytes 
control their maturation through several signals such as TNFa (tumour necrosis 
factor alpha) or ADNF (activity-dependent neurotrophic factor) which induce the 
insertion of glutamate receptors and NMDA receptors unto post-synaptic 
membranes respectively (Eroglu and Barres, 2010). Finally, astrocytes can also 
limit the number of synapses or be involved in the elimination of synapses in the 
CNS (Verkhratsky and Butt, 2013). 
 
• they contribute to CNS microenvironment regulation by maintaining the 
extracellular space (ECS) water and pH homeostasis and preventing neurotoxicity 
by neurotransmitter uptake; Astrocytes express water channels termed 
aquaporins on their perivascular and subpial endfeet, through which they regulate 
water exchange between the blood supply and the CNS ECS in response to 
changes in the extracellular osmolarity (Kimelberg, 1992) or in cases of high 
synaptic activity, during which the ECS surrounding active synapses is restricted 
thus increasing the efficacy of synaptic transmission (Nagelhus et al., 2004; Haj-
Yasein et al., 2012). Moreover, astrocytes are involved in the maintenance of 
extracellular pH in the CNS by releasing protons and lactate via the MCT-1 
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transporter or by removing protons via glutamate transporters. These mechanisms 
are controlled by transmembrane ion gradients and can operate in forward or 
reverse modes (Verkhratsky and Butt, 2013). Importantly, astrocytes are 
responsible for the uptake of neurotransmitters following synaptic activity, thus 
preventing accumulation of these molecules in the synaptic cleft. More 
specifically, they possess glutamate transporters via which they remove glutamate 
from the synaptic cleft, convert it into glutamine with the enzyme glutamine 
synthetase and finally transport the glutamine back into neurons via the 
glutamate-glutamine shuttle, where it is converted back into glutamate and 
released during the next synaptic potential (Danbolt, 2001; 
Eulenburg and Gomeza, 2010). In the case of inhibitory neurons, astrocytes uptake 
GABA through glutamate transporters GAT-3 and GAT-1. Importantly, GABA is 
synthesised from glutamate in neuronal terminals which also arrives from the 
glutamate-glutamine shuttle, which in this case is termed GABA-glutamine shuttle 
(Ortinski et al., 2010). Finally, removal of ATP is also undertaken by astrocytes via 
specifically expressed transporters (Boison et al., 2010). 
 
• they help regulate the ECS ion homeostasis through the various ion channels and 
transporters they express; The maintenance of the extracellular ion composition 
by astrocytes will be discussed in detail throughout this thesis. 
 
Even within a region, astrocytes differ in their morphology as well as the 
expression of ion channels as they must adapt to the functional requirements of 
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different brain regions (Allen and Barres, 2009; Matyash and Kettenmann, 2010; 
Verkhratsky and Butt, 2013). 
 
Figure 1. 1: Mouse optic nerve astrocyte in culture, immunostained for GFAP (red). The nucleus is 
stained with Hoechst Blue (Papanikolaou, unpublished) 
 
1.1.2. Oligodendrocytes 
The exclusive function of oligodendrocytes (Figure 1.2) is the production and 
preservation of large sheets of compacted myelin (myelin sheaths) that provide 
insulation to neuronal axons within the CNS and form the nodes of Ranvier which 
facilitate the saltatory transmission of axonal signals. A single oligodendrocyte can 
myelinate multiple (as many as 50) axons; failure to form myelin (hypomyelination), or 
failure to maintain the myelin sheath (demyelination), impairs the conduction of 
signals in the affected nerves and can lead to neurological disease such as Multiple 
Sclerosis (MS) and Cerebral Palsy. 
There are several oligodendroglial specific markers, used to distinguish between 
OPCs and mature oligodendrocytes. Among the most commonly used is Proteolipid 
Protein (PLP), a myelin protein produced by mature oligodendrocytes (Mela and 
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Goldman, 2009; Azim et al., 2012) and the NG2 chondroitin sulfate proteoglycan used 
to distinguish OPCs (Nishiyama et al., 1996). 
 
Figure 1. 2: Oligodendrocyte in the mouse striatum. Myelinating processes are stained for PLP and are 
ensheathing multiple axons (arrows). The nuclei were stained with Hoechst Blue (Papanikolaou, 
unpublished) 
 
1.1.3. Oligodendrocyte progenitor cells (OPCs) 
During development, OPCs give rise to oligodendrocytes and then persist in the 
adult CNS as a pool of OPCs throughout the brain parenchyma (Figure 1.3). In the adult 
CNS, 90 % of OPCs are not mitotically active, but following injury or demyelination they 
become mitotically active and regenerate oligodendrocytes, astrocytes and possibly 
neurones (Leoni et al., 2009; Zhao et al., 2009). OPCs have been shown to form 
functional synapses with neurones (Kukley et al., 2008; Bergles et al., 2010). 
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 Figure 1. 3: Oligodendrocyte progenitor cell (Adapted from Paez lab, Buffalo University) 
 
1.1.4. Microglia 
Microglial cells (Figure 1.4) comprise 10-15% of the glial population and they are 
usually referred to as “the resident macrophages of the CNS” (Kettenmann et al., 
2011). They remain into a resting state in physiological conditions but when a 
pathogenic factor is identified, they are activated and act rapidly by attacking the 
pathogen and subsequently removing the remains of the damage by phagocytosis 
(Verkhratsky and Butt, 2013; Amor et al., 2010).  
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 Figure 1. 4: Microglial cell in the mouse brain (Nimmerjahn et al., 2005). 
 
 
1.1.5. Ependymal cells  
Ependymal cells line the ventricles and the central canal of the spinal cord. The 
majority of ependymal cells are ciliated and responsible for the constant flow of the 
cerebrospinal fluid (CSF). There is a special group of ependymal cells within the 
ventricles; the choroid plexus, that are responsible for CSF production and forming the 
blood-CSF barrier (Chojnacki et al., 2009). 
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1.2. Excitability of Neural Cells 
Neuronal excitability is well described in text books. In brief, activation of post-
synaptic neurotransmitter receptors triggers a shift in the membrane potential, either 
an excitatory or inhibitory post synaptic potential (EPSP, IPSP), which is transmitted to 
the cell soma and thence to the axon hillock, or initial segment, the site of action 
potential initiation. The action potential is a rapid change in the membrane potential 
that depends on the membrane being depolarized sufficiently to a threshold. Whether 
the membrane is depolarized to threshold to generate the all-or-nothing action 
potential depends on the sum of the EPSP and IPSP electrical signals transmitted from 
the dendrites. Even though glial cells are not electrically excitable, i.e. they cannot 
generate action potentials like neurones, they display what have been termed ‘calcium 
excitability’ and ‘sodium excitability’, involving a range of plasmalemmal and 
intracellular calcium (Ca2+) channels and sodium (Na+) channels (Nedergaard et al., 
2010; Kirischuk et al., 2012). The main route for glial responses to chemical stimulation 
is via Ca2+ release from intracellular Ca2+ stores such as the Endoplasmic Reticulum (ER) 
and the mitochondria, and by triggering Ca2+ influx through plasmalemmal Ca2+ 
channels. Sodium signalling has also been described in astrocytes and is thought to 
represent an additional mechanism for neurone-glial signalling (Hamilton et al., 2008; 
Verkhratsky et al., 2012; Verkhratsky and Butt, 2013). 
 
All of these events in neural cell excitability are dependent on the expression and 
site-specific localisation of families of voltage-gated ion channels, which mediate Ca2+- 
and Na+-signalling in glia and synaptic signalling and electrical activity in neurones. The 
main differences between neurons and glia is the expression of high densities of 
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voltage-gated Na+  and Ca2+ channels in neurones, which mediate the action potential 
and synaptic signaling, respectively as well as different ion distributions across their 
cell membranes (Figure 1.5). In addition, glia and neurons differ in their intracellular 
ion concentrations, in particular a higher concentration of Na+ and Cl-, due to the 
activity of Na+-Cl- co-transporters (Verkhratsky and Butt, 2013). A key feature of glia 
compared to neurons is their much higher K+ selective permeability of their 
plasmalemma, which is due primarily to high expression of inwardly rectifying 
potassium channels (Kir), and which maintains the characteristic strongly negative glial 
resting membrane potential (RMP), close to the equilibrium potential for potassium 
(EK). Kir channels are also a feature of neurones, with important roles in stabilizing the 
neuronal membrane potential and repolarisation of axons during the action potential 
(Armstrong and Hille, 1998). 
 
Figure 1. 5: Cytoplasmic ion concentrations in neurones and astrocytes. (Verkhratsky and Butt, 2013). 
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1.2.1. Sodium (Na+) 
Na+ channels can be found in both electrically excitable (neurones) and electrically 
silent cells (glia), where they display the same molecular structure and biophysical 
properties. The main difference is the density of channel expression on the cell 
membrane; on neuronal cell membranes their density can reach up to 10000 channels 
per µm2 whereas glial cells express about one channel per 10µm2. Glial progenitor cells 
show much denser Na+ channel expression than mature glia which is thought to 
suggest their involvement in glial proliferation, differentiation and migration, whereas 
their functions in mature astrocytes and oligodendrocytes have yet to be elucidated. 
The main route for Na+ influx in mature glia is through ionotropic glutamate and 
purinoceptors, which produce substantial Na+ fluxes upon activation and possibly via 
Transient Receptor Potential (TRP) channels (Parpura and Verkhratsky, 2012, 
Verkhratsky and Butt, 2013). Na+ signals are responsible for moderating important 
astroglial functions such as metabolic support for neurones, K+ buffering ([Na+]i levels 
regulate the function of the Na+/K+-ATPase and the Na+/K+/Cl− co-transporter NKCC1), 
pH homeostasis, and even Ca2+ signalling by moderating the activity of the Na+/Ca2+ 
exchanger (NCX) (see details in subsection 1.2.5) (Kirischuk et al., 1997; Suzuki et al., 
2011; Kirischuk et al., 2012) 
 
1.2.2. Calcium (Ca2+) 
Ca2+-permeable ion channels that allow Ca2+ influx into the cell are represented by 
several families, including the highly Ca2+ selective voltage-gated Ca2+ channels (Cav), 
cationic channels with various degrees of Ca2+ permeability, such as ionotropic 
neurotransmitter receptors (e.g. glutamatergic, purinoreceptors), and the family of 
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TRP channels, as well as the plasmalemmal Ca2+-release activated Ca2+ channels 
(CRAC). Intracellular Ca2+ channels include the inositol 1,4,5-trisphosphate receptors 
(IP3R) and ryanodine receptors (RyR), which cause an increase in [Ca2+]i by releasing 
Ca2+ from the ER stores into the cytoplasm. The maintenance of [Ca2+]i levels is brought 
about by sequestration of Ca2+ into the ER lumen by transporters such as the Sarco- 
endoplasmic reticulum ATPases (SERCA or Sarco- endoplasmic reticulum Ca2+ pumps) 
or by extrusion of Ca2+ into the ECS by plasmalemmal Ca2+ ATPases (PMCA) and ion 
exchangers, such as NCX (Solovyova and Verkhratsky, 2003; Verkhratsky and Butt, 
2013). The mitochondria, which are able to accumulate Ca2+  through the 
Ca2+ uniporter and to release Ca2+ through the mitochondrial Na+/Ca2+ exchanger are 
also involved in regulating cellular Ca2+ homeostasis (Nicholls, 2005; Parpura and 
Verkhratsky, 2012). 
 
As with Na+ channels, Cav channels are more highly expressed in glial progenitors 
than mature glia and are thought to regulate early developmental processes in 
oligodendrocytes, including expression of myelin genes. Their expression persists in 
mature oligodendrocytes, in which they are suggested to modulate Ca2+ entry in 
processes and controlling myelination, but there is little evidence for functional 
expression of Cav channels in mature astrocytes (Verkhratsky and Butt, 2013). 
However, there are indications of their upregulation in astrocytes in pathology, for 
example in reactive astrogliosis and epilepsy (Parpura et al., 2011).   
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The IP3R is a cation-selective channel gated by IP3 and located on the ER 
membrane. There are 3 mammalian subtypes of IP3R; IP3R1, IP3R2 and IP3R3 
(Bezprozvanny, 2005; Stutzmann and Mattson, 2011). IP3R2 is the main subtype 
expressed in astrocytes and IP3-mediated Ca2+ signalling is also present in OPCs, 
oligodendrocytes and microglia even though IP3R expression in OPCs and 
oligodendrocytes has not been resolved (Zhao et al., 2000; Fiacco and McCarthy, 2006; 
Butt, 2006; Kettenmann et al., 2011; Kanno and Nishizaki, 2012). The IP3Rs are 
simultaneously controlled by IP3 and Ca2+ ions and therefore local increase in 
[Ca2+]i facilitates receptor opening and promotes Ca2+-induced Ca2+ release (CICR) 
through neighbouring IP3R. In addition to intracellular and luminal Ca2+, IP3R can be 
modulated by ATP and pharmacological modulators (Alexander et al., 2009). All the 
aforementioned modes of IP3R activation underlie the propagation of Ca2+ waves 
which are important in many aspects of glial physiology, such as long range signalling 
via the astrocytic syncytium, the transfer of signal from distal astrocytic processes to 
the soma and neurotransmitter release. These Ca2+ waves can be completely stopped 
by blockade of SERCA pumps (e.g. by thapsigargin) or inhibition of phospholipase C 
(PLC), which catalyses the production of IP3 by hydrolysing phosphatidylinositol 4,5-
bisphosphate (PIP2) (Porter and McCarthy, 1995; Kirischuk et al., 1995; Kirischuk et al., 
1996; Kirischuk et al., 1999). Moreover, blockade of IP3R using the membrane-
permeable antagonist diphenylboric acid 2-aminoethyl ester (2-APB) is also sufficient 
to inhibit Ca2+ waves in astrocytes and Ca2+-dependent neurotransmitter release (Hua 
et al., 2004; Fellin et al., 2004; Shigetomi et al., 2008). Previous studies have linked IP3R 
with some neurodegenerative diseases. In ischaemic stroke, Ca2+ release through IP3R 
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is enhanced (Stutzmann and Mattson, 2011). In AD, presenilin (PS) 1 activates IP3R to 
release Ca2+ and increase [Ca2+]i (Berridge, 2010). 
 
1.2.3. Ca2+ and neural cell death 
Ca2+ is an important intracellular messenger that mediates many of the 
physiological responses to chemical and electrical stimulation. However, it can also 
activate caspases, so excessive influx may lead to the activation of apoptotic pathways 
and cell death (Mattson, 2007). Intracellular Ca2+ ([Ca2+]i) overload has been implicated 
in several neurodegenerative diseases, such as ischaemic stroke, amyotrophic lateral 
sclerosis (ALS), Parkinson's disease (PD), Alzheimer's disease (AD) and Huntington's 
disease (HD) (Mattson, 2007; Stutzmann and Mattson, 2011). In stroke for example, 
compromised blood flow (ischaemia) results in a massive release of glutamate which 
can activate glial and neuronal N-Methyl-D-aspartate (NMDA) receptors and result in 
Ca2+ influx (Salter and Fern, 2005). In addition, membrane associated oxidative stress 
can also impair the function of glutamate transporters, promote membrane 
depolarization and result in further Ca2+ influx (Mattson, 2007). However, the [Ca2+]i 
increase is not solely due to Ca2+ influx, but also due to release from intracellular Ca2+ 
stores. As soon as Ca2+ enters the cell, it binds with receptors present on the ER and 
can activate CICR and more Ca2+ to be released into the cytosol via IP3R and RyR 
(Berridge, 2010). 
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1.2.4. Store Operated Calcium Entry (SOCE) 
Store-operated Ca2+ entry (SOCE) is present in most electrically excitable and non-
excitable cells and it refers to the opening of plasmalemmal Ca2+ channels and 
subsequent Ca2+ influx in response to low Ca2+ concentration in the ER lumen ([Ca2+]L) 
(Parekh and Putney, 2005).  SOCE activation provides Ca2+ for replenishment of the ER 
store, but it is also important for producing the sustained (“plateau”) phase of the 
Ca2+ signal that often lasts even after the agonist-evoked signal has ended. There are 
several parts comprising the molecular machinery of SOCE. Some cells express store-
operated plasmalemmal channels characterised by extremely high Ca2+ selectivity and 
very low single channel conductance (ICRAC). For the activation of these channels, the 
stromal interaction molecule (STIM) proteins that are located on the ER membrane 
and detect [Ca2+]L are translocated near the cell membrane and interact with Orai 
proteins that form the plasmalemmal channel (Feske et al., 2006; Putney, 2007; 
Verkhratsky and Butt, 2013). Astrocytes show functional expression of SOCE with 
Stim1/Orai1 overexpression or silencing resulting in the modulation of thrombin-
induced intracellular Ca2+ dynamics (Pivneva et al., 2008; Akita and Okada, 2011; 
Moreno et al., 2012; Motiani et al., 2013).  
 
In recent years, it has been shown that SOCE may also involve activation of TRP 
channels. The superfamily of TRP channels are non-selective cation channels that are 
expressed in many cell types and can be activated by various intra- and extracellular 
signals (Venkatachalam and Montell, 2007). TRP allow both Na+ and Ca2+ ions to enter 
the cell in both excitable and non-excitable tissues (Ramsey et al., 2006). TRP channels 
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constitute at least seven subfamilies, TRPA (TRP-ankyrin), TRPC (TRP-canonical), TRPM 
(TRP-melastatin), TRPV (TRP-vanilloid), TRPP (TRP-polycystin), TRPML (TRP-mucolipin) 
and TRPN (TRP-NOMPC) which is not found in mammals. More specifically the TRPC 
(canonical) subfamily; Trpc1 mRNA and protein have been detected in astrocytes and 
these channels have been shown to modulate astroglial Ca2+ signals while involvement 
of Trpc4 and Trpc5 as auxiliary subunits has also been postulated (Grimaldi et al., 2003; 
Golovina, 2005; Smyth et al., 2006; Malarkey et al., 2008). 
 
1.2.5. Pumps and transporters 
Plasmalemmal Na+/K+-ATPase is a member of the P-type family of active cation 
transport proteins, which is ubiquitous in animal cells, that catalyses the efflux of three 
Na+ and influx of two K+ per ATP hydrolysed, resulting in a net loss of positive charge 
within the cell (Jorgensen et al., 2003). The glial Na+/K+-ATPases are activated following 
an increase in intracellular Na+ concentration ([Na+]i) and hence every transient 
[Na+]i elevation promotes Na+ efflux in exchange for K+ influx.  In addition, their 
saturation is much higher than the neuronal pumps (up to 15mM compared to 3mM 
respectively) which is suitable mechanism for the removal of extracellular K+ ([K+]o) 
during neuronal action potential propagation (Parpura and Verkhratsky, 2012; 
Verkhratsky and Butt, 2013). 
Na+/Ca2+ exchanger (NCX) is expressed in the plasma membrane of virtually all 
animal cells and it is arguably the most physiologically important ion exchanger in glia. 
It can operate either in the forward mode (removal of one Ca2+ in exchange for the 
import of three Na+ ions) or in the reverse mode (extrusion of Na+ and influx of Ca2+ 
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ions). The mode of operation depends on the membrane potential and the 
transmembrane concentration gradients for Na+ and Ca2+. As the resting [Na+]i of 
astrocytes is quite high (15-20mM), the reversal potential of the NCX is close to the 
RMP (-80mV) which results in the NCX dynamically fluctuating between 
forward/reverse mode, thus mediating both Ca2+ and Na+ fluctuations. Even mild 
depolarisation of the glial membrane or Na+ influx through either ionotropic receptors 
or neurotransmitter transporters can trigger NCX reversal.  In mammals, there are 
three genes encoding for the NCX: NCX1, NCX2, and NCX3 and they can all be found in 
glia (Blaustein and Lederer, 1999; Parpura and Verkhratsky, 2012; Verkhratsky and 
Butt, 2013). The NCLX is the mitochondrial Na+/Ca2+ exchanger and it is also involved in 
regulating glial Na+ (Nicholls, 2005; Palty et al., 2010). 
Na+/Ca2+ -K+ exchanger (NCKX) allows the influx of four Na+ ions in exchange for 
one Ca2+ and one K+ ion. The genes encoding for NCKX are NCKX1 and NCKX2 (Kraev et 
al., 2001). 
 
1.2.6. Potassium (K+) 
Potassium channels fall into four major classes, namely; i) Voltage Gated, ii) 
Calcium activated, iii) Inwardly Rectifying and iv) Tandem Pore Domain (Gutman et al., 
2005). 
Various members from all of the different classes have been observed in glial cells 
where they display similar biophysical characteristics to those that are found in 
neurones or muscle cells. K+ channels are the most abundant detected in glia and the 
glial resting membrane conductance is dominated by passive K+ currents (Verkhratsky 
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and Butt, 2013). Generally, the expression of outwardly rectifying K+ channels has been 
implicated in regulation of their proliferation, as they show a down-regulation trend 
with glial differentiation. However, various subtypes of voltage gated K+ channels (Kv), 
Ca2+ -activated K+ channels (KCa) and  rapidly inactivating A-type K+ currents (KA) have 
been detected in mature, non-proliferating glia although their functional relevance is 
still unclear (Verkhratsky and Steinhäuser, 2000; Verkhratsky and Butt, 2013). Glia also 
express voltage independent K+ channels which are represented by the two pore 
forming domain channels (K2P) and are hypothesized to affect glial membrane 
potential; however, direct experimental evidence for this is lacking (Bay, 2013; 
Verkhratsky and Butt, 2013).  
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1.3. Kir channels 
Undoubtedly the most physiologically relevant K+ channels (and by far the most 
studied) in CNS glia are the inwardly rectifying K+ channels (Kir). These are 
predominantly responsible for maintaining the glial resting membrane potential, which 
is close to the EK. Kir channel expression and more specifically the Kir2.x and Kir3.x 
subtypes have also been found in neurones, where they have been implicated with the 
regulation of postsynaptic excitability (Hibino et al., 2010). 
Since 1993, genes encoding several Kir channel proteins have been identified and 
can be categorised into 7 subfamilies (Kir1.x to Kir7.x) based on sequence homology. 
These Kir subfamilies can be further grouped (Figure 1.6) based on their functional 
attributes including their degree of rectification, single channel conductance and 
sensitivities to chemical blockers such as barium (Ba2+) or caesium (Cs+)(Hibino et al, 
2010). 
 
Figure 1. 6: Kir channel subunits can be categorized into four functional groups. (Figure modified from 
Hibino et al, 2010) 
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The characteristic inward rectification of Kir channels results primarily from a 
voltage-dependent block by intracellular organic cations such as polyamines or Mg2+ 
ions, which physically block the conduction pathway during depolarization, thereby 
impeding the outward flow of K+. The polyamines spermine and spermidine are the 
most potent inducers of rectification although contributions of putrescine and Mg2+ 
are also important (Osawa et al., 2009). The degree of rectification varies greatly 
among members of the Kir superfamily and is critical to their respective functional 
roles. Kir2.x and Kir3.x subunits form classical "strong" inward rectifier channels, while 
other members encode channels with “intermediate” (Kir4.x) or “weak” (Kir1.1, Kir6.x 
and Kir7.x) rectification. Structurally, each Kir subunit consists of two transmembrane 
domains separating a pore forming loop (Figure 1.7).  
 
Figure 1. 7: Overall architecture of Kir channels. a. Schematic drawing of a Kir channel subunit. Each 
subunit comprises two transmembrane helices (M1 and M2), a pore-forming region containing the pore-
helix (P), and a cytoplasmic domain formed by the amino (N) and carboxy (C) termini. b. Side view of a 
Kir channel showing the transmembrane domain of two subunits (green and blue) and the C-terminal 
domains of their neighbouring subunits (red and yellow). White spheres represent K+ ions in the 
selectivity filter. 
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Functional Kir channels are assembled as tetramers of subunits surrounding a 
single transmembrane aqueous pore (Bichet et al., 2003). Kir channels can be 
assembled as homotetramers (i.e. four identical protein subunits), however the simple 
architecture and strong homology between the basic subunits allows for 
heterotetrameric combinations to form functional Kir channels. 
Kir channels have variable functions in multiple cell types including macrophages, 
cardiac myocytes, endothelial cells and CNS cells. For example, in cardiac myocytes, 
Kir2.x, Kir3.x and Kir6.x subfamilies are important for the maintenance of prolonged 
action potential by slowing membrane repolarisation (Anumonwo and Lopatin,2010), 
whereas in kidney Kir1.x, Kir2.x, Kir4.x, Kir5.x and Kir7.x subfamilies regulate Na+, K+ and 
Mg2+ transport through epithelial cells (Wang et al., 2010). In endothelial cells, vascular 
smooth muscle (VSM) cells and pericytes, Kir2.x and Kir6.x subfamilies are involved in 
dilation, induced by elevated extracellular K+ (Jackson, 2005), and in pancreatic β cells 
Kir6.2 are involved in regulation of insulin release induced by elevated glucose levels 
and in response to an increase in ATP concentration (Flechtner et al., 2006). 
 
1.3.1. Glial Kir channels 
The research evidence that has been produced so far, confirms that CNS glia can 
express most of the Kir channel subfamilies. The Kir4.1 subtype is highly specific, 
widespread and strongly expressed in the CNS and has been demonstrated in 
astrocytes and oligodendrocytes of the grey and white matter (Poopalasundaram et 
al., 2000; Li et al., 2001; Kalsi et al., 2004), in Bergmann glia and Muller glia (Takumi et 
al., 1995; Ishii et al., 1997; Schröder et al., 2000; Higashi et al., 2001). There is evidence 
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demonstrating strong expression of Kir5.1 in astroglial endfeet, in Muller glia as well as 
in oligodendrocytes in vitro (Kalsi and Butt, 2004; Brasko, 2013). In addition, the 
strongly rectifying Kir2.1 and Kir2.2 have also been identified in retinal Muller glia 
(Kofuji et al., 2002; Ishii et al., 2003; Raap et al., 2002) and hippocampal astrocytes 
(Schröder et al., 2002). Moreover, immunolabelling for Kir2.2 has been demonstrated 
in Bergmann glia and astrocytes of the cerebellum (Leonoudakis et al., 2001), while 
astrocytes and oligodendrocytes of the forebrain and hindbrain displayed 
heterogeneous labeling for Kir2.1, Kir2.2 and Kir2.3. Cultured astrocytes also seem to 
express Kir2.1 (Perillán et al., 2000). The expression of the Kir6.x subtypes has been 
shown in Muller glia (Eaton et al., 2002) and astrocytes of the dorsal vagal nucleus, as 
well as in astrocytes and oligodendrocytes of the corpus callosum and cerebellar white 
matter (Zhou et al., 2002). However, in previous studies no expression had been found 
for Kir6.2 mRNA in hippocampal, cortical and cerebellar astrocytes, oligodendrocytes 
(Dunn-Meynell et al., 1998) or Bergmann glia (Thomzig et al., 2001). The data on glial 
expression of Kir3.x is sparse but there is evidence of immunopositivity of astrocytes in 
vitro and mRNA expression in Muller cells of the Guinea pig retina.  
The main functions of Kir channels in glia are:  
• To maintain the highly negative RMP, which is around -85 mV, and its high 
permeability for K+ ions.  
• To undertake repolarisation of the glial membrane after the influx of Na+ or Ca2+ 
during neuronal action potentials.  
• Potassium buffering by means of the glial syncytium, which facilitates the 
movement of K+ ions from areas of the brain with increased [K+]o to distant areas 
with lower [K+]o. 
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• They are also involved in ion and water transport by being colocalised with water 
channels (aquaporins) (Saadoun et al., 2003; Goodyear et al., 2009). 
Some of the most important functions of astrocytes and oligodendrocytes are 
dependent on the strongly negative RMP and K+ permeability and it is safe to say that 
these functions depend on their expression of Kir channels.  
 
1.3.2. Astrocytes and K+ buffering 
A major function of astrocytes is the maintenance of extracellular [K+]. During their 
repolarisation after the transmission of an action potential, neurones release K+ into 
the ECS. The K+ concentration in the ECS is maintained at 3 –5 mM (Jurkat-Rott et al., 
2009), and an excessive increase has pathological effects on the membrane potentials 
of neurones and glia, on intra- and extracellular pH, further synaptic transmissions, as 
well as on cerebral blood flow and energy metabolism. Therefore, it is of immense 
importance for the overflow of K+ to be removed (Ransom et al., 2000). The process of 
redistribution of the excess potassium ions within the ECS was named “spatial 
buffering” by Orkand et al (Orkand et al., 1966) and in 1983 it was recognized that it is 
glial cells that carry out this function (Coles and Orkand, 1983) (Figure 1.8). 
The dominant role of Kir channels for K+ buffering was originally demonstrated by 
Newman in retinal Müller cells from a frog (Newman, 1986) and more recently in 
murine Müller cells (Kofuji et al., 2000). A few years later the role of Kir channels in 
spatial buffering and the restoration and maintenance of the membrane potential was 
shown also in hippocampal astrocytes in Kir4.1 knockout mice (Djukic et al., 2007) and 
in astrocytes of the spinal cord (Olsen et al., 2006). In Kir4.1 knock-out mice, ablation of 
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Kir4.1 results in a dramatic reduction in Kir currents, depolarization and reduced 
capacity for K+ buffering in glia.  
Kir channels have also been connected to astrocytic differentiation. It has been 
discovered that while mature astrocytes show high activity of Kir channels, the process 
of astrocytic de-differentiation during reactive gliosis results in Kir down-regulation 
(Kalsi et al., 2004). 
 
 
Figure 1. 8: The astrocytic syncytium (Verkhratsky and Butt, 2013). 
 
28 
 
1.3.3. Oligodendrocytes and Myelination 
The importance of Kir4.1 expression in oligodendrocytes was documented when 
Neusch et al (2001) observed significantly decreased motor functionality in mice with a 
null mutation the Kir4.1 gene. The main cause for this motor impairment was 
hypomyelination of the spinal cord followed by neuronal degeneration and the 
scientists found that cultured oligodendrocytes from these mice were depolarized and 
had underdeveloped morphological characteristics. It became obvious that Kir4.1 in 
oligodendrocytes are responsible for retaining the RMP thus managing important cell 
functions such as signalling, differentiation and myelination as well as regulating the 
extracellular [K+] within the spinal cord. 
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1.4. Kir7.1 - the newest member of the Kir family 
1.4.1. Structure and physiology 
The gene encoding for Kir7.1 (KCNJ13) was first cloned in 1998, by three 
independent research groups (Döring et al., 1998; Partiseti et al., 1998; Krapivinsky et 
al., 1998). Its amino acid sequence and biophysical characteristics are quite distinct 
from other Kir channels and it is only 38% identical to its closest relative Kir4.2. As a 
result, Kir7.1 channels are relatively insensitive to Ba2+ and Cs+, classical blockers of Kir 
channels, with IC50 values of >1mM and >10mM respectively. Moreover, the 
permeability of Kir7.1 is independent of [K+]o and it displays an exceptionally small 
single channel conductance. The residue responsible for these unusual characteristics 
of the Kir7.1 channel pore (Figure 1.9) is methionine125 (M125), which is located in the 
same position as arginine148 (R) in all other Kir subtypes. Replacement of this residue 
with the conserved R dramatically increased the single channel conductance of the 
channel by ~20 fold, Ba2+ sensitivity by ~10 fold and allowed the channel to exhibit the 
rectification profile of other Kir channels (Sabirov et al., 1997; Döring et al., 1998; 
Krapivinsky et al., 1998). 
 
Figure 1. 9: Comparison of Kir channel pore regions. The conserved leucine (L), arginine (R) and glutamic 
acid (E) are replaced by serine (S), methionine (M) and glycine (G) in Kir7.1  (Krapivinsky et al., 1998). 
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The low unitary conductance in conjunction with the lack of specific 
pharmacological blockers has made the electrophysiological study of native Kir7.1 
currents very challenging. However, recently a novel specific blocker for ROMK and 
Kir7.1 channels was discovered. The new compound, termed VU590, blocks Kir1.1 and 
Kir7.1 channels at low micromolar concentrations without inhibiting Kir4.1 or Kir2.1 
channel activity (Lewis et al., 2009; Bhave et al., 2010). Despite the relative simplicity 
and similarity of Kir channels, structurally different compounds display such specificity 
in their blockade. For example, tricyclic antidepressants such as nortriptyline block 
Kir4.1 channels, whereas the antimalarial agent chloroquine inhibits Kir2.1 and it is 
noteworthy that they exhibit no effect on Kir1.1 (Rodríguez-Menchaca et al., 2008; 
Furutani et al., 2009). It has been postulated that VU590 at high micromolar 
concentrations may partially inhibit endogenous HEK-293 currents consisting mainly of 
Kv. However, this blockade was as low as 10% (Bhave et al., 2011). 
At present, evidence for heteromeric assembly of Kir7.1 with other Kir subunits is 
lacking, although this does not negate the possibility of the existence of heteromers.  
Furthermore, Partiseti et al. (1998) reported that Kir7.1 channels, unlike the related Kir6 
subfamily members, do not associate with SUR1 accessory subunits when the two are 
co-transfected in HEK293 cells. 
 
1.4.2. Distribution of Kir7.1 in human and animal tissues 
Kir7.1 protein and/or mRNA has been detected in various organs such as epithelial 
cells in the kidney, thyroid and retina, in CNS neurones, ependymal cells, choroid 
plexus epithelium and spinal cord, myometrial smooth muscle, small intestine, neural 
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regions of the gastric mucosa as well as gastric parietal cells, and also in the lung, 
prostate, liver, pancreas, cochlear nucleus, testis and ovaries (Table 1.1).  
Table 1. 1: Kir7.1 expression in various tissues. 
Organ Species Method Reference 
Kidney Human, Rat,  
Guiney Pig 
rtPCR; Northern Blot; 
Immunohistochemistry; 
Western Blot 
Krapivinsky et al., 1998; 
Partiseti et al., 1998; Döring et al., 
1998; Ookata et al., 2000; Derst et 
al., 2001; Suzuki et al., 2003; 
Pondugula et al., 2006; Yang et 
al., 2008 
Brain Human, Rat,  
Guiney Pig, 
Rabbit, Cichlid 
rtPCR; Northern Blot; 
In situ hybridisation; 
Immunofluorescence; Western 
Blot; 
Mass Spectrometry 
Krapivinsky et al., 1998; Partiseti 
et al., 1998; Döring et al., 1998; 
Nakamura et al., 1999; Kusaka et 
al., 2001; Derst et al., 2001; 
Malinowska et al., 2004; Schindler 
et al., 2006; Watanabe et al., 
2007; Millar et al., 2007; Yang et 
al., 2008 
GI Tract Human, Rat, 
Rabbit 
rtPCR; Northern Blot; 
Immunofluorescence; Western 
Blot 
Krapivinsky et al., 1998; 
Partiseti et al., 1998; Nakamura et 
al., 1999; Nakamura et al., 2000; 
Fujita et al., 2002; Malinowska et 
al., 2004 
Testis Human, Rat, 
Cichlid 
rtPCR; Northern Blot Krapivinsky et al., 1998; Döring et 
al., 1998; Nakamura et al., 2000; 
Watanabe et al., 2007 
Ovary Cichlid rtPCR Watanabe et al., 2007 
Liver Human rtPCR Krapivinsky et al., 1998 
Prostate Human rtPCR Krapivinsky et al., 1998 
Lung Rat,  
Guiney Pig, 
Rabbit 
rtPCR; Northern Blot Döring et al., 1998; Derst et al., 
2001; Malinowska et al., 2004 
Thyroid Human, Rat Northern Blot; 
Immunofluorescence; Western 
Blot 
Nakamura et al., 1999 
Spinal Cord Human Northern Blot Nakamura et al., 1999 
Retinal 
Pigment 
Epithelium 
Human, Rat, 
Bovine, Porcine, 
Monkey 
rtPCR; qRT-PCR; 
Northern Blot; 
Immunofluorescence; 
Western Blot 
Kusaka et al., 2001;  
Shimura et al.,2001; Yang et al., 
2003; Yasuda et al., 2003; Yang et 
al., 2008a,b; Hejtmancik et al., 
2008 
Pancreatic 
Acini 
Rat rtPCR Kim et al., 2000 
Cochlear 
Nucleus 
Rat rtPCR; qRT-PCR; SAGE; 
Microarray 
Friedland et al., 2007 
Uterus Human, Mouse qRT-PCR; 
Immunohistochemistry; 
Western Blot 
McCloskey et al., 2014 
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More detailed studies on the cellular localisation of the channel have been 
performed in the retinal pigment epithelium (RPE), choroid plexus, gastric parietal cells 
and kidney where it was found to be localised in a polarised way and co-expressed 
with the Na+/K+-ATPase (Nakamura et al., 1999; Ookata et al., 2000; Kusaka et al., 
2001; Fujita et al., 2002; Yang et al., 2003; Pondugula et al., 2006). There are no 
previous reports of the expression of Kir7.1 in astrocytes and oligodendrocytes, but 
protein has been shown to be expressed in Purkinje neurones of the cerebellum and 
pyramidal neurones of the hippocampus (Krapivinsky et al., 1998). 
Their presence in polarised epithelial cells and its co-expression with Na+/K+-
ATPase has led to a hypothesis that Kir7.1 channels play a role in transepithelial K+ 
transport. More specifically, Döring et al (1998) hypothesised that Kir7.1 channels in 
the choroid plexus are crucial for the clearance of K+ from cerebrospinal fluid (CSF), in 
which [K+] is tightly controlled. However, Krapivinsky et al. (1998) demonstrated that 
Kir7.1 channel protein is expressed in Purkinje and pyramidal neurones and attribute to 
it a neurone specific function. Kir7.1 are strongly expressed by retinal pigment 
epithelium (RPE), where it has an important role in the regulation of the subretinal 
space volume, by facilitating K+ efflux from the cells when [K+]o is low, i.e. upon 
illumination and activation of retinal photoreceptor cells, thus enabling water efflux 
from the RPE. Moreover, due to its weak inward rectification, Kir7.1 maintains a 
constant K+ efflux, thus counteracting and enabling the function of Na+/K+-ATPase, a 
function termed "K+ recycling" (Wimmers et al., 2007).  A loss of function mutation in 
Kir7.1, results in the autosomal dominant disorder of the eye called Snowflake 
Vitreoretinal Degeneration (SVD) and manifests itself as a severe impairment of 
transepithelial ion and water transport via the RPE (Hejtmancik et al., 2008). 
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1.5. Hypothesis and Aims 
The hypothesis underpinning this thesis is that Kir7.1 has unresolved functions in 
glial cells of the CNS. The overall aim of this PhD project is to characterise the 
expression and physiological function of the inwardly rectifying potassium channel, 
Kir7.1, in the mammalian central nervous system. 
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Chapter 2 - Materials and Methods 
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2.1. Animals 
2.1.1. Declaration 
Animals were humanely killed by cervical dislocation, in accordance with the 
regulations issued by the Home Office of the United Kingdom under the Animals 
(Scientific Procedures) Act (ASPA), 1986. 
2.1.2. Animal Strains 
Several different strains of mice were used; C57BL/6 and C57BL/10 (Wild type 
black) and transgenic strains;  
• SOX10-lox-GFP-4xPolyA-lox-DTA, which expresses the enhanced green 
fluorescent protein (EGFP) under transcriptional control of the SOX10 gene (Kessaris et 
al., 2006; Matsuoka et al., 2005). The SOX10-EGFP transgenic line was a gift from 
William D Richardson and Nikoleta Kessaris’ lab (UCL).  
• TgN (GFAP-EGFP) GFEC-FKi, expressing EGFP under the control of the GFAP 
gene promoter, resulting in green astrocytes (Nolte et al., 2001).  
• TgN (PLP-DsRed1), expressing enhanced red fluorescent protein (DsRed - 
drFP583, from Discosoma species) under the control of the PLP gene promoter, 
resulting in red myelin (Hirrlinger et al., 2005). The GFAP-EGFP and PLP-DsRed 
transgenic lines were a generous gift from Dr. Frank Kirchhoff (Max Planck Institute for 
Experimental Medicine, Gottingen, Germany). 
• NG2-DsRed BAC, in which DsRed is expressed under the control of the NG2 
promoter (Ziskin et al., 2007; Zhu et al., 2008). The NG2-DsRed transgenic line was a 
gift from Dr. Akiko Nishiyama (University of Connecticut, USA). 
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All transgenic animals used in this study display no unusual phenotype; moreover, 
their breeding habits and life span are aligned with wild type. 
2.1.3. Animal Ages 
Mice of both sexes were used at ages P7 (i.e. post natal day 7), P12 or >P35 for the 
qRT-PCR experiments. For the optic nerve explant cultures, P7-P12 mice were used 
while adult mice (>P30) were used for brain sections. Optic nerves from P12-P14 mice 
were used for the oxygen and glucose deprivation and calcium imaging experiments. 
Finally, new born wild type mice (P0-P2) were used for setting up the cortical neuron 
and astrocyte cultures. 
2.1.4. Tissue Fixation Protocols 
Three different fixation protocols have been used in the duration of this project:  
a) 1% PFA with 15% Picric acid for 10 mins to fix cultured cells  
b) 4% PFA with 15% Picric acid to plunge-fix mouse brains and optic nerves for 24-
48 hrs depending on mouse age and size of brain. Brains were cut along the 
longitudinal cerebral fissure to separate the hemispheres and improve PFA penetration 
in the tissue.  
 c) 4% PFA to perfuse adult mice before removing the brain and plunge fix 
according to fixation protocol b. 
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2.2. Cell Culture 
All cell cultures were completed within a routinely sterilized room containing a 
laminar flow cabinet (Life Technologies) and cell culture incubator (Fisher). 
2.2.1. Cover Slip Preparation 
13mm diameter glass cover-slips were sterilised by immersion in 70% ethanol and 
placed in 24-well plates (Greiner Bio-One, Manchester, UK) and left to dry in the 
culture hood. 100 µl of 1% poly L-lysine (Sigma-Aldrich, Dorset, UK) in double distilled 
sterilised water (ddH2O) was placed on each cover-slip and left overnight at 37°C. Poly 
L-lysine was removed and replaced with 25 µl of 0.5% laminin (Life Technologies, 
Paisley, UK) in sterile ddH2O. After two hours, laminin was replaced with 30 µl of 
sterile ddH2O and the cover-slips were left in the incubator until required. Poly L-lysine 
coated cover-slips and slides provide higher adhesion, reducing the chance of tissue or 
cell loss during processing. This pre-preparation of cover-slips is required when 
culturing cells that do not adhere well. 
2.2.2. Optic Nerve Explant Cultures 
Optic nerve explants were cultured as previously described (Greenwood and Butt, 
2003). Briefly, optic nerves were dissected from P7 to P12 mice and placed directly 
into 50µl dissecting medium consisting of high glucose Dulbecco’s Modified Eagle 
Medium (DMEM) (Sigma-D5671) containing 10% Fetal Calf Serum (FCS; Life 
Technologies), L-Glutamine (Sigma) and 0.1% Gentamycin (Life Technologies). Next, 
they were finely chopped with a scalpel blade and triturated with pipettes of 
decreasing diameter (P1000 then P200) to further break up the tissue. After adding 50 
µl more dissecting medium, the solution was pipetted evenly between cover slips 
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(approx. 1 nerve per cover-slip) and left for the initial stick down period. After 
approximately 24 hrs the dissecting medium was replaced with a low serum (0.5%) 
modified Bottenstein and Sato (B&S) culture medium (Bottenstein and Sato, 1979) 
without  thyroid hormones in which 10 ng/ml of recombinant human PDGF-a (R&D 
Systems) was added to encourage OPC proliferation. After 3-4 days in vitro (DIV) the 
medium was replaced with B&S medium supplemented with 0.5 mM dbc-AMP (Sigma) 
until DIV10.  
 
2.2.3. Cortical Neuron Cultures 
Primary cultured cortical neurons were prepared from C57Bl/6 and C57Bl/10 wild 
type mice aged between postnatal days P0 to P2. Brains were collected in ice cold 
HBSS (Life Technologies) containing 1% Pen/Strep (Life Technologies) and cortices 
were dissected under a dissection microscope (Leica MZ8) and all brain membranes, 
corpus callosum and hippocampus were carefully removed. The cortical pieces were 
then placed in fresh ice-cold HBSS in a 15 ml falcon tube. Tissue was left to settle at the 
base of the tube before HBSS was exchanged with fresh solution. This gentle washing 
step was repeated three times so that any remaining pieces of brain membranes were 
washed away. The cortical pieces were then incubated at 37°C for 15-20 mins in NB-A 
medium (Life Technologies) supplemented with B27, Pen/Strep, L-Glutamine (Sigma) 
and 10% trypsin (Life Sciences). Following trypsinisation, the media was replaced with 
FCS (Life Technologies) and incubated at 37°C for 5-10 mins which inactivated any 
remaining enzyme. The cortical pieces were then washed with NB-A medium and were 
triturated with a fire polished glass pipette. Finally, the media was filtered through a 
39 
 
70 µm nylon mesh pre-separation filters (Miltenyi Biotec, Bergisch 
Gladbach, Germany) and brought up to a volume of 5100 µl (5.1 ml). The cells were 
then counted and seeded on 13 mm coverslips pre-treated with poly-l-lysine and 
laminin in 24 well plates, as previously described (Section 2.2.1). 
 
2.2.4. Cell Counting 
To estimate the percentage of viable cells, cells were counted in a VI-CELL™ Series 
Cell Viability Analyser (Beckman Coulter). In order to verify cell viability, the VI-CELL™ 
uses trypan blue, a dye which is only taken up by dead cells which are permeabilised, 
whereas the live cells which are not permeable to trypan blue are not stained 
(Marchenko and Flanagan, 2007). To perform a cell count, 100 µl of the re-suspended 
pellet of cells was placed into a VI-CELL tube with 900 µl of NB-A medium to produce a 
dilution factor of 10:1. The vial was then placed in the analyser’s carousel for the 
count.  
Finally, cells were further diluted accordingly in order for 106 cells to be seeded 
per cover-slip for immunostaining, and grown as monolayers in an incubator at 37°C 
under normoxic culturing conditions (95% air/5% CO2). 
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2.3. Immunostaining techniques 
2.3.1. Antibodies 
All antibodies used during this project are listed in Table 2.1 and 2.2, along with 
information concerning their epitope localisation, host species and reactivity, working 
concentration and source. 
The secondary antibodies must be raised in the same species as the serum used 
for blocking, and against the type of animal from which the primary antibody is 
derived. 
Table 2.1: Primary antibodies 
Antibody (epitope) Host ICC/IHC Western Blot Dilution Source 
GFAP (IC) Chicken √  1:500 Chemicon1 
Kir7.1 (EC) Rabbit √ √ 1:300 Alomone2 
Kir4.1 (IC) Rabbit √  1:300 Alomone 
Na+/K+ ATPase a1 (IC) Mouse √  1:300 Abcam3 
β3-Tubulin (Tuj1) (IC) Mouse √  1:300 Millipore4 
β-actin Mouse  √ 1:3000 Sigma 
Key Immunocytochemistry (ICC); Immunohistochemistry (IHC). 
Intracellular Epitope (IC); Extracellular Epitope (EC) 
 
Table 2.2: Secondary antibodies 
Conjugate Reactivity Dilution Source 
Alexa Fluor® 488 Gt-a-Rb, Dk-a-Rb 1:400 Life Technologies 
Alexa Fluor® 568 Gt-a-Rb, Dk-a-Rb, Gt-a-Ck 1:400 Life Technologies 
DyLight 647 Gt-a-Ms 1:250 Stratech5 
HRP Gt-a-Ms, Gt-a-Rb 1:5000 Dako6 
 
1 Chemicon, Temecula, CA, USA 
2 Alomone, Jerusalem, Israel 
3 Abcam, Cambridge, UK 
4 Millipore, Darmstadt, Germany 
5 Stratech, Suffolk, UK 
6 Dako, Stockport, UK 
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2.3.2. Immunocytochemistry 
Cultured cells were fixed for 10 mins with 1% paraformaldehyde (PFA-TAAB 
Laboratories Equipment, UK) dissolved with 15% Picric Acid in 0.2 M Phosphate Buffer. 
After washing 3 x10 mins with PBS (Sigma), cells were blocked for 75 mins at room 
temperature using blocking solution containing 5% Normal Goat Serum (NGS; 
Invitrogen) or Normal Donkey Serum (NDS; Invitrogen) in order to preventnon-specific 
binding of both the primary and secondary antibodies (Abs) to other antigens on the 
cells. Where primary antibodies targeted an intracellular epitope of a protein (e.g. 
Kir4.1, GFAP), 0.01% detergent (Triton X, Sigma) was incorporated into the blocking 
solution, for cell membrane permeabilisation. After blocking, cells were not washed 
again. Primary antibodies were diluted in PBS. Incubation was performed overnight 
according to manufacturer’s recommendations at 4°C. Cells were then washed 3 x 10 
mins with PBS. The secondary antibody conjugates were diluted in PBS and added to 
the cells for 1 hr at room temperature on an orbital shaker and protected from light by 
wrapping the 24-well plate in foil. During this step, the DNA dye Hoechst Blue 
(Molecular Probes) was added at a concentration of 1:500. After completion of 
immuno-staining, the cells were once again washed 3 x10 mins with PBS and cover-
slips were mounted on clean slides, using mounting medium (Vectashield; Vector Labs 
or Fluoromount G; Southern Biotech). 
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2.3.3. Immunohistochemistry 
Mouse brains separated into two hemispheres and complete with the cerebellum, 
pons and medulla oblongata, and optic nerves were dissected and fixed with perfusion 
and submersion in 4% PFA with 15% picric acid for 24-48 hrs. After fixation, tissues 
were washed 3 times in PBS and stored at 4°C, in PBS containing 0.05% NaN3 (Sigma) 
until used. Brain sections were cut using a vibratome (Leica) at a thickness of 40-70 µm 
and used immediately or stored at 4°C in PBS/NaN3 in 24 well plates. The meninges 
were removed were possible. Tissue was blocked with 10% serum (NGS or NDS) for 1-2 
hrs, washed 3 times in PBS, and incubated overnight in the antibody solution which 
comprised of the primary antibody diluted in blocking solution containing Triton-X. 
Whole optic nerves were incubated in the primary antibody for 48 hrs. Tissues were 
then washed 3 times again in PBS and incubated with secondary antibody diluted in 
blocking solution for 1 hr at room temperature on an orbital shaker, or  in the case of 
whole optic nerves, incubated overnight and protected from the light by wrapping the 
24-well plate in foil. Following secondary antibody incubation, tissues were washed 3 
times with PBS before being mounted on glass slides and covered with mounting 
medium and glass coverslips ready for imaging. 
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2.3.4. Confocal Microscopy 
Fluorescence-stained cells and sections were examined under a confocal 
microscope with the following characteristics (Table 2.3); 
Table 2.3: Confocal microscope characteristics 
Microscope Zeiss Axiovert LSM 710 VIS405, 
Zeiss LSM 5 Pascal Axioskop 2 
Laser confocal system and LED Light 
Source (Colibri) 
Lasers Argon, helium-neon (HeNe1) 
and diode lasers 
Sequential excitation at wavelengths 
488nm, 568nm and 405nm 
Image 
Acquisition 
Zeiss LSM 510NLO confocal 
scan head 
x20(air), or x40, x63 and x100 (oil 
immersed) objectives 
Image analysis Zeiss Software LSM and Zen 9000 Software 
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2.4. Western Blot 
2.4.1. Protein Extraction 
Whole cell protein content was extracted from mouse optic nerve, cortex, 
cerebellum and whole brain. Tissue was dissected from adult mice and immediately 
frozen in liquid nitrogen and allowed to thaw slowly on ice in homogenisation buffer 
containing (in mM) 12.5 NaCl (Fisher, Loughborough, UK), 2 Tris·HCl (pH8; Sigma), 0.2 
phenylmethylsulphonyl fluoride (PMSF; Sigma) and 1x protease inhibitor cocktail 
(Roche). Tissues were disrupted and homogenised using the TissueRuptor and 
disposable probes of approximately 10 mm diameter (Qiagen, Crawley, West Sussex, 
UK). Disruption was performed in 10 sec bursts to avoid overheating that could cause 
protein degradation. Samples were then centrifuged at 4°C, at 14000 rpm using a 
refrigerated table top centrifuge (Fisher) for 4 mins and resuspended in PBS. 
Homogenates were stored at -80°C. 
 
2.4.2. Bicinchoninic Acid Assay (BCA) for Determination of Protein Content 
The bicinchoninic acid assay (BCA assay), also known as the Smith assay, was used 
to determine the protein concentration of samples. Serial dilutions of a protein 
standard (1 mg bovine serum albumin/ml in 0.15 M NaCl, 0.05% NaN3 (Sigma)) were 
made using sterile ddH2O.  A plate reader (POLAR star OPTIMA, BMG LabTech) was 
used to measure protein standards in order to generate a standard curve from which 
the protein concentration of prepared samples was determined. Samples were 
subsequently diluted with lysis buffer to obtain homogenous protein levels across 
different samples. 
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2.4.3. Protein Separation, Transfer and Detection 
For SDS polyacrylamide gel electrophoresis (PAGE), 8% running gels (2.31 ml 
ddH2O; 1.33 ml 30% (v/v) bis-acrylamide; 1.25 ml 1.5M Tris/HCL pH 8.8; 50 µl 10% 
(w/v) SDS; 50 µl Ammonium Persulfate (0.05 g/500 µl); 5 µl TEMED) with a 5% stacking 
gel (3.4 ml ddH2O; 830 µl 30% (v/v) bis-acrylamide; 630 µl 0.5M Tris/HCl pH 6.8; 50 µl 
10% (w/v) SDS; 50 µl Ammonium Persulfate (0.05g/500µl); 5 µl TEMED) were 
prepared. Cell lysates were diluted 1:1 in Laemli buffer (Biorad) containing 5% β-
mercaptoethanol (Sigma) and were heated for 5 mins at 95°C. 30 µg protein was 
loaded into each gel lane alongside a pre-stained protein molecular weight marker 
(Presicion Plus Protein Kaleidoscope standard; Biorad, Hercules, California, USA) which 
was used for protein size indication. The electrophoretic separation was carried out at 
a constant voltage of 100V (vertical slab gel, 1.5 mm x 14 cm x 14 cm) for 1.5 hrs in 
electrophoresis buffer containing 25 mM Tris, 190 mM glycine, 0.1% SDS and pH 8. 
Following this, gels were subjected to semi-dry transfer to a polyvinylidene fluoride 
(PVDF) membrane (GE healthcare). The gel and membrane were sandwiched between 
two stacks of filter paper that had been pre-wetted with transfer buffer containing; 25 
mM Trizma Base, 192 mM Glycine and 20% Methanol, and ran for 2 hrs at constant 
Amperage of 75 mA per gel. To confirm protein transfer, the PDVF membrane was 
stained using Ponceau S (Sigma) following manufacturer instructions. Membranes 
were washed in distilled water (dH20) to remove any staining and washed twice for 10 
mins in TRIS buffered saline (TBS) at pH 7.4 and incubated for 2 hrs at room 
temperature (RT) in blocking solution containing 5% milk powder in TBS with 0.1% 
Tween. Membranes were incubated overnight at 4°C in blocking solution containing 
primary antibody. After primary incubation, membranes were washed three times with 
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TBS-Tween for 10 mins followed by a 3 hr incubation in TBS-Tween containing HRP-
conjugated secondary antibodies. Finally, membranes were washed twice in TBS-
Tween for 10 mins. An enhanced chemiluminescent (ECL) detection mix (GE 
healthcare) was prepared by mixing enhanced luminal to oxidising agent in a ratio 1:1. 
The reagent was spread on the membrane and incubated for 5 mins at RT.  After 
removing excess reagent, the membrane was exposed to an ECL detection system 
(Amersham Biosciences) coupled to a PC and images captured digitally. 
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2.5. Oxygen and Glucose Deprivation (OGD) 
Optic nerves from P12–14 transgenic GFAP-eGFP or Sox10-eGFP mice were 
isolated intact and immediately placed in aCSF for 30 mins at 37°C in a normoxic 
incubator (95% air/5% CO2) and allowed to stabilise. Control groups were incubated 
for a further 1 hr in normal aCSF containing glucose with 5% CO2/95% O2 (Oxygen and 
Glucose Normal; OGN) without the addition of pharmacological modulators. Oxygen-
glucose deprivation (OGD) was achieved using the method of Fern and colleagues 
(Salter and Fern, 2005), by incubating nerves for 1 hr at 37°C in glucose-free aCSF 
(osmolarity was maintained by replacing glucose with sucrose), and switching the 
chamber atmosphere to 5% CO2/95% N2.  
Pharmacological modulators were added to the aCSF solution of test groups 
during OGN and OGD: the small-molecule Kir7.1 channel blocker 7,13-bis(4-
nitrobenzyl)-1,4,10-trioxa-7,13-diazacyclopentadecane (VU590; 100 μM, Tocris), 6-
Nitro-2-[(6-nitro-1H-benzimidazol-2-yl)methoxymethyl]-1H-benzimidazole 
hydrochloride (VU591; 100 µM, Tocris) or the general Kir channel blocker Ba2+ (Barium 
Chloride; 100 µM, Sigma).  
 
2.5.1. Quantification of glia 
At the end of the 60 mins incubation period, optic nerves were fixed and whole-
mounted for image capture using a Zeiss LSM 710 metaconfocal microscope (as 
previously described). Cells expressing the GFAP-eGFP or SOX10-eGFP reporters were 
visualised at 488 nm using an argon laser and x40 oil immersion lens with high 
numerical aperture (1.3 nm); images were captured maintaining the acquisition 
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parameters constant between samples (Figure 5.1A-D). In each nerve, the total 
number of cells was counted in five FOV along the length of the optic nerve. The FOV 
comprised a constant volume of 20 x 20 µm in the x-y-plane and 15 x 1 µm optical 
sections in the z-plane, commencing 15 µm below the pial surface. Cell counts are 
expressed as mean number of cells per FOV + SEM (n>5, where ‘n’ represents the 
number of nerves), and significance was determined by ANOVA and Newman–Keuls 
multiple comparison post-hoc analysis, using Graphpad Prism5.0. 
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2.6. Molecular Biology 
All tissues, except the optic nerve tissue, were disrupted and homogenized using 
the TissueRuptor and disposable probes of approximately 10 mm diameter (Qiagen, 
Crawley, West Sussex, UK). Due to the abundance of myelin in the optic nerve, Trizol 
and chloroform protocol was used. A standard table top refrigerated centrifuge 
(Fisher) was used for all spin protocols. 
2.6.1. Total RNA Extraction 
Extraction of RNA was performed using the RNeasy Micro Kit (Qiagen) following 
the manufacturer’s instructions, from approximately 5 mg of whole mouse brain and 
separately from mouse cortex, cerebellum and optic nerve. When extracting RNA from 
adult optic nerves, the tissue was placed in 500 µl of ice cold Trizol (Sigma) and 
mechanically disrupted using a sterile plastic pestle (Fisher) and homogenised by being 
passed through a 23G syringe 10 times on ice. Homogenate was allowed to rest for 5 
mins and then passed through a QIAshredder column (Qiagen) for further 
homogenisation. 100 µl chloroform (Sigma) was added and the homogenate shaken 
vigorously for 15 secs before being allowed to rest for 3 mins at room temperature. 
Then, samples were centrifuged at 12000 g for 5 mins at 4°C. Finally, the top clear, 
aqueous phase containing the RNA was aspirated and transferred into a new 1.5 ml 
eppendorf where it was mixed at 1:1 ratio with 70% ethanol. The RNeasy Micro Kit 
procedure was followed from that point onwards. For whole brain, cortical and 
cerebellar RNA extraction, approximately 5 mg of tissue was placed in RNA later until it 
was disrupted and homogenized using the TissueRuptor in a round bottomed 
collection tube containing a guanidine thiocyanate (GITC) lysis buffer (RLT) and then 
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centrifuged for 3 mins at 13000 rpm. GITC is a chaotropic salt, i.e. a potent protein 
denaturant which inactivates RNases thus allowing for the RNA to be isolated intact. 
The supernatant was carefully removed and placed in a new collection tube before 
adding 70% molecular grade ethanol at 1:1 ratio. It was then transferred onto an 
RNeasy spin column containing a silica-gel membrane upon which the RNA would bind 
during subsequent centrifugation at 10000 rpm for 15 secs. A further wash with 350 µl 
of a chaotropic salt containing buffer (RW1) was performed at 10000 rpm for 15 secs 
in order to wash away any remaining contaminating impurities such as degraded 
proteins and a last was with ethanol was utilised to wash away the salts. A dry spin for 
5 mins at full speed was performed to remove all ethanol residues from the 
membrane. Complete removal of ethanol is essential for high yields of clean eluent. If 
there is ethanol remaining on the column then the nucleic acids will not be completely 
rehydrated and elution will result in low yields. Finally, high quality total RNA was 
eluted in 10µl RNA-free water by centrifuging for 1 min at full speed. 
An extra DNase digestion step using DNase I (Qiagen) was performed in order to 
eliminate genomic DNA that was released in the lysate, as the homogenisation 
protocol disrupted the nucleic as well as the cell membranes. One of the whole brain 
samples was left untreated and was used as a positive control in PCR reactions. All RNA 
samples were stored at -80°C. 
The purity and concentration of isolated total RNA was assessed using a ND-1000 
Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) to measure the 
UV absorption of samples. The absorption at 260 nm (A260) was used to determine the 
concentration of RNA in undiluted samples. The ratio of absorptions at 260 nm and 
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280 nm (A260/A280 ratio) was used to determine the samples’ purity, where a ratio of 
>1.8 indicated high RNA purity. As RNA optimally absorbs light at a wavelength of 260 
nm due to its high content of nucleotides, while proteins and other impurities that 
might be contaminating the isolated RNA absorb best at 280 nm, the A260/A280 ratio 
is the preferred way to assess if an RNA sample is pure. Furthermore, a subset of the 
samples were separated on a 1% agarose gel by gel electrophoresis in 1x TAE buffer 
and visualised by ethidium bromide staining subsequent exposure to UV light. 
 
2.6.2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
First strand cDNA synthesis was carried out using the Transcriptor First Strand 
cDNA Synthesis Kit (Roche, Burgess Hill, West Sussex, UK). Briefly, a minimum of 1 µg 
total RNA was incubated in a two-step process with anchored Oligo dT primers, 
deoxynucleotide mix and the Transcriptor Reverse Transcriptase enzyme to generate 
full length cDNA following the manufacturers guidelines. High quality cDNA libraries of 
the whole mouse brain, cortex, cerebellum and optic nerve were stored at -20°C to be 
used in downstream Polymerase Chain Reactions (PCR) with primers for Kir7.1. The PCR 
reaction volume was 50 µl (14 µl ddH2O; 1 µl cDNA (1 µg); 25 µl DreamTaq (2x); 5 µl 
Forward Primer (10 µM); 5 µl Reverse Primer (10 µM)). The primers were designed 
using the National Center for Biotechnology Information (NCBI) Primer-BLAST tool 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and synthesised by Invitrogen 
(Table 2.4). PCR cycling parameters were as follows; 95°C for 2 mins, followed by 35 
cycles of 95°C for 30 secs, 59°C for 30 secs and 72°C for 1 min followed by a final 
extension of 72°C for 10 mins using a C1000 Touch Thermal Cycler (Biorad, Hercules, 
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CA). The product amplified by the primers is a 251 bp amplicon spanning exons 2 and 3 
of the mouse KCNJ13 gene. 
Table 2.4: PCR primers. 
Kir7.1 Forward Primer CACATCACCAGCTTCACAGC 
Kir7.1 Reverse Primer GGTTTGCCATCTTTGTGAGC 
 
 
2.6.3. Agarose Gel Electrophoresis 
RT-PCR amplicons were separated on a 1% agarose gel containing 1 µg/ml 
ethidium bromide (Sigma) for visualisation of the bands under UV light. Gel 
electrophoresis was performed in TAE Buffer (40 mM tris-acetate, 20 mM acetic acid, 1 
mM EDTA, pH 8.0) for approximately 45 mins at 5 V/cm. Gel images were captured 
under UV light using a BioRad Gel Doc EZ System (BioRad). 
 
2.6.4. Quantitative real time PCR (qRT-PCR) 
The RT2 First Strand Kit (Qiagen) was used for in vitro transcription of extracted 
RNA into cDNA to be used for qRT-PCR, following the manufacturer’s instructions. The 
quantity of RNA that was transcribed was the same for all samples (500 ng). 1350 µl of 
2x SYBR Green qPCR Mastermix (Qiagen) was mixed with 102 µl cDNA and 1248 µl 
ultra-pure water (Ambion) and 25 µl was pipetted in each well of the 96 well-plate 
arrays. All arrays used were purchased from SABiosciences (Qiagen) and thermocycled 
on a Roche Lightcycler 96 instrument (Roche). The protocol used was the following; 
95°C for 15 secs (1 cycle), followed by 60°C for 1 min (45 cycles). Data normalisation 
was performed using the best housekeeping genes for each experiment. Optimal 
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housekeeping genes were chosen using the NormFinder logarithm (Andersen et al., 
2004) and the standard deviation (SD) method (Mane et al., 2008). The method of 
Comparative Quantitation was used to study the expression level of ion channels with 
the following formula; 
Ct Sample – Ct Calibrator = ∆Ct 
Relative quantity = Av(2-∆Ct) 
The fold change in mRNA transcript levels between different ages was calculated 
using the ∆∆Ct method and tested for significance using ANOVA and post hoc 
Bonferroni’s tests. Statistical analysis was performed using the Prism v3.02 software 
(GraphPad).  
54 
 
2.7. Calcium Imaging 
2.7.1. Optic nerve dissection and dye loading 
Optic nerves were excised from P10-P14 wild type or PLP1-DsRed transgenic mice 
and incubated for 1 hr in aCSF containing 4 µM Fluo-4/AM (Molecular Probes) which is 
a green-fluorescent Ca2+ dye in its acetoxymethyl ester form. In this form, an 
acetoxymethyl ester group renders the dye membrane permeable. Once taken up by a 
cell, cytosolic esterases remove this ester group and the dye remains intracellular 
(Garaschuk et al., 2006).  
 
2.7.2. Imaging parameters 
Dye loaded nerves were washed in aCSF to remove excess dye, then placed in a 
perfusion chamber under a Zeiss LSM 5 Pascal Axioskop 2 confocal microscope and 
continuous perfusion with aCSF in the bath was established. A 20x/0.50 WPh2 
Achroplan water immersion lens objective was used to visualise the intracellular Ca2+ 
changes after excitation of the optic nerves at 543 nm for PLP1-DsRed and at 488 nm 
for Fluo-4. Optical z-sections (typically 7-8 sections at 2–3 µm intervals) were obtained 
using the Zeiss LSM Image Examiner software (Zeiss, Germany). Regions of interest 
(ROI) covering single-cell bodies were selected within the z-stacks and the change in 
fluorescence intensity was measured.  
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2.7.3. Typical experiment 
The nerve was continuously bathed in aCSF via a multitap system that allowed 
rapid turnover to solutions containing agents of interest, such as ATP or VU590. The 
health of the optic nerves was assessed by briefly (60 secs) inducing an ATP response 
at the beginning and end of each experiment and in the cases that [Ca2+]i increase was 
not observed in response to ATP, the nerve was excluded from analysis. In any given 
cell, the response to ATP provided a measure of the maximal rise of glial [Ca2+]i, 
irrespective of the level of Fluo4 loading (Hamilton et al., 2008). Thus, quantification of 
the change in glial [Ca2+]i could be measured as the change in fluorescence from 
baseline (∆F/F), and data expressed relative to the ATP response in the same cell, so 
that comparison can be made between treatments.  
 
2.7.4. Solutions 
 aCSF (in mM): NaCl,133; KCl, 3; CaCl2, 1.5; NaH2PO4, 1.2; MgCl2, 1.0; D-glucose. 
10; HEPES, 10; pH 7.3 NaOH. 
 ZERO-Ca2+aCSF (in mM): NaCl, 133; KCl, 3; NaH2PO4, 1.2; MgCl2, 5; D-glucose. 
10; HEPES, 10; EGTA, 1; pH 7.3 NaOH. 
 See Table 2.5 for agonists and antagonists. 
 
2.7.5. Statistical analysis 
Statistical analysis was carried out using Microsoft Excel and GraphPad Prism 6.0. 
In all experiments paired t-test or unpaired t-test with Welch’s correction for unequal 
variances were used (n=5 optic nerves and n>15 ROIs per nerve). 
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Table 2.5: List of pharmacological agonists and antagonists. 
 
 
 
 
 
 
Name 
Concentration 
used 
Function Company 
ATP (Adenosine 
5 triphosphate) 
100µM P2purinergic agonist; increases activity of Ca2+-
activated K+ channels; substrate for ATP-
dependent enzyme systems 
Sigma 
VU590 100µM Intracellular blocker of Kir7.1 and Kir1.1 Tocris 
VU591 100µM Intracellular blocker of Kir1.1 Tocris 
BaCl2 (Barium 
chloride) 
100µM 
Kir channel blocker (Ba2+) Sigma 
Verapamil 100µM L-type calcium channel blocker Tocris 
BayK 
10µM and 
100µM 
L-type Ca2+-channel activator Tocris 
Thapsigargin 
2µM and 
10µM 
Potent inhibitor of sarco-endoplasmic reticulum 
Ca2+ -ATPases 
Tocris 
2APB (2-
Aminoethoxydi
phenylborane) 
10µM and 
50µM 
D-myo-inositol 1,4,5-trisphosphate (IP3) receptor 
antagonist .  Stimulates store-operated calcium 
(SOC) release at low concentrations (< 10 μM) 
and inhibits it at higher concentrations (up to 
50 μM).  Blocks TRPC1, TRPC3, TRPC5, TRPC6, 
TRPV6, TRPM3, TRPM7, TRPM8 and TRPP2 and 
at higher concentrations stimulates TRPV1, 
TRPV2 and TRPV3. Also blocks specific gap 
channel subtypes. 
Tocris 
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Chapter 3 – Potassium Channel Profile 
of the Mouse Optic Nerve 
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3.1. Introduction and Aims 
It is now well established that astrocytes and oligodendrocytes express many of 
the same ion channels as neurons (Verkhratsky and Steinhäuser, 2000), although glial 
cells are electrically inexcitable and the precise roles for many glial ion channels have 
not been fully elucidated. The exception is the characteristic high expression of 
plasmalemmal K+ channels, which are the molecular basis of the archetypal strongly 
negative RMP in glia and their primary physiological function of K+ homeostasis (Butt 
and Kalsi, 2006). Even here, the precise K+ channels involved are unclear, although a 
key role for Kir4.1 has been demonstrated in astrocytes (Kofuji and Newman, 2004). 
Furthermore, the maturation of glial functions is related to a developmental shift from 
predominantly Kv to Kir currents (Olsen and Sontheimer, 2008), although the K+ 
channels involved have not been clearly defined in vivo. The primary aim of this section 
was to provide a comprehensive qRT-PCR analysis of developmental changes in 
potassium ion channel expression in the mouse optic nerve, a typical CNS white matter 
tract that is used as a model tissue for studying glial cell function physiology (Butt et 
al., 2004; Bolton and Butt, 2005). 
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3.2. Results 
To determine developmental changes in the transcriptome profile of the main 
potassium channels in the optic nerve, tissue was analysed in mice aged P9 (pre-
myelination), P12 (active myelination) and P35 (post-myelination/mature). mRNA 
expression levels were determined by qRT-PCR using the Mouse Neuronal Ion 
Channels RT2 Profiler™ qPCR array, which contained the primary potassium channels, 
and a custom RT² Profiler™ qPCR array for glial channels not included in the neuronal 
array, such as Kir4.1 (Sabiosciences, Qiagen). Total RNA was extracted from P9, P12 and 
P35 tissue and then used to create cDNA libraries for analysis (n=10 optic nerves for 
each experimental group, run in triplicate). The method of Relative Quantification was 
used to study the relative expression levels of ion channels and the 2-ΔΔCT method was 
used to calculate the fold changes in gene expression between the various ages tested. 
Ct values were previously normalised to the most stable housekeeping genes (see 
below). Data are presented as mean ± SEM (n=3) and were tested for significance using 
ANOVA and post hoc Bonferroni’s tests in Prism v3.02 software (GraphPad). 
Throughout the results of this section, the gene and protein names are given in the 
tables. The more commonly used protein names of the ion channels are used in the 
text and the reader is directed to the tables for the respective gene names. 
 
A limitation of this study was that whole mouse optic nerve extracts were used 
and hence it was not possible to unequivocally identify the ion channel profiles of 
specific glial cell types. qRT-PCR on purified glial cells was not feasible in the optic 
nerve, due to the large number of mice required (the present study utilised 10 mice for 
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each experimental group to obtain sufficient optic nerve RNA). Nonetheless, it has 
been previously shown that the vast bulk of the RNA in whole optic nerve extracts is 
from astrocytes and oligodendrocytes (>90% of cells), together with minor 
components from microglia and OPCs (together comprise <10% of cells), and trace 
levels from the vasculature and axons (Salter and Fern, 2005); the optic nerve does not 
contain neuronal somata. Hence, it is reasonable to conclude that the most highly 
expressed transcripts are the most important functional ion channels in astrocytes 
and/or oligodendrocytes. An important consideration is the developmental changes in 
oligodendrocytes, whereby the numbers of OPCs may be greater at P9 and decline 
thereafter as they differentiate into oligodendrocytes (Butt and Ransom, 1993), 
although OPCs persist in the adult nerve as a small stable population of ~5% of the 
cells (Butt et al., 1999). 
 
3.2.1. Determination of most stable reference genes 
The Mouse Neuronal Ion Channels RT² Profiler™ qPCR Array contained multiple 
reference genes, and the NormFinder algorithm (Andersen et al., 2004) was used to 
establish which single gene or combination of genes was the most stable and therefore 
appropriate to use for normalisation. The top five most stable options are presented in 
Figure 3.1 and a combination of two genes, Gapdh and Hsp90ab1 with a stability value 
of 0.004, was determined as the best references for normalisation. 
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 Figure 3. 1: Estimation of stability of candidate reference genes using NormFinder. Genes are ranked 
according to their expression stability across all samples. The lowest value indicates the most stable 
reference gene or combination of genes (arrow). 
 
Mane et al. (2008) demonstrated that the ideal reference genes should have a 
normal distribution across samples and a low standard deviation. In the customised 
plate for Kir4.1, statistical analysis was performed to identify reference genes with the 
lowest standard deviation of the Ct values across all optic nerve samples, which 
confirmed that Gapdh was a suitable stable gene for normalisation in the customised 
array (Figure 3.2), and allowed comparison with the Mouse Neuronal Ion Channel 
array, where Gapdh was highly stable (Figure 3.1). 
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 Figure 3. 2: Calculation of stability of candidate reference genes based on Ct stability across replicate 
samples. Genes are ranked according to their expression stability. The lowest value indicates the most 
stable reference gene (arrow).  
 
3.2.2. Voltage gated K+ channels (Kv) 
Kv channels are comprised of α and β subunits. The Kv α subunits form the channel 
conducting pore and there are 12 subtypes, Kvα1-12, which are grouped according to 
their function (e.g. delayed rectifier, A-type, etc.), and subgrouped according to their 
sequence homology (e.g. Kv1.1/KCNA1, Kv1.2/KCNA2, etc.) (Gutman et al., 2005). The 
Kv β subunits (e.g. Kvβ1/KCNAB1, Kvβ2/KCNA2, Kvβ3/KCNA3) are auxiliary proteins that 
do not have the ability to form functional channels in their own right, but associate 
with α subunits to modulate their function, in an α4β4 stoichiometry (Pongs and 
Schwarz, 2010). The main roles of Kv channels include the determination and 
maintenance of the RMP, regulation of firing patterns and shaping of action potentials 
in neurons, as well as the modulation of neurotransmitter release, and they are 
involved in ion transport in epithelial cells and glia (Hille, 2001). Tables 3.1 and 3.2 
display the Kv channels, the mRNA level of which was investigated in the optic nerve 
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for the purposes of this project, providing both the gene and protein names, and the 
results are illustrated in Figure 3.3. 
Table 3. 1: Voltage Gated K+ Channel Alpha Subunits (Kvα). 
Delayed Rectifier (slowly or non-inactivating) 
Classification Family Gene Name (Protein Name) 
Kvα1.x Shaker Kcna1 (Kv1.1), Kcna2 (Kv1.2), Kcna5 (Kv1.5), Kcna6 (Kv1.6) 
Kvα2.x Shab Kcnb1 (Kv2.1), Kcnb2 (Kv2.2) 
Kvα3.x Shaw Kcnc1 (Kv3.1), Kcnc2 (Kv3.2) 
Kvα7.x - Kcnq1 (Kv7.1), Kcnq2 (Kv7.2), Kcnq3 (Kv7.3) 
Kvα10.x - Kcnh1 (Kv10.1) 
A-Type (rapidly inactivating) 
Classification Family Gene Name (Protein Name) 
Kvα4.x Shal Kcnd2 (Kv4.2), Kcnd3 (Kv4.3) 
Slowly Activating 
Classification Family Gene Name (Protein Name) 
Kvα12.x - Kcnh3 (Kv12.2) 
Inwardly Rectifying 
Classification Family Gene Name (Protein Name) 
Kvα11.x ERG Kcnh2 (Kv11.1), Kcnh6 (Kv11.2), Kcnh7 (Kv11.3) 
Modifier/Silencer 
Classification Family Gene Name (Protein Name) 
Kvα9.x - Kcns1 (Kv9.1) 
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Table 3. 2: Voltage Gated K+ Channel Beta Subunits (Kvβ) 
Beta Subunits (Modulators) 
Classification Family Gene Name (Protein Name) 
Kvβx - Kcnab1 (Kvβ1), Kcnab2 (Kvβ2), Kcnab3 (Kvβ3) 
 
Results from the qRT-PCR array signified that the most abundant Kv channel 
subunit mRNA in the mouse optic nerve was the delayed rectifier Kv1.1, 5-times 
greater than the next most abundant, the delayed rectifier Kv1.6, and a factor greater 
than all the other transcripts (Figure 3.3). Next in rank order were the transcript levels 
of the delayed rectifiers Kv7.3 and Kv1.2, together with the A-Type channel Kv4.3, 
followed by Kv2.1, Kv7.2 and Kv4.2. Also detected at very low levels were the delayed 
rectifiers Kv2.2, Kv3.1, Kv3.2, and Kv7.1, and Kv10.1, together with the inwardly 
rectifying Kv channels Kv11.1, Kv11.2 and Kv11.3. Negative or barely detectable levels of 
transcript were observed for Kv1.5, which is reported to be expressed by OPCs 
specifically in the G1 phase of the cell cycle (Chittajallu et al., 2002, Vautier et al., 
2004), or the slowly activating Kv12.2 and the modifier Kvα subunit Kv9.1. The results 
are consistent with the literature that the Kv1.x family are ubiquitously expressed in 
glia (Olsen and Sontheimer, 2006), and indicate Kv in optic nerve astrocytes and 
oligodendrocytes are comprised mainly of Kv1.1, together with Kv1.6 and Kv1.2. 
Notably, the prominent expression of Kv7.3 may be indicative of OPCs (Wang et al., 
2011), whereas Kv7.x are reportedly lost in differentiated oligodendrocytes and have 
not been reported in astrocytes; Kv7.2/Kv7.3 are also the principle axonal delayed 
rectifier Kv at nodes of Ranvier, although the relative level of axonal expression of 
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transcripts is most likely a factor lower than that observed for Kv7.3 (0.042 + 0.002 at 
P35), as indicated by axonal Nav1.6 (0.003 + 0.0004 at P35; Figure 3.6), which is highly 
concentrated at nodes of Ranvier and initiates the action potential (Poliak and Peles, 
2003). mRNA transcripts encoding for the β subunits Kvβ1 and Kvβ2 were robustly 
expressed, as reported throughout the brain, where they are expressed with all 
members of the Kv1α-subunit subfamily (Rhodes et al., 1996), whereas Kvβ3 was barely 
detectable at any age. 
 
The expression levels of most Kv channel mRNA transcripts were virtually 
unchanged developmentally, with the exception of Kv1.1, which exhibited a clear 
developmental upregulation, increasing almost 10-fold between P9 and P35 (Figure 
3.3; p<0.01, ANOVA, followed by Bonferroni's Multiple Comparison test). However, a 
number of other Kv that were not highly expressed displayed statistically significant 
developmental regulation (p<0.05, ANOVA’s, followed by Bonferroni's Multiple 
Comparison tests); Kv4.2 was markedly downregulated between P12 and P35, whereas 
Kv7.1 and Kv11.3, which were barely detectable, were respectively downregulated and 
upregulated.  
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Figure 3. 3: Relative expression of Kv channels in the mouse optic nerve. Channels were grouped according to accepted classification. The relative expression of delayed 
rectifier Kv1.1 is illustrated in the inset, because expression levels were a factor higher than other transcripts. Tested for significance by ANOVA (**p<0.01) and post hoc 
Bonferroni's tests (*p<0.05). 
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 3.2.3. Inwardly rectifying K+ channels (Kir) 
There are seven subfamilies of Kir channels, Kir1 - Kir7, and each subfamily has 
multiple members (e.g. Kir2.1, Kir2.2, Kir2.3, etc.). In addition, Kir channels can form as 
homotetramers or heterotetramers, usually between members of the same subfamily 
(e.g. between Kir2.1 and Kir2.3), although Kir3.1 and Kir5.1 do not form functional 
homomeric channels and respectively associate with other Kir3.x or Kir4.1 to form 
functional heteromeric channels (Pessia et al., 1996; Rojas et al., 2007). Glia exhibit 
prominent and ubiquitous expression of Kir4.1, together with the Kir2.x, Kir3.1 and Kir6.x 
families, which have a primary function in K+ spatial buffering during neuronal activity 
(Butt and Kalsi, 2006; Kofuji and Newman, 2004). Table 3.3 displays the Kir channels the 
mRNA level of which was investigated in the optic nerve for the purposes of this 
project, providing both the gene and protein names, and the results are illustrated in 
Figure 3.4. 
Table 3. 3: Inwardly Rectifying K+ Channels (Kir). 
Class Classification Gene Name (Protein Name) 
Classical Kir Kir2.x Kcnj2 (Kir2.1), Kcnj12 (Kir2.2), Kcnj4 (Kir2.3), Kcnj14 (Kir2.4) 
G-Protein Coupled Kir Kir3.x Kcnj3 (Kir3.1), Kcnj6 (Kir3.2), Kcnj9 (Kir3.3), Kcnj5 (Kir3.4) 
KATP Channels Kir6.x/SUR Kcnj11 (Kir6.2) 
K+ Transport Kir 
Kir1.x Kcnj1 (Kir1.1) 
Kir4.x Kcnj10 (Kir4.1) Kcnj15 (Kir4.2) 
Kir5.x Kcnj16 (Kir5.1) 
Kir7.x Kcnj13 (Kir7.1) 
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 The rank order of the most highly expressed Kir in the Mouse Neuronal Ion 
Channel array is Kir7.1 > Kir2.1 > Kir2.2 > Kir5.1 > Kir3.1 (Figure 3.4). The high expression 
of Kir7.1 is a novel finding, whereas the remaining Kir are consistent with previous 
reports on glia (Verkhratsky and Butt, 2013). Kir4.1 is not included in the Mouse 
Neuronal Ion Channel array and was examined using a separate custom qRT-PCR array, 
and is compared with the Mouse Neuronal Ion Channel array using Gapdh as the 
housekeeping gene (inset, Figure 3.4). The results indicate Kir4.1 and Kir7.1 are 
expressed at the same level, without developmental regulation, significantly greater 
than Kir2.1 and Kir5.1 (p<0.01, ANOVA, followed by Bonferroni's Multiple Comparison 
test); notably, Kir4.1 and Kir7.1 are expressed at the same levels as Kv1.1 in the early 
postnatal nerve, but are individually significantly lower than Kv1.1 in the adult nerve. 
None of the more abundant mRNA transcripts encoding for Kir channels were 
developmentally regulated between P9 and P35 (p>0.05, ANOVA), although analysis of 
Kir4.1 in the cortex indicated a significant developmental upregulation of 4.2-fold 
between P9 and P35 (p<0.01, ANOVA, followed by Bonferroni's Multiple Comparison 
test; not illustrated). Kir2.3 was expressed at very low levels, but was significantly 
developmentally downregulated, being almost completely lost between P12 and P35 
(p<0.01, ANOVA, followed by Bonferroni's Multiple Comparison test). Similarly, Kir3.2 
was expressed at very low levels, but was apparently increased between P12 and P35, 
although not statistically significant. The remaining transcript levels for Kir examined 
were negligible (Kir1.1, Kir2.4, Kir3.3, Kir3.4, Kir6.2). 
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Figure 3. 4: Relative expression of Kir Channels in mouse optic nerve. Inset shows relative expression levels for Kir4.1, which was determined on a customised array, 
compared to the key K+ channels using Gadph as the housekeeping gene. The remaining Kir were examined using the Mouse Neuronal Ion Channels RT
2 profiler PCR array, 
using  two genes, Gapdh and Hsp90ab1, for greater accuracy. Data tested for significance by ANOVA and post hoc Bonferroni's tests (*p<0.05, **p<0.01).  
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 3.2.4. Calcium activated K+ channels (KCa) 
The KCa channel family contains 8 members and they are grouped according to 
their transmembrane domain homology and biophysical characteristics in three 
classes; BK (Big Potassium, KCa1.1α and β subunits β1-4), characterised by a large 
potassium conductance, IK (Intermediate Potassium, KCa3.1), and SK (Small Potassium, 
KCa2.1-KCa2.3), which display very small conductance. The α subunits make homo- and 
hetero-tetrameric complexes and BK channels are composed of at least two different 
subunits, the pore-forming α subunit and modulatory β subunit. Although KCa channels 
are named due to the fact that they are activated by increases in intracellular calcium, 
BK channels are also activated by transmembrane voltage changes independently of 
Ca2+, unlike SK channels which are solely gated by Ca2+. The efflux of K+ ions that occurs 
when KCa channels are opened leads to hyperpolarisation and, as a result, neuronal 
excitability is dampened. Glia display BK and SK currents, the latter being mediated 
KCa3.1 (Tiwari-Woodruff et al., 2001; Schlichter et al., 2010; Longden et al., 2011). 
Table 3.4 displays the KCa channels, the mRNA level of which was investigated in the 
optic nerve for the purposes of this project, providing both the gene and protein 
names, and the results are illustrated in Figure 3.5. 
Table 3. 4: Calcium Activated K+ Channels (KCa). 
Class Classification Gene Name (Protein Name) 
BK Channel – Alpha Subunit KCa1.1 Kcnma1 (KCa1.1) 
BK Channel – Beta Subunit  Kcnmb4 (KCa Subunit β4) 
SK Channel KCa2.x Kcnn1 (KCa2.1), Kcnn2 (KCa2.2), Kcnn3 (KCa2.3) 
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  All the KCa channel transcripts investigated were present in the mouse optic 
nerve (Figure 3.5), the most prominent being the BK channel KCaβ4 subunit, which was 
significantly developmentally downregulated (p<0.05, ANOVA, followed by 
Bonferroni's Multiple Comparison test). At P35 all KCa channel transcripts tested were 
expressed at similar levels (Figure 3.5). 
 
 
Figure 3. 5: Expression of Calcium Activated K+ Channels (KCa) in mouse optic nerve. Tested for 
significance by ANOVA and post hoc Bonferroni's tests (*p<0.05). 
 
3.2.5. Voltage gated Na+ channels (Nav) 
Voltage gated sodium channels (Nav channels) are generally associated with 
initiating the neuronal action potential, but are also ubiquitous in astrocytes and 
oligodendrocytes (Olsen and Sontheimer, 2005; De Biase et al., 2010). Nav channels 
comprise an α subunit, which have 9 members (Nav1.1-1.9) and form the channel pore 
and voltage sensing apparatus, together with associated β subunits (Navβ1-4), which 
link the channel to the cytoskeleton and modulate its gating properties. Table 3.5 
displays the Nav channels, the mRNA level of which was investigated in the optic nerve 
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 for the purposes of this project, providing both the gene and protein names, and the 
results are illustrated in Figure 3.6.  
  
Table 3. 5: Voltage Gated Na+ Channels 
Classification Gene Name (Protein Name) 
Nav1.x Scn1a (Nav1.1), Scn2a (Nav1.2), Scn3a (Nav1.3), Scn8a (Nav1.6), Scn9a 
(Nav1.7), Scn10a (Nav1.8), Scn11a (Nav1.9) 
Beta Subunits Scn1b (Nav Subunit β1) , Scn2b (Nav Subunit β2) 
 
 
The most abundant Nav channel transcripts in the mouse optic nerve were the β 
and α subunits Navβ1 and Nav1.2, followed by the Navβ2 subunit and Nav1.3 and 
Nav1.6 α subunits (Figure 3.6); the remaining Nav channel transcripts tested were 
barely detectable or not present. We found no significant developmental regulation of 
Nav channels but there is a downregulation trend; consistent with these findings in the 
optic nerve, astrocytes and OPCs/oligodendrocytes have been reported to specifically 
express Navβ1 with Nav1.2, Nav1.3, and Nav1.6, with evidence that Nav1.3 mRNA is 
downregulated as OPCs differentiate into myelinating oligodendrocytes (De Biase et 
al., 2010). In addition, axonal mRNA can be detected in optic nerve extracts (Salter and 
Fern, 2005) and it is possible that some message for Nav reflects their axonal 
concentration at nodes of Ranvier, where they are responsible for action potential 
initiation. However, mature nodes are characterised by Nav1.6 (Rasband et al., 1999; 
Boiko et al., 2001; Kaplan et al., 2001), and the low level of Nav1.6 detected in the P35 
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 samples is consistent with the vast bulk of transcripts in this analysis of optic nerve 
extracts being glial with an ultralow ‘contamination’ of axonal mRNA. 
 
Figure 3. 6: Expression of Voltage Gated Na+ Channels (Nav) in mouse optic nerve. No significant 
developmental changes were found when tested for significance by ANOVA and post hoc Bonferroni's 
tests. 
 
3.2.6. Acid Sensing Ion Channels (ASIC) 
Acid sensing ion channels (ASIC) are related to the larger family of Epithelial 
Sodium/Degenerin Channels (ENaC/Deg). They are voltage independent cation 
channels with preference for Na+ and Ca2+ and they are activated by extracellular [H+]. 
There are four known subunits and all but ASIC3 are believed to be expressed in the 
CNS (Jasti et al., 2007; Carattino, 2011). Table 3.6 displays the ASICs, the mRNA level of 
which was investigated in the optic nerve for the purposes of this project, providing 
both the gene and protein names, and the results are illustrated in Figure 3.7.     
Table 3. 6: Acid Sensing Ion Channels (ASIC). 
Classification Gene Name (Protein Name) 
Asicx Accn1 (ASIC1), Accn2 (ASIC2), Accn3 (ASIC3) 
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 Asic1 is the most abundant mRNA transcript in the optic nerve, followed by Asic2, 
whilst mRNA for Asic3 is barely detectable (Figure 3.7). ASIC1 was significantly 
developmentally downregulated (p<0.05, ANOVA, followed by Bonferroni's Multiple 
Comparison test) and levels of all ASIC transcripts were very low at P35. Interestingly, 
Asic1 channel protein and mRNA transcript is expressed by OPCs and is downregulated 
during their differentiation into myelinating oligodendrocytes (Feldman et al., 2008). 
Astrocytes have been reported to express all 3 ASICs (Huang et al., 2010). 
 
Figure 3. 7: Expression of Acid Sensitive Ion Channels (ASIC) in mouse optic nerve. Tested for 
significance by ANOVA and post hoc Bonferroni's tests (*p<0.05). 
 
3.2.7. Key developmental changes in optic nerve ion channels  
Volcano plot analysis (Sabiosciences Rt2 Array Data Analysis) was used to identify 
the ion channels that were significantly (unrelated t-test, p<0.05) developmentally 
regulated greater than 2-fold between P9 and P35 (Table 3.7). The results indicate an 
overall developmental downregulation ASIC and KCa, and upregulation of both Kv and 
Kir, whereas Nav were not altered overall (Figure 3.8). 
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Table 3. 7: Developmentally regulated ion channel transcripts in the mouse optic nerve. Data was 
obtained by qRT-PCR analysis of 3 biological replicates (n=10 optic nerves per group) of acutely isolated 
optic nerves from mice aged P9 compared to P35. Statistical analysis was performed by volcano plot 
(Sabiosciences Rt2 Array Data Analysis) (unrelated t-test P<0.05; FC>2.0). 
Ion Channel Regulation p-value  Ion Channel Regulation p-value 
Kv1.1 ↑ 9.8 0.0097  Kv7.1 ↓ -3.1 0.0283 
Kv11.3 ↑ 2.3 0.0455  Kv4.2 ↓ -2.9 0.0064 
    Kv10.1 ↓ -2.8 0.0145 
    KCa2.3 ↓ -2.7 0.0208 
    KCaγ4 ↓ -2.7 0.0296 
    Asic1 ↓ -2.5 0.0069 
    Kir4.2 ↓ -2.4 0.0060 
    Kir6.2 ↓ -2.1 0.0229 
    Nav1.3 ↓ -2.1 0.0260 
 
 
 
 
Figure 3. 8: Key developmental changes in optic nerve K+ and Na+ channels. Data are presented as 
collective relative expression of the different ion channel families, to illustrate the proportional change 
in gene expression from P9 to adulthood. 
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 3.3. Discussion 
Astrocytes and oligodendrocytes have been shown to express a wide range of ion 
channels in vitro and in vivo using electromolecular biological techniques in a variety of 
preparations (see Chapter 1 and Verkhratsky and Butt, 2013). An important feature of 
glial cells is that their ion channel expression is regionally diverse and developmentally 
regulated. In this section, I have provided the potassium ion channel profile of the 
postnatal and adult optic nerve, which is summarised in Table 3.8.  The optic nerve is 
widely used as a model of white matter tissue for studying glial cell development and 
function, because it comprises mainly astrocytes and oligodendrocytes, whose 
functions are to support and myelinate the axons of retinal ganglion cells (Butt et al., 
2004). The results demonstrate that optic nerve glia express a preponderance of 
delayed rectifier Kv and inward rectifier Kir channels, the mRNA levels of which 
together comprise >50% of the transcripts in the optic nerve. Kir4.1 was one the most 
highly expressed transcripts at all ages, supporting a principle role for this channel in 
glia (Butt and Kalsi, 2006). A key novel finding is an equivalent high level of expression 
of Kir7.1, which has not previously been identified in glia. In addition, there was a 
marked developmental upregulation of the outwardly rectifying (voltage-dependent) 
Kv1.1 channel. Kv are abundant in astrocytes, but they are generally considered to be 
down-regulated during astrocyte differentiation, whereas transcripts for Kv1.1 are the 
most highly expressed in the adult optic nerve. This study identifies Kv1.1, Kir4.1 and 
Kir7.1 as the molecular basis of the characteristic high K+ resting membrane 
conductance of glia, which determines the strongly negative RMP that underpins glial 
physiological functions. 
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 3.3.1. Accuracy of the qRT-PCR analysis 
There are a number of important considerations when examining the qRT-PCR 
results, which determine the overall accuracy of the data and their interpretation. 
Probably the most important methodological variable is differences between samples 
in terms of the quantity of starting material (RNA) and the efficiency of enzymes (e.g. 
polymerase). In this project, this variability was addressed by normalisation to 
housekeeping (reference) genes that were included and ran on the same PCR arrays as 
the target genes. Other methods of normalisation were not practicable, such as 
normalisation to the original number of cells, which is only applicable to cultured cells 
and blood samples (Bustin, 2000), or normalisation to the total RNA quantity, which in 
itself can lead to inaccuracies due to differences in rRNA/mRNA ratios between 
samples (Solinas et al., 2001) and spectrophotometric (A260) RNA quantification 
inaccuracies (Bustin, 2002). Multiple endogenous reference genes were examined (i.e. 
Gapdh, Hsp90ab1 and Rpl13a), since this addressed the potential issue that any one 
reference gene may not be expressed constantly and at the same level between 
samples and experimental conditions (Cook et al., 2009). The Qiagen arrays 
(Sabiosciences) used in this thesis determined gene expression by the Relative 
Quantification method, where the quantity of genes of interest are expressed relative 
to reference genes within the same sample, as opposed to Absolute Quantification, 
where the exact number of copies of a gene of interest is calculated. The most 
appropriate reference genes that were constantly present and stably expressed in all 
samples were selected by the standard deviation method, in combination with the 
NormFinder algorithm (Casadei et al., 2011). The optimal way to determine the most 
appropriate reference genes with the lowest difference between samples would be to 
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 use RNA sequencing or to run a variety of candidate reference genes in triplicates for 
all samples and different experimental conditions. These methods were not feasible in 
my study because of the large number of mice that would require. Nonetheless, the 
three reference genes used were expressed in a highly constant and stable manner in 
all samples and therefore the results were considered accurate. Gapdh is the most 
widely used reference gene across the literature and has been shown to be the most 
stable gene in the mouse brain during development and in ageing (Kraemer et al., 
2012; Sieber et al., 2010), consistent with the findings of my analysis. In addition, I 
determined that Hsp90ab1 was optimal in combination with Gapdh in the Mouse 
Neuronal Ion Channels RT2 profiler PCR array; Hsp90ab1 is a member of the heat shock 
protein 90 family and was previously found to be among the five most stable genes in 
mouse tissue out of 13 genes tested (Wang et al., 2010).  
 
3.3.2. Relative levels of mRNA as a measurement of functional glial ion 
channels 
The relative quantification and 2-ΔΔCT method used here are the simplest and most 
commonly used methods for accurately determining relative expression levels and 
changes in expression of transcripts. This technique should only be used if PCR 
efficiencies for the target and reference genes are close to 100% (Schmittgen and 
Livak, 2008), and this was confirmed in my samples using three positive PCR controls in 
each array, run for all replicate samples. However, an important consideration when 
interpreting the data is how well the relative levels of mRNA reflect expression of 
functional ion channel proteins. The qRT-PCR method is extremely sensitive, and the 
presence of a small amount of mRNA is unlikely to represent a functionally important 
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 ion channel. In addition, there are many different post-transcriptional and post-
translational regulatory mechanisms that may lead to mismatches between mRNA and 
protein levels (Greenbaum et al., 2003; Vogel and Marcotte, 2012). For example, 
functional Kir4.1 expression has been shown to be dynamically regulated by cAMP in 
optic nerve glia (Bolton et al., 2006; Bolton and Butt, 2006), and multiple regulatory 
mechanisms regulate protein translation and subsequent targeting of K+ channels to 
the plasmalemma, and their biophysical properties will be further regulated by diverse 
intracellular and extracellular factors including ancillary proteins (Heusser and 
Scwappach, 2005; Ruppersberg, 2000). Nonetheless, with this caveat in mind, the most 
highly expressed transcripts are likely to be the most important functional ion channels 
in optic nerve glia. 
 
A further limitation is that whole mouse optic nerve extracts were analysed and 
the ion channel profiles of specific glial cell types could not be determined. It was not 
feasible to perform comprehensive qRT-PCR on purified glial cells using ion channel 
arrays, due to the large numbers of mice this would require. However, this could now 
be performed in future studies for the key ion channels identified in my study. 
Nonetheless, the vast bulk (>90% of cells) of the RNA extracted in whole optic nerves is 
from astrocytes and oligodendrocytes (Salter and Fern, 2005). Hence, it can be 
hypothesised that the most highly expressed genes identified in my study, such as 
Kv1.1 and Kir4.1, are the most important functional ion channel proteins in astrocytes 
and/or oligodendrocytes. This is supported by an analysis of the relative levels of 
expression of a group of the known major glial Kv and Kir channels in comparison with 
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 the main axonal channel Nav1.6, which is localised to nodes of Ranvier and not 
reported in glia, together with Cav3.1 and KCa2.3, which are constitutively expressed by 
OPCs and microglia, respectively, but are not prominent in astrocytes or 
oligodendrocytes (Figure 3.9). This analysis suggests that a relative expression level of 
~0.03 represents the lower limit of the main astrocyte and oligodendrocyte channels, 
whilst channels in OPCs and microglia are detected at relative expression levels of 
>0.01, and channels with relative expression values <0.005 reflect contamination from 
non-glial sources. On this basis, the main channels expressed by optic nerve glia are 
given in Table 3.8. However, it should be noted that some channels reported to be 
expressed by glia, such as Kv1.4 and KCa3.1, were not present in the arrays used here, 
but a recent microarray study performed in our lab did not find either to be 
significantly expressed in the adult optic nerve (Rivera, 2014).  
 
Figure 3. 9: Comparison of relative expression levels of the main glial Kv and Kir with the main axonal 
channel Nav1.6, together with Cav3.1 and KCa2.3, which are constitutively expressed by OPCs and 
microglia, respectively, but are not prominent in astrocytes or oligodendrocytes. 
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 Table 3. 8: Main ion channels expressed by optic nerve glia. 
 ------------Astrocytes/Oligodendrocytes--------------/------ OPC/Microglia--------- Developmental 
Change 
Kv Kv1.1 >> Kv1.6  > Kv7.3 >> Kv1.2  > Kv2.1  = Kv4.3 > Kv4.2 
Kv1.1 strongly 
upregulated 
Kir Kir4.1  = Kir7.1  > Kir2.1  > Kir2.2  > Kir5.1  > Kir3.1 > Kir3.2 Not regulated 
Kca 
    
KCaβ4  > KCa2.3> KCa2.2 Downregulated 
Nav 
   
Nav1β Nav1.2> Nav1.3 
 
Downregulated 
ASIC 
    
ASIC1 > ASIC2 
 
ASIC1 
downregulated 
 
3.3.3. Voltage Gated Potassium Channels (Kv) 
Diverse delayed rectifier and rapidly inactivating A-type Kv were strongly 
expressed in the optic nerve with a rank order of Kv1.1 >> Kv1.6 > Kv7.3 >> Kv1.2 > Kv2.1 
= Kv4.3 > Kv4.2. Only Kv1.1 and Kv4.2 were significantly developmentally regulated, with 
a marked 6-fold upregulation of Kv1.1, and 3-fold downregulation of Kv4.2 to below the 
‘glial threshold’.   
 
With respect to the delayed rectifying Kv, our results are largely consistent with 
studies in astrocytes showing they mainly express transcripts for Kv1.1 and Kv1.6, as 
well as Kv1.2, Kv2.1 and Kv7.3 (Smart et al., 1997). These results agree with a 
microarray study in our lab, in which RNA encoding for Kv1.1 was identified as the most 
highly expressed among Kv channel transcripts in the adult optic nerve (Rivera, 2014).  
In addition, Kv1.1 is expressed from early on in development; it has been reported in 
radial glia of the ventricular zone as early as E9.5, with immunoreactivity peaking in 
glial precursors and radial glia of the subventricular zone (Hallows and Tempel, 1998). 
Similarly, transcripts for Kv1.1, Kv1.2, Kv1.5 and Kv1.6 were detected by single cell RT-
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 PCR in mouse cultured OPCs, and protein expression was confirmed by 
immunocytochemistry for Kv1.5 and Kv1.6, whereas immunopositivity for Kv1.1 was 
only seen in a small subset of cells, and Kv1.2 was negative for protein expression 
(Attali et al., 1997). Moreover, the current profile of OPCs was not found to be 
dependent on Kv1.1 (Schmidt et al., 1999; Tiwari-Woodruff et al., 2006). At the mRNA 
level, Kv1.5 and Kv1.6 were downregulated during OPC differentiation, and Kv1.2 
protein in mature cultured oligodendrocytes was confirmed by Western Blot (Attali et 
al., 1997), which correlates with our finding of significant Kv1.2 levels at the mRNA 
level in the optic nerve. In addition, Kv1.2 and Kv1.6 are expressed at low levels in 
‘resting’ microglia, while early migrating microglia express Kv1.1 and Kv1.2 (Kotecha 
and Schlichter, 1999). It should be noted that Kv1.1 and Kv1.2 are known to be 
colocalised in high density clusters in the axolemma in the juxtaparanodal region of 
nodes of Ranvier (Bhat et al., 2001; Robbins and Tempel, 2012), where they have been 
shown to form heterotetramers (Utsunomiya et al., 2008). Colocalised expression of 
Kv1.1, Kv1.2 and Kv1.6 in clusters was also found in juxtaparanodes of adult rat optic 
nerves (Rasband et al., 1999).  It is possible that low levels of axonal transcripts for 
these channels are detected in my analysis, but these are likely to be negligible in 
relation to glial expression, as indicated by the ultralow levels of nodal Nav1.6 detected 
in my samples (Figure 3.10).  
 
The Kvβ1 and Kvβ2 subunits were also strongly expressed in the optic nerve and 
are closely associated with Kvα subunits: Kvβ1 associates extensively with Kv1.1 and 
Kv1.4 in neurons (Rhodes et al., 1997), and Kvβ2 colocalises with Kv1.1 and Kv1.2 at 
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 juxtaparanodal regions, which has been shown in mouse optic nerve (Poliak et al., 
2003) and spinal cord (Jukkola et al., 2012). More recently, Kvβ2 was shown to interact 
with TRPV1 (Bavassano et al., 2013). To our knowledge, glial expression of Kvβ subunits 
has only been reported in cultured hippocampal astrocytes (Bekar et al., 2005). Since 
astrocytes and oligodendrocytes express Kv1.1 and Kv1.2, it is likely that Kvβ1 and Kvβ2 
are associated with these channels and regulate their function/localisation. 
 
In addition, relatively high levels of Kv2.1 mRNA were detected and were not 
developmentally regulated. Kv2.1 protein is absent from axons in the mouse cortex and 
hippocampus (Du et al., 1998), but forms clusters on neuronal cell bodies adjacent to 
astrocytic processes, which play a significant role in rapidly removing extracellular K+ 
after an action potential and in neuroprotection during ischaemia (Misonou et al., 
2008). It is possible that Kv2.1 is expressed in a similar functional manner at perinodal 
astrocyte processes. Oligodendrocytes may also express Kv2.1, which has been linked 
with myelination in the PNS (Peretz et al., 2000).  
 
Strong expression of Kv7.3 mRNA as the third most abundant Kv in the optic nerve 
was also found at all ages. Delayed rectifier Kv7.2 and Kv7.3 channels have recently 
been reported in oligodendrocyte lineage cells at all stages of development (Wang et 
al., 2011), supporting our findings that Kv7.3 mRNA levels are relatively high, indicating 
expression in a major glial population. Heteromers of Kv7.2 and Kv7.3 are also highly 
expressed at nodes of Ranvier (Gómez-Posada et al., 2010), and the very low levels of 
Kv7.2 detected in my samples may reflect axonal mRNA, whereas the high levels of 
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 Kv7.3 in comparison are likely to be glial. High densities of Kv7.2 and Kv7.3 have been 
found in the axon initial segment (AIS) of CA1 hippocampal neurons, where they are 
bound to Ankyrin G thus colocalising with Na+ channels (Chung et al., 2006; Pan et al., 
2006; Rasmussen et al., 2007). These subunits form the low-threshold voltage-gated K+ 
channel originally termed “M-channel” due to the fact that it is inhibited by muscarinic 
acetylcholine receptor (mAChR) agonists. Due to their activation at sub-threshold 
potentials (≈ -60mV) and the fact that they do not inactivate, they are considered to be 
involved in stabilizing both the neuron’s resting membrane potential and to regulate 
the action potential threshold thus controlling over-excitability. Expression of Kv7.3 in 
glia could also be an indication of its involvement in regulating the resting membrane 
potential, especially in immature oligodendrocytes which have not yet developed the 
Kir channel profile that characterizes the fully differentiated myelinating 
oligodendrocytes (Brown and Passmore, 2009). Kv7.1 has been studied in the choroid 
plexus epithelium (Roepke et al, 2011), in the heart, where it has been linked with 
cardiac arrhythmias (Wang et al, 1996) and in the stria vascularis of the cochlear duct 
(Yanget al, 2013) but it is not among the axonal Kcnqx subtypes (Padillaet al, 2009).  
The low levels of Kv7.1 that we found in the optic nerve could actually be from its 
expression in the vascular endothelium. 
 
The rapidly inactivating A-type channel Kv4.3 was also amongst the top Kv channels 
expressed at the mRNA level in the optic nerve. This correlates well with reports of 
astrocyte Kv4.3 expression (Bekar et al., 2005). Bekar et al. (2005) showed that 70% of 
total inactivating currents in cultured rat hippocampal astrocytes are associated with 
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 the Kv4.x family and intense staining for Kv4.3 was demonstrated throughout the 
astrocytic cell somata and processes (Bekar et al., 2005). The Kv4.2 protein has not 
been reported on glia, but is found on somato-dendritic regions of neurons and not 
axons (Kerti et al., 2012). Neurons are not present in the optic nerve, and so the 
relatively high level of mRNA encoding for Kv4.2 detected in the optic nerve seems 
likely to reflect glial expression. Moreover, the significant downregulation of Kv4.2 
transcript post-myelination suggests that it may be expressed by developing OPCs. 
 
Notably, the slowly-activating Kv12.2 and inwardly rectifying Kv11.x (ERG) channels 
were absent or barely detectable in the optic nerve. ERG-type currents have been 
detected in hippocampal astrocytes, where they were implicated in [K+]o clearance, 
and there is immunohistochemical and RT-PCR evidence that cortical astrocytes 
specifically express Kv11.1 (Emmi et al., 2000). However, these channels do not appear 
to be highly expressed in the optic nerve, with only Kv11.3 being slightly upregulated 
post-myelination. It is likely that inwardly rectifying Kv are regionally expressed, as 
demonstrated for many other astrocyte channels, including Kir4.1 in astrocytes, and 
reflects the different K+ clearance requirements between different regions (Olsen et al, 
2007).  
 
The functional role of Kv channels in astrocytes and oligodendrocytes is not 
absolutely clear, but they are generally considered to be negatively linked with 
differentiation (Sontheimer et al., 1989; Berger et al., 1991; Gallo et al., 1996; Knutson 
et al., 1997). A key finding is that we did not observe an overall developmental 
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 downregulation of Kv, due to the prominence of Kv1.1, which was markedly 
upregulated with development. Nonetheless, we did observe a 3-fold downregulation 
of Kv4.2 between P12 and P35, which is worthy of further study, since it has been 
reported in astrocytes and is implicated in epilepsy (Aronica et al., 2009). Interestingly, 
Kv1.5 is reported to be selectively upregulated with Kv1.3 in OPCs and plays a central 
role in promoting their proliferation (Chittajallu et al., 2002; Vautier et al., 2004; 
Soliven et al., 2003), but Kv1.5 was not detected in the optic nerve at any age; Kv1.3 
was not included in the arrays used in my study, but a microarray study performed in 
our lab supported the finding of this section and called Kv1.3 and Kv1.5 as absent or 
barely detectable (Rivera, 2014). These results suggest many of the Kv may be 
downregulated prior to P9, when the majority of astrocytes and oligodendrocytes are 
generated (Butt and Ransom, 1993; Barres and Raff, 1993). These possibilities should 
be examined in younger nerves. Nonetheless, the developmental upregulation of Kv1.1 
is a completely novel finding and it seems highly likely that Kv1.1 are important for 
maintaining the RMP of optic nerve glia and in their primary function of [K+]o 
regulation, which future studies should examine using immunohistochemical and 
electrophysiological techniques. 
 
3.3.4. Inward Rectifying Potassium Channels (Kir) 
 Most of the Kir examined were detected in the optic nerve, with a rank order of 
Kir4.1 = Kir7.1 > Kir2.1 > Kir2.2 > Kir5.1 > Kir3.1 > Kir3.2. The strong and widespread 
expression of the Kir4.1 channel subunit throughout the CNS first indicated a key role 
for this channel in glial function (Butt et al., 2005; Hibino et al., 2010). Further studies 
proved beyond doubt that astrocytes and oligodendrocytes of white matter tracts such 
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 as the optic nerve express the Kir4.1 channel from P5 (Li et al., 2001; Ishii et al., 2003; 
Kalsi et al., 2004), with western blot and qPCR results showing concomitant protein 
and transcript up-regulation during development (Nwaobi et al., 2014). Positive 
immunolabelling and mRNA expression has been established in astrocytes and 
oligodendrocytes (Olsen and Sontheimer, 2008; Osawa et al., 2009; Bichet et al., 2003; 
Higashi et al., 2001; Greenwood et al., 2005; Poopalasundaram et al., 2000), as well as 
in retinal glia (Kofuji et al., 2002). The results of this section corroborate these earlier 
findings that Kir4.1 is an archetypal glial K+ channel.  
 
The most novel finding of this study was the high expression of Kir7.1, which has 
not previously been reported in astrocytes or oligodendrocytes. Kir7.1 expression has 
been demonstrated in cerebellar Purkinje neurons and pyramidal neurons of the 
hippocampus, and a role in K+ transport in the choroid plexus has been established 
(Krapivinsky et al., 1998). It is also known that Kir7.1 plays a significant role in K+ 
transport in the retinal pigment epithelium (Yang et al., 2008). In my study, mRNA 
transcripts for Kir7.1 displayed the highest relative expression with Kir4.1, and second 
only to transcripts encoding for Kv1.1 in the adult nerve. No significant developmental 
regulation of Kir7.1 was evident, suggesting it plays a prominent role in glial cell 
physiology throughout life. 
 
 High mRNA levels for the strongly rectifying Kir2.1 and Kir2.2 channels was also 
detected in the optic nerve, which have been previously reported in retinal Müller glia 
and hippocampal astrocytes at the mRNA level (Schröder et al., 2002). Protein 
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 expression has been shown for Kir2.1 in Müller glia (Kofuji et al., 2002) and Kir2.2 in 
Bergmann glia and cerebellar astrocytes (Leonoudakis et al., 2001). Heterogeneous 
expression of Kir2.1, Kir2.2 and Kir2.3 was also reported in astrocytes of the forebrain 
and hindbrain (Stonehouse et al., 1999), while expression of Kir2.3 has been reported in 
hippocampal astrocytes in situ (Schröder et al., 2002) and in vitro (Perillán et al., 2000). 
In my study, mRNA levels for Kir2.3 were very low and they are unlikely to be important 
in optic nerve glia. Kir2.1 and Kir2.3 have previously been reported to be extensively 
expressed in somata of RGCs but not in dendrites or axons (Chen et al., 2004), which 
supports high levels of Kir2.1 in the optic nerve being exclusively glial. Interestingly, 
Kir2.1 is also reported to form heteromers with Kir4.1 and this has been detected in our 
lab by immunolabelling and co-immunoprecipitation (Brasko, 2013). 
  
 The detection of Kir5.1 also agrees with findings from past studies in retinal and 
brain astrocytes (Raap et al., 2002). The Kir5.1 subunits do not form functional 
homomeric channels, but selectively heteromerise with Kir4.1 to form functional 
channels with distinctive rectification and kinetic properties (Hibino et al., 2004; Pessia 
et al., 1996; Casamassima et al., 2003). Double immunolabelling for Kir4.1 and Kir5.1 
performed in our laboratory indicated that these subunits are colocalised to a high 
degree in optic nerve astrocytes and oligodendrocytes in situ and in vitro (Brasko, 
2013). 
 
 The G-protein coupled channels Kir3.1 and Kir3.2 were expressed at very low 
levels, indicative of OPCs and microglia, or very low expression in astrocytes and 
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 oligodendrocytes. Immunopositivity as well as electrophysiological evidence for Kir3.1 
has been shown in astrocytes in vitro (Britz et al., 2005), but expression was negative 
for Kir3.1, Kir3.2 and Kir3.3 at the protein level in Müller glia in situ (Skatchkov et al., 
2002). Kir3.2 expression has been previously reported on RGC axons (Chen et al., 2004), 
so it is possible that the low mRNA levels we observed for this channel reflect axonal 
transcripts. Inwardly rectifying K+ currents were reported in microglia more than two 
decades ago (Brockhaus et al., 1993; Walz et al., 1993; Nörenberg et al., 1994a; Fischer 
et al., 1995), but Kir are not expressed in resting microglia and they have come to be 
considered as an early marker of microglial activation (Lyons et al., 2000). 
 
 The primary function of Kir channels in glia is in the regulation of K+ (Kofuji and 
Newman, 2004). Specifically, studies using global knock-out and targeted deletion in 
astrocytes have demonstrated Kir4.1 are critical for K+ regulation (Olsen and 
Sontheimer, 2008; Bay and Butt, 2012; Chever et al., 2010). Moreover, Kir4.1 is 
essential for generating the glial RMP and its ablation results in hypomyelination 
(Neusch et al., 2000). In addition, my analysis identified Kir7.1 as potentially being 
important in these glial functions. Moreover, Kir were not developmentally 
upregulated between P9 and P35, consistent with a previous Kir4.1 expression study in 
the optic nerve (Kalsi et al., 2004). A developmental increase in Kir currents is 
important in the maturation of oligodendrocytes and astrocytes in other brain regions 
(Knutson et al., 1997; Sontheimer et al., 1989; Seifert et al., 2009), and we observed 
upregulation of Kir4.1 in the cortex (not illustrated), where glia mature later than in the 
optic nerve. Developmental changes in Kir may occur prior to P9 in the optic nerve, 
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 during the major period of glial differentiation (Butt and Ransom, 1993; Barres and 
Raff, 1993), which requires further examination.   
 
3.3.5. Calcium Activated Potassium Channels (KCa) 
The KCa channel β4 subunit was strongly expressed in the optic nerve, together 
with the SK α subunits KCa2.2 and KCa2.3, whereas the BK KCa1.1 subunit was expressed 
at a low level, equivalent to axonal Nav1.6. This suggests optic nerve glial KCa comprise 
mainly SK2 and SK3 channels, although the high level of β4 subunits implies multimeric 
KCaα1.1/β4 BK channels may be functional in the optic nerve; the auxiliary β4 subunit is 
the primary neuronal subunit and by associating with KCaα1.1 endows it with greater 
Ca2+ sensitivity, and shifts the voltage range of current activation to more negative 
potentials than the auxiliary β1 subunit (Behrens et al., 2000), which would make these 
channels in glia more active under physiological conditions. Pharmacological studies in 
the optic nerve did not indicate KCa in regulating action potential conduction (Gordon 
et al., 1988; Gordon et al., 1990), and so the low levels of KCa transcripts most likely 
reflect glial expression. Astrocytes exhibit both BK and SK currents in vitro and in situ in 
postnatal brain slices, and KCa2.3 (SK3) expression has been shown in astrocytes of the 
supraoptic nucleus (Armstrong  et al., 2005). The BK channel β4 subunit has been 
reported in cultured astrocytes (Gebremedhin et al., 2003) and it is known to interact 
with the BK α subunit KCa1.1, which was expressed at very low levels in the optic nerve 
and seems unlikely to be of major importance in astrocytes. The relatively low levels of 
KCa transcripts in the whole optic nerve tissue might obscure high expression in a small 
population of cells, in which case the developmental downregulation observed could 
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 be very important in this specific cell population. This is consistent with evidence that 
OPCs express KCa currents that diminish as they differentiate into oligodendrocytes 
(Bevan et al., 1987; Sontheimer et al., 1989; Verkhratsky and Steinhäuser, 2000). In 
addition, microglia constitutively express KCa2.3 (SK3) in situ in the healthy adult 
striatum, and their blockade inhibits their activation (Schlichter et al., 2010).  
 
3.3.6. Voltage Gated Sodium Channels (Nav) 
Glial cells express Nav channels with similar properties as those found in neurons. 
The function of glial Nav channels has not been resolved, but their downregulation in 
mature astrocytes and oligodendrocytes, as well as their high levels of expression in 
tumours of glial origin are thought to suggest an involvement in the control of cell 
proliferation, differentiation and even migration (Karadottir et al, 2008; Verkhratsky 
and Butt, 2013). As observed for KCa, mRNA transcripts encoding for the β subunits of 
Nav were more highly expressed than the α subunits, which had a rank order of Nav1.2 
>> Nav1.3 > Nav1.6, although Nav1.3 transcript levels were greater in postnatal nerves. 
Nav1.6 is the main Na+ channel isoform at adult nodes of Ranvier, whereas Nav1.2 and 
the β2 subunit, but not Nav1.6 or the β1 subunit, are clustered in developing nodes 
(Kaplan et al., 2001). The clustering of Nav1.6 channels is induced by myelination and 
occurs after P9 (Kaplan et al., 2001; Rasband et al., 1999). Equivalent developmental 
changes were not detected in optic nerve transcript levels of Nav1.2 and Nav1.6 or 
their β1 and β2 subunits, indicating the transcripts are of glial origin. It cannot be 
excluded that the low level of Nav1.6 transcript in the optic nerve may reflect axonal 
mRNA, since Nav1.6 has not been reported in glia, but Navα1.2/β1 seems likely to 
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 represent glia (Verkhratsky and Butt, 2013). Voltage-gated Na+ currents have been 
recorded in situ and in vitro in astrocytes isolated from hippocampus, spinal cord and 
the optic nerve (Sontheimer et al., 1996), and Nav1.2 mRNA transcripts have been 
demonstrated in rat astrocytes in vitro and in vivo (Oh et al., 1994; Steinhäuser and 
Seifert, 2002). In situ, immunopositivity was found for Nav1.2 in astrocytes (Black et al., 
1994), consistent with my findings in the optic nerve. Furthermore, immunopositivity 
for Nav has been detected in astrocyte perinodal processes (Sontheimer et al., 1996), 
suggesting they are involved in ion regulation at nodes of Ranvier. In addition, the 
relatively low level of expression and the developmental downregulation of Nav1.3 is 
consistent with the loss of voltage-gated Na+ currents in OPCs when they differentiate 
into oligodendrocytes (Káradóttir et al., 2008; Chen et al., 2008; De Biase et al., 2010).  
Glia are electrically inexcitable and the function of Nav is unknown. Intracellular 
Na+ fluctuations in which Nav are involved may be important for the ability of 
astrocytes to clear K+ from the extracellular space during action potential propagation 
(Kofuji and Newman, 2009). An early hypothesis was that Na+ influx through Nav 
channels might be important for maintaining the activity of the Na+/K+ pump 
(Sontheimer et al., 1994), although reports are contradictory on whether Nav channels 
allow significant Na+ influx into astrocytes under resting conditions (Verkhratsky and 
Steinhäuser, 2000; Rose and Karus, 2013). In addition, the Navβ1 subunit was highly 
expressed and as well as modulating Nav function, serves as a cell adhesion molecule 
(CAM) (Chen et al., 2007). Nav1β has been shown to mediate neurite outgrowth in the 
CNS postnatally (Brackenbury et al., 2008) and knock out mice were shown to have less 
severe EAE symptoms compared to wild type due to axonal sparing (O'Malley et al., 
2009). Additionally, Navβ1 expression was demonstrated in cultured rat astrocytes 
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 after treatment with cAMP (Oh et al., 1997), raising the possibility that it may act as a 
CAM in these cells. 
 
3.3.7. Acid Sensing Ion Channels 
Asic1 and Asic2 were expressed in the optic nerve, and the former was 
significantly and markedly developmentally downregulated, so that both were barely 
expressed in the adult nerve. The results are consistent with studies showing 
expression of ASICs in OPCs and their downregulation in mature oligodendrocytes 
(Feldman et al., 2008). Lin et al. (2010) provided evidence for proton sensitive currents 
and immunopositivity for Asic1 in hippocampal NG2+ OPCs (Lin et al., 2010). ASIC are 
activated by extracellular [H+] and allow the passage of mainly Na+, although they are 
also permeable to Ca2+, and they may be important in intracellular pH regulation in 
OPCs (Ro and Carson, 2004). It has also been hypothesised that Ca2+ influx through 
ASICs might be involved in oligodendrocyte cell death during ischaemia (Feldman et al., 
2008). Importantly, a recent study by Vergo et al. (2011) implicated Asic1 up-
regulation in oligodendrocytes with increased axonal and myelin damage in a rodent 
MS model, and demonstrated neuro- and myelo-protection when blocking Asic1 with 
amiloride (Vergo et al., 2011).  A similar study in the Asic1 knockout mouse supported 
the hypothesis that these channels contribute to axonal degeneration (Friese et al., 
2007). Nuclear expression of Asic1-Asic3 has also been detected in situ and in cultured 
rat astrocytes, using immunocytochemistry and western blot (Huang et al., 2010), 
whereas there is no evidence of ASIC expression in microglia.  
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 3.4.  Summary and Conclusions 
The overall aim of this section was to provide an insight into the K+ channel profile 
of optic nerve glia, using qRT-PCR, and the key findings are summarised in Figure 3.10. 
It is evident from the results that K+ channels are most abundantly expressed in glia 
and the data indicate that astrocytes and oligodendrocytes are dominated by Kv1.1, 
Kir4.1 and Kir7.1. Key novel findings are the hitherto unrecognised high expression of 
mRNA encoding for Kir7.1 in glia, and the marked developmental upregulation of Kv1.1, 
indicating an important role for these two K+ channels in addition to the recognised 
role of Kir4.1 in glial physiological functions of K+ homeostasis and myelination. A 
developmental shift in the RMP of optic nerve glia has been shown to occur between 
P9 and P15 and has been considered to be largely dependent on the upregulation of Kir 
channels (Bolton et al., 2006; Bolton and Butt, 2006; Bay and Butt, 2012). A 
corresponding developmental shift in Kir transcripts was observed (Figure 3.8), which is 
considered as one of the functional hallmarks of differentiation in both 
oligodendrocytes (Kettenmann et al., 1991, Williamson et al, Knutson et al., 1997, 
1997, Attali et al., 1997) and astrocytes (MacFarlane and Sontheimer, 2000). An 
important question that should be addressed in future studies is whether 
developmental changes in Kv1.1 are important in the maturation of glial biophysical 
properties. 
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Figure 3. 10: Profile of the major K+ and Na+ channels expressed by optic nerve glia. 
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Chapter 4 - Expression of Kir7.1 in the 
mouse CNS 
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 4.1. Introduction and Aims 
Glial cells in the CNS express a wide variety of K+ channels and many Kir subtypes. 
Most notably, Kir4.1 is almost exclusively “glial” in the CNS and has been shown to be 
the main channel mediating inward currents in retinal Müller glia, grey and white 
matter astrocytes, cerebellar Bergmann glia and oligodendrocytes (Kalsi and Butt, 
2006). However, the qRT-PCR results of Chapter 3 revealed for the first time high 
expression of Kir7.1 in the mouse optic nerve, a typical white matter tract that contains 
mainly astrocytes and oligodendrocytes that support retinal ganglion cell axons. The 
expression of Kir7.1 has not previously been identified in glia, and in the CNS has only 
been reported in cerebellar Purkinje neurones and pyramidal cells of the hippocampus 
(Krapivinsky et al., 1998), in the choroid plexus (Döring et al., 1998; Nakamura et al., 
1999), and in spinal cord DRG neurones (Zhu and Oxford, 2011). In addition, Kir7.1 is 
prominent in K+ transporting epithelial cells, most notably the retinal pigment 
epithelium (RPE) (Kusaka et al., 2001; Shimura et al., 2001; Yang et al., 2003), small 
intestine (Partiseti et al., 1998), gastric parietal cells (Fujita et al., 2002; Malinowska et 
al., 2003), kidney (Ookata et al., 2000; Derst et al., 2001; Suzuki et al., 2003), and 
thyroid follicular cells (Nakamura et al., 1999). The primary aim of this chapter was to 
examine expression of Kir7.1 in astrocytes and oligodendrocytes, using 
immunolabelling in mouse brain sections and in vitro in cultures of neurones and glia. 
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 4.2. Results 
Immunohistochemical and western blot analysis of Kir7.1 expression was 
performed using an anti-Kir7.1 antibody (aKir7.1) raised in rabbit against the peptide 
(C)EMNGDLEIDHDVPPE, corresponding to amino acid residues 80-94 of the 
extracellular loop domain of the rat Kir7.1 channel, which is 100% identical to the same 
domain in mouse Kir7.1 (Alomone Labs, Jerusalem, Israel). Negative controls comprised 
pre-incubation with the blocking peptide against which the antibody was raised and 
omission of the primary antibody, and the absence of staining confirmed the specificity 
of immunolabelling. Immunohistochemistry was performed on 70 µm thick sections of 
brains, immersion fixed in 4% PFA, unless otherwise stated. Expression of Kir7.1 in 
neurones and glia was identified by double immunofluorescence labelling with well-
characterised cell-specific antibodies, such as GFAP for astrocytes and β3 Tubulin 
(Tuj1) for neurones, and using transgenic reporter mice to identify glial cell types: 
GFAP-eGFP for astrocytes, Sox10-eGFP for all oligodendrocyte lineage cells (OPCs and 
oligodendrocytes), PLP1-DsRed for differentiated oligodendrocytes, and NG2-DsRed 
for OPCs and pericytes; these mouse strains have been characterised extensively in our 
lab (Azim and Butt, 2011; Hawkins and Butt, 2013; Leoni et al., 2009). Confocal images 
were captured using a Zeiss LSM 710 confocal microscope, with x20 (air) or x40, x63, 
x100 (oil immersion) objectives (numerical aperture 0.5, 1.3, 1.4 respectively). 
Fluorescence was detected using excitation wavelengths of 488nm (green), 568nm 
(red), 633nm (far red) and 405nm (blue), with an argon, HeNe1 and diode lasers, 
respectively. Images were captured using optimal settings for pinhole diameter (0.13-
0.3 μm), detector gain and offset acquisition, to detect the positive signal with minimal 
background. Z-stacks contained 4-15 series of 1024x1024 pixel images were used to 
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 generate three dimensional images (voxel size 43-76 nm xy/ 76-283 nm z). Multi track 
image capture was used with 2, 3 and 4 channels so that different wavelengths could 
be imaged separately with minimal overlap in excitation spectra. Identical settings 
were then used to image negative controls. Images were projected using Zen 2009 
Light software (Zeiss) and images were imported to Volocity 6.1.1 (Perkin Elmer) for 
iterative restoration (deconvolution), to remove out of focus fluorescent scatter from 
labelled structures above and below the focal plane. In this study, co-expression of the 
various cell markers and the aKir7.1 immunostaining is identified when emission of 
fluorescence from the two channels is simultaneous, for example when a red pixel and 
a green pixel are less than 10 pixels apart, co-expression appears yellow, but without 
this meaning that the two proteins are colocalised (Zinchuk and Zinchuk, 2009); 
colocalisation was not determined, because aKir7.1 labels the extracellular loop of the 
plasmalemmal ion channel, whereas all the cell-specific markers used are intracellular, 
e.g. Tuj1 and GFAP. 
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 4.2.1. Antibody Validation 
For the validation of the specificity of the primary and secondary antibodies used 
in this project, a range of techniques were used, as summarised in Table 4.1. 
Table 4.1: List of techniques and antibody validation methods. 
Technique Validation Method 
rt-PCR Expression in brain and optic nerve 
Protein blast search Protein Alignment Check 
Western Blot Expression in mouse cortex and cerebellum 
Immunohistochemistry  
Application of antibody on known non-expressing tissue (sk.muscle) 
Application of antibody on known expressing tissue (Cerebellum and 
Choroid plexus) 
Primary antibody pre-bound with peptide 
Omission of primary antibody 
 
First, prior to using the antibody to analyse cellular localisation of Kir7.1, the 
expression of Kir7.1 mRNA in the mouse brain and optic nerve was confirmed using rt-
PCR (Figure 4.1). Total RNA was extracted from adult mouse brain (using the RNeasy 
kit, Qiagen) and optic nerves (using Trizol, Invitrogen), and 1 μg of total RNA was used 
to synthesise cDNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche). PCR 
was performed on 1 µg of the cDNA with primers for Kir7.1 on a c1000 Touch Thermal 
Cycler (Biorad, Hercules, CA). The Kir7.1 primers used were designed by the National 
Center for Biotechnology Information (NCBI) Primer-BLAST tool 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and synthesized by Invitrogen: 
forward, CACATCACCAGCTTCACAGC, reverse GGTTTGCCATCTTTGTGAGC. The results 
demonstrate Kir7.1 product detected at the expected 251 bp band, and no band was 
detected in the absence of cDNA in the reaction mix (Figure 4.1). 
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Figure 4.1: rt-PCR detection of Kir7.1 in adult mouse brain and optic nerve. The specificity of the PCR 
primers was demonstrated by the amplification of the expected Kir7.1 product and the detection of a 
251 bp band. No band was detected in the negative control in the absence of cDNA in the reaction mix. 
 
Next, a BLAST (Basic Local Alignment Search Tool) search and western blot was 
performed on the Alomone aKir7.1 antibody (Figure 4.2). The antibody is raised against 
the peptide sequence EMNGDLEIDHDVPPE on the extracellular loop of the C-terminus 
of the Kir7.1 protein, corresponding to amino acid residues 80-94 of rat Kir7.1. The 
BLAST search of the peptide sequence of the antibody was performed using the 
National Centre for Biotechnology Information (NCBI) website 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), and confirmed that the Kir7.1 protein 
sequence of the rat is identical to the mouse protein and, moreover, that there are no 
significant peptide alignments with any mouse proteins other than Kir7.1. The closest 
target sequence match was found to be the olfactory receptor 1491 [Mus musculus], 
with query coverage of 60%, but which includes a 3 amino acid gap and therefore 
should not bind the aKir7.1 antibody (Figure 4.2A).To further confirm the specificity of 
the Kir7.1 antibody, we performed western blot analysis of total protein lysates in the 
brain of adult mice, which identified three bands at approximately 40.5, 46 and 49 kDa, 
and positive bands were eliminated by the competitive peptide (Figure 4.2B). The 
densest band detected corresponds to the predicted molecular weight of 40.5 kDa, 
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 and the higher molecular weight bands are likely to be related to the extent of 
glycosylation and phosphorylation of the channels (Kusaka et al., 2001). 
 
 
 
Figure 4.2: Validation of the Alomone aKir7.1 primary antibody. (A) BLAST search of the peptide 
against which the Kir7.1 antibody was raised identified no significant peptide alignments with any other 
mouse protein, and the closest target sequence match was the olfactory receptor 1491, with query 
coverage of 60% and a 3 amino acid gap. (B) Western Blot analysis revealed that the aKir7.1 antibody 
recognised three major antigens with apparent molecular weights of 40.5, 46 and 49 KDa. (C) The full 
Western Blot for Kir7.1 in the mouse cortex and cerebellum. 
 
 
Finally, a number of positive and negative immunohistochemistry controls were 
performed using the Alomone aKir7.1 antibody (Figures 4.3 and 4.4). Kir7.1 
b actin Cortex CBL 
C 
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 immunolabelling using other antibodies has been demonstrated previously in Purkinje 
neurones of the cerebellum (Krapivinsky et al., 1998) and choroid plexus epithelial cells 
(Nakamura et al., 1999). In contrast, skeletal muscle has been found to be negative for 
Kir7.1 expression at the transcript level, using Northern Blot and rtPCR (Partiseti et al., 
1998; Nakamura et al., 1999; Döring et al., 1998; Shimura et al., 2001; Derst et al., 
2001). Therefore, immunohistochemistry using the Alomone aKir7.1 antibody was 
performed on sections from the adult mouse brain and skeletal muscle (Figure 4.3). 
We observed strong aKir7.1 immunolabelling of Purkinje neurones (Figure 4.3A) and 
the choroid plexus epithelium (Figure 4.3B), whereas no Kir7.1 immunolabelling was 
detected in skeletal muscle (Figure 4.3C). In negative controls, immunolabelling in the 
cerebellum was abolished by pre-incubating sections with the blocking peptide against 
which the aKir7.1 antibody was raised (Figure 4.3A inset) or by omitting the primary 
antibody (not illustrated), and equivalent results were observed in other brain regions 
and cell cultures (not illustrated). In the absence of Kir7.1 knock-out tissue, the results 
provide the strongest evidence of the specificity of the aKir7.1 Alomone antibody used 
in this thesis. 
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Figure 4.3: Specificity of Kir7.1 immunolabelling in mouse tissue. (A) Kir7.1 immunolabelling (green) 
identifies Purkinje cells of the cerebellum in brain sections from adult PLP1-DsRed mice, in which the 
reporter identifies myelinated white matter and oligodendrocytes (red). In negative controls, no 
immunolabelling was observed following pre-incubation of the primary antibody with the 
complimentary peptide (inset A) or omission of the primary antibody (not illustrated); Hoechst Blue was 
used to stain the cell nuclei. (B) Kir7.1 immunolabelling (red) of the choroid plexus epithelium of adult 
mice; Hoechst Blue (HB) was used to stain the cell nuclei. (C) Kir7.1 immunolabelling (green) was not 
detected in skeletal muscle section from adult mouse; Hoechst Blue was used to stain cell nuclei and the 
inset illustrates collagen immunolabelling in the same section (red). Scale Bars=100µm in A and C, and 
20µm in B. 
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 4.2.2. Kir7.1 expression in the forebrain 
Immunofluorescence labelling of the adult mouse brain revealed wide expression 
of Kir7.1 in the cortex and hippocampus (Figure 4.4). The most intensely labelled area 
of the cortex appeared to be Layer IV of the somatosensory cortex, the posterior 
parietal association area and extending all the way to area 4 of the visual cortex. In the 
hippocampus, areas CA2 and CA3 showed the most expression along with the 
molecular (mo) and polymorph (po) layer of the dentate gyrus (DG). Moreover, 
noticeable expression was revealed for the caudoputamen area of the striatum and 
the dorsal thalamus. High expression of Kir7.1 was also seen in the ependymal cell layer 
of the Lateral Ventricle (LV) and the glia limitans which delineates the body of the 
Corpus Callosum. 
 
To investigate astrocyte expression of Kir7.1, immunohistochemistry was 
performed on brain sections from adult GFAP-eGFP mice, focusing on the 
hippocampus and cortex. First, the overall distribution of Kir7.1 in the different layers 
of the hippocampus was examined in relation to that of astrocytes (Figure 4.5). In the 
dentate gyrus (DG), Kir7.1 expression was seen in the molecular (mo) and polymorph 
(po) layers but not in the granule cell layer. The lacunosum and molecular layer (slm) 
also displayed widespread expression of Kir7.1; this layer, along with the molecular and 
polymorph layers of the dentate gyrus, contained large numbers of astrocytes. 
Moreover, the stratum oriens (so) and stratum radiatum (sr) displayed less intense, 
punctate expression which is interesting as the stratum oriens contains the 
basal dendrites of pyramidal neurones which receive input from pyramidal 
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 neurones, septal fibres and commissural fibres from the contralateral hippocampus; 
the stratum radiatum also contains septal and commissural fibres. It is possible that 
the punctate labelling reflects expression of Kir7.1 at the nodes of Ranvier of these 
axons, which requires further examination. Finally, the pyramidal neuron layer was 
also positive for Kir7.1 expression, but with higher intensity in the CA2 and CA3 areas 
and less so in the CA1 (Figure 4.5C). Higher magnification resolved intense Kir7.1 
immunopositivity on the cell somata and processes of astrocytes in the dentate gyrus 
of the hippocampus (Figure 4.6Ai-ii), and double immunofluorescence labelling with 
the neuronal marker Tuj1 demonstrated Kir7.1 expression on the neuronal somata, 
primary dendrites and axons of pyramidal neurones of the CA1 region (Figure 4.6Bi-iii).  
 
In the frontal cortex, Kir7.1 appeared to be localised mainly on astrocyte cell 
bodies, while the strongest expression was found on the somata of cortical neurones 
and their axons (Figure 4.7Ai-iii). Immunohistochemistry for Kir7.1 in GFAP-eGFP 
transgenic mouse brain sections revealed intense Kir7.1 immunolabelling on astrocytic 
perivascular end-feet (Figure 4.7Bi-iii). In contrast, NG2-positive pericytes that 
surround blood vessels in the mouse cortex did not display Kir7.1 immunopositivity 
(Figure 4.7Ci-iii), and neither did cortical oligodendrocytes (not illustrated). Neuronal 
expression of Kir7.1 in the adult mouse cortex was demonstrated using the neuronal 
marker Tuj1, with the pyramidal cell somata, primary dendrites and axons being 
immunopositive for Kir7.1 (Figure 4.7Di-iii). 
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Figure 4.4: Expression of Kir7.1 in the adult mouse forebrain. Confocal low magnification 
photomicrograph of sagittal brain sections, immunolabelling for Kir7.1 (green) and counterstained with 
the nuclear dye Hoechst blue. Kir7.1 expression in the adult mouse cortex (Layers I - VI) and 
hippocampus (Regions CA1-CA3 and DG) are illustrated in the overlay (A) and individual green (B) and 
blue (C) channels. Scale Bars: 300µm. Kir7.1 immunostaining was absent in negative controls (Not 
illustrated). 
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Figure 4.5: Expression of Kir7.1 in the mouse hippocampus. Confocal low magnification 
photomicrograph of sagittal brain sections from adult GFAP-eGFP mouse, immunolabelled for Kir7.1 
(red); expression of the eGFP reporter identifies astrocytes (green). The overlay (A) and individual green 
(B) and red (C) channels are illustrated. Important anatomical structures are specified; SUB – Subiculum, 
CA – Cornu Ammonis (Ammon’s Horn); so – stratum oriens, sp–stratum pyramidale (pyramidal neuron 
layer), sr – stratum radiatum, slm – stratum lacunosum/moleculare, DG – Dentate Gyrus; mo – 
molecular layer, sg – stratum granulosum (granule cell layer), po – polymorph layer. Scale Bars: 300µm. 
Kir7.1 immunostaining was absent in negative controls. (Not illustrated). 
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Figure 4.6: Kir7.1 expression in hippocampal astrocytes and neurones. Confocal photomicrograph of 
sagittal brain sections from adult mouse. (A) Double immunofluorescence labelling for Kir7.1 (red); 
expression of the eGFP reporter identifies astrocytes (green). Kir7.1 expression was found on astrocyte 
cell bodies (arrows) and processes (arrowheads); astrocytes and Kir7.1 immunolabelling are most dense 
in molecular (mo) and polymorph (po) layers, while the granule cell layer (sg) is largely devoid of 
astrocytes and appears immunonegative for Kir7.1 (asterisks). (B) Double immunofluorescence labelling 
for Kir7.1 (green) and Tuj1 (red) identifies Kir7.1 expression on the cell bodies (asterisks) and axons 
(arrows) of hippocampal pyramidal neurones; Kir7.1 Immunopositivity can also be seen in Tuj1-negative 
cells, most likely astrocytes (arrowheads). Individual channels and the overlay are illustrated. Kir7.1 
immunostaining was absent in negative controls (Not illustrated). Scale Bars: 50µm 
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Figure 4.7: Kir7.1 expression in the adult mouse cortex. Confocal photomicrograph of sagittal brain 
sections from adult mouse. (A) Astrocytes were identified by expression of the GFAP-eGFP reporter 
(green) and immunolabelling for Kir7.1 (red) indicated expression on their cell bodies (arrows); neuronal 
somata (asterisks) and axons (arrowheads) were also immunopositive for Kir7.1.  (B) Astrocyte 
perivascular endfeet (green, arrows) are immunopositive for Kir7.1 (red), and co-expression appears 
yellow in the overlay (Bi); Kir7.1 immunolabelling is also evident in the somata of astrocytes (arrowhead) 
and neurones (asterisks). (C) Pericytes identified by expression of the NG2-DsRed reporter are seen to 
line the blood vessels (red) but are immunonegative for Kir7.1 (green). (D) Double immunofluorescence 
labelling for Kir7.1 (green) and Tuj1 (red) demonstrates cortical neurones express Kir7.1 on their cell 
bodies (asterisks) and axons (arrows); co-expression appears yellow in the overlay (Di) and Kir7.1 
immunopositivity can be seen in Tuj1-negative cells, which are likely to be astrocytes (arrowheads). 
Individual channels and the overlay are illustrated. Kir7.1 immunostaining was absent in negative 
controls (not illustrated).  Scale Bars=20µm in all panels. 
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 4.2.3. Kir7.1 expression in forebrain white matter 
To investigate the expression of Kir7.1 in astrocytes and oligodendrocyte lineage 
cells in white matter of the adult forebrain, immunohistochemistry was performed on 
70 µm sagittal and coronal brain sections from SOX10-eGFP and GFAP-eGFP transgenic 
mice. Intense immunolabelling for Kir7.1 could be observed in the choroid plexus and 
ependymal cells of the lateral ventricle, as well as in the cerebral cortex above the 
corpus callosum and the caudate putamen, but the myelinated fibre tracts that make 
up the corpus callosum (CC) and striatum were not as strongly immunopositive (Figure 
4.8). Higher magnification confocal images were acquired to examine the expression of 
Kir7.1 in white matter astrocytes of GFAP-eGFP mice (Figure 4.9A) and 
oligodendrocytes of Sox10-eGFP mice (Figure 4.9B, C). Strong somatal expression was 
observed in most astrocytes of both the corpus callosum and striatum (Figure 4.9A). In 
contrast, only a small proportion of Sox10-eGFP+ oligodendrocyte lineage cells were 
found to be positive for Kir7.1 expression in the corpus callosum (Figure 4.9B). The 
same variable expression in oligodendrocytes was observed in the striatum, where 
some oligodendrocytes within the myelinated axon bundles were immunopositive for 
Kir7.1 (some indicated by arrows in Figure 4.9C), whereas OPCs within the neuronal 
parenchyma appeared immunonegative for Kir7.1 (some indicated by arrowheads in 
Figure 4.9C); Kir7.1 immunopositive striatal neurones were apparent between the 
myelinated axon bundles in the striatum (Figure 4.9B, C). 
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Figure 4.8: Kir7.1 expression in adult mouse myelinated tracts. Low magnification confocal images of coronal brain section from adult Sox10-eGFP mouse to identify 
oligodendrocyte lineage cells (green) immunolabelled for Kir7.1 (red). Strong immunopositivity for Kir7.1 is detected in the choroid plexus and ependyma of the lateral 
ventricle (LV).The myelinated fibres of the corpus callosum (CC) and striatum are clearly identified by the dense expression of the Sox10-eGFP reporter (green) but are not 
strongly immunopositive for Kir7.1 (red). Individual channels and the overlay are illustrated. Kir7.1 immunostaining was absent in negative controls (not illustrated). Scale 
Bars: 200µm. 
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Figure 4.9: Kir7.1 expression in white matter of the adult mouse forebrain. Confocal images of brain 
sections from adult GFAP-eGFP mouse (A) and Sox10-eGFP mouse (B, C) immunolabelled for Kir7.1. (A) 
Sagittal section illustrating the corpus callosum (CC) from a GFAP-eGFP reporter mouse, in which most 
astrocytes (green) are seen to be immunopositive for Kir7.1 (red), some indicated by arrows; Kir7.1 
immunostaining can also be seen in GFAP-eGFP-negative cells, that are probably oligodendrocytes 
(arrowheads) and striatal neurones (asterisks). (B) Sagittal section illustrating the corpus callosum (CC) 
from a Sox10-eGFP reporter mouse, in which a small proportion of oligodendrocytes (green) are seen to 
be immunopositive for Kir7.1 (red), some indicated by arrowheads, together with Sox10-eGFP-negative 
cells that are most likely astrocytes (arrows); the strongest Kir7.1 immunolabelling was observed in the 
striatal neurones (asterisks), interpolated amongst the myelinated axon bundles (green). (C) Coronal 
section of the striatum from a Sox10-eGFP reporter mouse illustrating the greatest Kir7.1 
immunolabelling (red) in the neurones (asterisks) surrounding the bundles of myelinated axons that 
contained the majority of oligodendrocytes (green). Only a small number of oligodendrocytes present 
clear somatal expression of Kir7.1 (arrows), whereas OPCs present within the neuronal somata appeared 
immunonegative for Kir7.1 (arrowheads).  Individual channels and the overlay are illustrated. Kir7.1 
immunostaining was absent in negative controls (not illustrated). Scale Bars: 100µm 
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 4.2.4. Kir7.1 expression in the cerebellum and pons (Metencephalon) 
The expression of Kir7.1 in the cerebellum is illustrated by immunolabelling of 
70µm sections from adult PLP1-DsRed and GFAP-eGFP reporter mice (Figures 4.10-
4.12). The strongest expression of Kir7.1 was found in the choroid plexus and the 
Purkinje neurones (Figure 4.10). Kir7.1 immunolabelling was also evident in the deep 
cerebellar nuclei, as well as the molecular cell layer and the granule cell layer (Figure 
4.10A and B). Less intense immunolabelling for Kir7.1 was observed along the 
myelinated fibre tracts (Arbor Vitae) (Figure 4.10A, B), but high magnification confocal 
images of PLP1-DsRed transgenic mouse cerebellar sections revealed Kir7.1 
immunolabelling on myelin, but not apparently on oligodendrocyte cell somata (Figure 
4.11A). In contrast to oligodendrocytes, Bergmann glia displayed somatal expression of 
Kir7.1, whereas the immunopositivity seen in the molecular cell layer (MCL) seemed to 
be due to high levels of Kir7.1 expression in the elaborate dendritic trees of Purkinje 
neurones and not apparently on Bergmann glial processes (Figure 4.11B). Indeed, 
closer examination of Purkinje neurones confirmed intense immunolabelling for Kir7.1 
on their soma (Figure 4.12A), their axons (Figure 4.12B) and dendrites (Figure 4.12C).
115 
 
  
Figure 4.10: Kir7.1 expression in the adult mouse cerebellum. Low magnification confocal images of 
sagittal cerebellar sections from adult PLP1-DsRed mouse (A) and GFAP-eGFP mouse (B) 
immunolabelled for Kir7.1. The strongest expression of Kir7.1 is observed in the choroid plexus (CP) and 
the Purkinje cell layer (arrows), with prominent immunolabelling in the molecular layer (MCL), where 
the radial processes of Bergmann glia are prominent. Positive expression can also be seen in the deep 
cerebellar nuclei (CBN) and to a decreasing extent in the granule cell layer (GCL) and the myelinated 
fibre tracts in the cerebellar white matter (WM). Individual channels and the overlay are illustrated. 
Kir7.1 immunostaining was absent in negative controls (Not illustrated). Scale Bars: 300µm. 
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Figure 4.11: Kir7.1 expression in oligodendrocytes and astrocytes of the mouse cerebellum. High 
magnification confocal images of brain sections from adult PLP1-DsRed mouse (A) and GFAP-eGFP 
mouse (B) immunolabelled for Kir7.1. (A) In the cerebellar white matter, Kir7.1 immunolabelling (green) 
appears to be expressed on myelin, or axons, but not oligodendrocyte somata (red). (B) In the Purkinje 
cell layer and molecular layer, Kir7.1 immunolabelling (red) is detected on the cell somata of Bergmann 
glia (green, co-expression appears yellow), together with the somata and dendritic tree of Purkinje 
neurones (asterisks). Individual channels and the overlay are illustrated. Kir7.1 immunostaining was 
absent in negative controls (Not illustrated). Scale Bars= 50µm. 
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Figure 4.12: Kir7.1 expression in Purkinje neurones of the adult mouse cerebellum. Confocal images of 
sagittal cerebellar sections from adult mouse immunolabelled for Kir7.1 (green). (A)  Low magnification 
illustrating the dense immunolabelling for Kir7.1 in Purkinje cell bodies compared to the other layers of 
the cerebellum. (B) High magnification illustrating Kir7.1 immunopositive Purkinje cell bodies, axons 
(arrows) and primary dendrites (arrowhead). (C) High magnification of the dendritic tree of Purkinje 
neurones, strongly immunopositive for Kir7.1. Kir7.1 immunostaining was absent in negative controls 
(not illustrated). Scale Bar= 50µmin A and 20µm in B and C. 
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 4.2.5. Kir7.1 expression in the pons 
Widespread immunolabelling for Kir7.1 immunolabelling was observed in the pons, 
with the exception of the pyramidal tracts, which include the corticospinal and 
corticobulbar tracts (Figure 4.13). These largely Kir7.1 immunonegative tracts contain 
the myelinated axons originating from the cerebral cortex, passing through the pons 
and terminating in the spinal cord and the brainstem, respectively. Higher 
magnification confocal images of sections from the GFAP-eGFP reporter mouse 
revealed that astrocytes in the pons express Kir7.1 on their cell somata and processes, 
while a few larger cell somata, most likely neurones, were also Kir7.1 immunopositive 
(Figure 4.14). 
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Figure 4.13: Kir7.1 expression in the mouse pons. Low magnification confocal images of sagittal sections 
from adult GFAP-eGFP reporter mouse (astrocytes are green) immunolabelled for Kir7.1 (red).  Kir7.1 is 
widely expressed in the pons, with intense expression in the choroid plexus of the third ventricle (CP), 
whilst the corticospinal tract appears immunonegative for Kir7.1 (arrows). Individual channels and the 
overlay are illustrated. Kir7.1 immunostaining was absent in negative controls (not illustrated). Scale 
Bars: 300µm. 
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Figure 4.14: Kir7.1expression in astrocytes in the pons. High magnification confocal images of sagittal sections from adult GFAP-eGFP reporter mouse (astrocytes are green) 
immunolabelled for Kir7.1 (red).  Astrocytes express Kir7.1 on their cell somata and processes (arrows), with apparent enrichment of Kir7.1 on perivascular endfeet (star), 
while the larger Kir7.1 immunopositive cell somata are most likely neurones (asterisks). Individual channels and the overlay are illustrated. Kir7.1 immunostaining was absent 
in negative controls (not illustrated). Scale Bars: 50µm. 
 
 
* 
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 4.2.6. Kir7.1 expression in optic nerve astrocytes and oligodendrocytes 
Kir7.1 immunolabelling was performed on 14 µm optic nerve cryosections from 
adult GFAP-eGFP and PLP1-DsRed reporter mice. Kir7.1 immunolabelling was 
widespread in the optic nerve and was localised to astrocyte somata (Figure 4.15A) 
and discrete interfascicular rows of oligodendrocyte somata (Figure 4.15B). 
 
 
Figure 4.15: Kir7.1 expression in the adult mouse optic nerve. Immunolabelling for Kir7.1 in optic nerve 
sections from adult mice. (A) Kir7.1 expression (red) in astrocytes (green) expressing the GFAP-eGFP 
reporter (arrows); rows of GFAP-eGFP-negative/Kir7.1-positive cells are most likely oligodendrocytes. (B)  
Kir7.1 expression (green) in oligodendrocytes (red) expressing the PLP1-DsRed reporter (asterisks). 
Individual channels and the overlay are illustrated. Kir7.1 immunostaining was absent in negative 
controls (not illustrated). Scale Bars: 50µm.  
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 4.2.7. Glia and neurones express Kir7.1 in vitro 
Due to the close apposition of cells in brain sections, it is often difficult to clearly 
resolve cellular localisation of immunolabelling. To confirm that glial cells express 
Kir7.1, explant cultures were prepared from optic nerves from P7-P12 wild type and 
SOX10-eGFP reporter mice and examined after 10 days in vitro (DIV) (Figure 4.16 and 
4.17). In addition, mixed neuron-astrocyte cultures were prepared from cerebral 
cortex isolated from P0-P2 wild type mice and examined after DIV14 (Figure 4.18). 
Cultured optic nerve oligodendrocytes identified by their expression of the Sox10-eGFP 
reporter are shown to express Kir7.1 protein on their cell somata and processes (Figure 
4.16A), and immunolabelling for GFAP demonstrates Kir7.1 expression in astrocytes 
(Figure 4.16B). For the Kir7.1 to be functional they should be localised to the cell 
membrane, and double immunofluorescence labelling for Kir7.1 with the 
plasmalemmal marker Na+/K+-ATPase (Figure 4.17A) and main glial channel Kir4.1 
(Figure 4.17 B) indicated co-expression with Kir7.1 on the astrocytic cell membrane. In 
addition, cultured cortical astrocytes identified by GFAP immunolabelling are also 
shown to display intense Kir7.1 expression (Figure 4.18A), and strong immunopositivity 
was observed for cultured cortical neurones, identified by Tuj1 immunolabelling 
(Figure 4.18B), in agreement with our findings in vivo (Figure 4.7). 
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Figure 4.16: Kir7.1 expression in optic nerve glial cultures. Optic nerve explant cultures from P7-P12 
mice were analysed for Kir7.1 immunocytochemistry after DIV10. (A) Immunolabelling for Kir7.1 (red) is 
evident on the cell somata and processes of oligodendrocytes identified by expression of the SOX10-
eGFP reporter (green). (B) Double immunofluorescence labelling for Kir7.1 (green) and GFAP (red) 
demonstrates Kir7.1 expression in astrocytes in vitro on their cell somata and processes. Individual 
channels and the overlay are illustrated, and co-expression appears yellow in the overlays (Ai, Bi). Kir7.1 
immunostaining was absent in negative controls (not illustrated). Scale Bars: 20µm.  
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Figure 4.17: Kir7.1 is localised to glial cell membranes. Optic nerve explant cultures from P7-P12 mice 
were analysed for Kir7.1 immunocytochemistry after DIV10. Double immunofluorescence labelling for 
Kir7.1 (green) and the plasmalemmal marker Na
+/K+-ATPase (red, A) and glial channel Kir4.1 (red, B) 
indicates Kir7.1 is expressed on glial cell membranes. Individual channels and the overlay are illustrated, 
and co-expression appears yellow in the overlays (Ai, Bi). Kir7.1 immunostaining was absent in negative 
controls (not illustrated). Scale Bars: 20µm. 
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Figure 4.18: Kir7.1 expression in cortical neuron-glial cultures. Cells were isolated from P0-P2 mouse 
cortex and analysed for Kir7.1 immunocytochemistry after DIV14. Double immunofluorescence labelling 
for Kir7.1 (green) and the astrocyte marker GFAP (red, A) or neuronal marker Tuj1 (red, B) identifies 
expression of Kir7.1 in cortical astrocytes and neurones; in (B) asterisks indicate Tuj1-negative/ Kir7.1-
positive cells that are most likely astrocytes, as indicated in (A). Individual channels and the overlay are 
illustrated, and co-expression appears yellow in the overlays (Ai, Bi). Kir7.1 immunostaining was absent 
in negative controls (not illustrated). Scale Bars: 50µm.  
 
 
 
 
 
 
 
126 
 
 4.3. Discussion 
The functional expression of the Kir7.1 channel subtype is poorly understood in the 
CNS, with a single study demonstrating immunolabelling in Purkinje neurones and 
pyramidal cells of the hippocampus (Krapivinsky et al., 1998). The 
immunohistochemical results of this chapter show for the first time that glial cells also 
express Kir7.1 throughout the brain, although the level of immunolabelling for Kir7.1 in 
glia was heterogeneous. Astrocytes are shown to express Kir7.1 in the cortex, which 
was confirmed in vitro, as well as in the hippocampus, pons, and white matter tracts, 
such as the corpus callosum and optic nerve. Astroglial Kir7.1 expression was especially 
prominent on perivascular endfeet and in Bergmann glial cell bodies. Oligodendrocytes 
exhibited relatively high expression in the optic nerve, which was confirmed in culture, 
while cortical and cerebellar oligodendrocytes appeared largely immunonegative, and 
in the corpus callosum and striatum immunopositivity was apparent only in a small 
proportion of oligodendrocytes. These novel results provide a new perspective on the 
widespread but heterogeneous expression of Kir7.1 in neurones and glia, which implies 
an uncharacterised important function for the channel in specific populations of cells. 
 
4.3.1. Antibody Validation 
Antibodies raised against proteins are among the most important tools for 
studying ion channels and receptors in neuroscience research. The necessity for 
antibody validation is therefore essential when using an antibody for the first time so 
that new findings are unambiguous. Although there are no universally accepted 
validation guidelines for best practice, there have been a number of publications on 
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 the subject, and an assortment of recommendations is available in the literature and 
online (Deutsch et al., 2008 – MISFISHIE). Ideally, it is preferable to compare multiple 
antibodies to the same protein and to use tissue from knock-out mice to test the 
specificity of the antibody. In the absence of alternative sources of the Kir7.1 antibody 
and Kir7.1 knock-out mice, we used a range of widely accepted techniques to confirm 
the specificity of the Alomone aKir7.1 antibody used in this Chapter.  
 
RT-PCR confirmed previous studies that Kir7.1 is expressed in the brain at the 
mRNA level and confirmed the qRT-PCR results of Chapter 3 demonstrating expression 
of Kir7.1 mRNA in the optic nerve. Furthermore, western blot using the Alomone 
aKir7.1 antibody confirmed the protein was also expressed in total extracts of adult 
mouse cortex and cerebellum. The predicted size for the Kir7.1 protein is 40.5 kDa, 
based on its amino acid sequence, and the results show the Alomone aKir7.1 antibody 
recognised a dense band at ~40.5 kDa, together with two further bands at ~46 and ~49 
kDa. Reported sizes for the Kir7.1 protein vary in the literature depending on the organ 
system that is being studied; protein size in the rat kidney and RPE has been reported 
to be ~52 kDa (Ookata et al., 2000; Kusaka et al., 2001; Yang et al., 2003; Suzuki et al., 
2003), whereas other reports found the protein in rat thyroid and small intestine to be 
~54 kDa (Nakamura et al., 1999), the same as the human Kir7.1 protein in RPE (Pattnaik 
et al., 2013). However, Kir7.1 protein extracted from rat brain was found to be ~46 kDa 
(Döring andKarschin, 2000). The various sizes for the Kir7.1 protein reported in 
literature as well as the bands identified in my study are most likely due to post-
translational modifications, such as glycosylation and phosphorylation, since Kir7.1 
possesses a potential N-glycosylation site, Asn-His-Thr at residues 95-97, and protein 
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 kinase C phosphorylation sites, Ser-Gln-Arg at residues 14-16, Ser-Ile-Arg at residues 
169-171, and Ser-Val-Arg at residues 201-203 (Kusaka et al., 2001). The implications of 
such modifications for the functionality of the protein are uncertain, however it is 
important to note that these are unlikely to affect the antibody binding site and 
therefore affect the interpretation of the immunohistochemical analyses detailed 
throughout the rest of the chapter. 
 
It has been previously shown by immunohistochemistry using different antibodies 
that Kir7.1 is most strongly expressed in cerebellar Purkinje neurones (Krapivinsky et 
al., 1998) and the choroid plexus epithelium (Döring et al., 1998; Nakamura et al., 
1999). In addition, multiple-tissue Northern blot studies in human tissues (Partiseti et 
al., 1998; Nakamura et al., 1999) and rat tissues (Döring et al., 1998), and cDNA PCR 
screening in multiple human tissues (Shimura et al., 2001) and guinea pig tissues (Derst 
et al., 2001) have all demonstrated that Kir7.1 is expressed in the brain but is absent 
from skeletal muscle. Here, this knowledge was used in order to provide confirmation 
of the specificity of the Alomone antibody, and the results demonstrated the most 
prominent immunolabelling for Kir7.1 in Purkinje neurones and the choroid plexus 
epithelium, and complete absence of immunolabelling in skeletal muscle. Moreover, 
pre-incubation in the blocking peptide completely abolished immunolabelling in tissue 
sections and in western blot, demonstrating the aKir7.1 antibody is specific to the 
peptide sequence against which it was raised, and a BLAST search confirmed the 
peptide sequence was specific to Kir7.1. 
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 Thus, the results provide the strongest evidence that Kir7.1 is widely expressed in 
glial cells as well as neurones throughout the CNS. Although epitope localisation may 
be altered by the fixation method (Schnell et al., 2012), and caution needs to be 
exercised when comparing cellular localisation patterns of the Kir7.1 protein between 
differently fixed tissues, no noticeable differences in the expression pattern was 
evident in the results of this section or compared to previous studies. 
 
4.3.2. Glial expression of Kir7.1 
The utilisation of reporter mice which express fluorescent proteins under the 
control of astrocytic and oligodendrocytic specific genes have been a great aid in 
identifying astrocytes and oligodendrocytes throughout the CNS. Glial expression of Kir 
channels is diverse in the CNS and mRNA and protein expression has been 
demonstrated in different degrees for all subfamilies (Hibino, 2010). The most 
prominently expressed and therefore most studied in glia are the Kir4.1 and Kir2.x 
subfamilies, and the functional importance of the strictly glial Kir4.1 is widely accepted 
(Kalsi and Butt, 2006). Extensive studies over the last decades have demonstrated the 
significance of Kir channels, and especially Kir4.1, for the maintenance of the strongly 
negative resting membrane potential of glia and in turn the ability of these cells to 
facilitate K+ transport between neurones and blood vessels alongside its key role  in K+ 
buffering involving the redistribution of K+ ions from areas with increased neuronal 
activity (and therefore high [K+]o) to areas with low [K+]o (Orkand et al., 1966; Newman 
et al., 1984). Moreover, Kir4.1 knock-out mice display hypomyelination due to the 
block of oligodendrocyte differentiation (Neusch et al., 2000), demonstrating another 
important role for this channel in the exit of glia from the cell cycle and their 
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 maturation (Kalsi and Butt, 2006; Verkhratsky and Butt, 2013). In some brain regions, it 
was shown that other mechanisms contribute to potassium homeostasis; for example, 
removal of [K+]o in the rat hippocampus was found to be dependent on glial and axonal 
Na+/K+-ATPase (D'Ambrosio et al., 2002; Meeks and Mennerick, 2007) and similarly in 
the optic nerve K+ clearance under physiological conditions was not dependent on 
Ba2+-sensitive Kir channels (Ransom et al., 2000). Moreover, synaptic transmission and 
normal rhythmic activity in the hippocampus is not affected in Kir4.1 knock-out mice 
(Neusch et al., 2006; Djukic et al., 2007). It is possible that other Kir channels such as 
Kir7.1, which is not sensitive to Ba2+, facilitate K+ buffering in these studies. 
 
Expression studies of Kir7.1 revealed specific patterns of localisation in polarised 
cells. In situ hybridisation studies revealed that Kir7.1 mRNA is expressed in the 
secretory epithelial cells of the choroid plexus and its expression is restricted to the 
apical membrane of the epithelial cells (Döring et al., 1998). Furthermore, in the retina, 
the channel is also expressed at the apical membrane of the pigment epithelial cells 
(Hughes and Takahira, 1996; Kusaka et al., 2001). On the other hand, Kir7.1 
immunoreactivity was detected at the basolateral membrane of thyroid follicular cells 
and of renal epithelia in the distal convoluted tubule, proximal tubule and collecting 
duct (Ookata et al., 2000; Derst et al., 2001). The epithelial cells of the choroid plexus 
and the retinal pigment epithelia have a unique polarity that is opposite to usual types 
of epithelial cells. These two types of epithelial cells are known to express the Na+/K+-
ATPase at their apical membrane (DiBona and Mills, 1979; Masuzawa et al., 1981; 
Caldwell and McLaughlin, 1984; Masuzawa et al., 1985; Ernst et al., 1986). In contrast, 
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 thyroid follicular cells and renal epithelial cells harbour the pump at their basolateral 
membrane (Hebert et al., 2005). The co-expression of Kir7.1 channels with the Na+/K+ -
ATPase in the RPE, kidney, choroid plexus and thyroid epithelia is indicative of a 
possible role of Kir7.1 in regulating potassium transport and in turn sodium expulsion 
from the cell. The function of Kir7.1 has been closely studied in the retinal pigment 
epithelium (RPE), where it has an important role in the regulation of the subretinal 
space volume by facilitating K+ efflux from the cells when [K+]o is low, i.e. upon 
illumination and activation of retinal photoreceptor cells, thus enabling water efflux 
from the RPE. Moreover, due to its weak inward rectification, it maintains a constant 
K+ efflux, thus counteracting and enabling the function of Na+/K+-ATPase, a function 
termed "K+ recycling" (Wimmers et al., 2007).  A loss of function mutation in Kir7.1, 
results in the autosomal dominant disorder of the eye called Snowflake Vitreoretinal 
Degeneration (SVD) and manifests itself as a severe impairment of transepithelial ion 
and water transport via the RPE (Hejtmancik et al., 2008). 
 
Water and potassium transport is an important physiological function of 
astrocytes and is implicated in osmolarity changes associated with K+ buffering. 
Astrocytes contacting blood vessels, ventricles and the pia show high expression of 
aquaporins (AQP, water channels) that mediate water transport (Nielsen et al., 1997). 
Aquaporins have been shown to be co-expressed with Kir4.1 and it is hypothesised that 
there is a functional relationship between the maintenance of the strongly negative 
glial RMP, which drives outward bicarbonate transport via the Na+-HCO3− transporter, 
and ultimately maintains the driving force for passive water fluxes through AQP4 
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 (Newman and Astion, 1991; Nagelhus et al., 2004). The water homeostasis functions 
performed by astrocytes are similar to the water transport facilitated by the RPE and 
renal epithelial cells in which Kir7.1 has been shown to play a role; therefore it can be 
hypothesised that the astrocytic Kir7.1 has analogous importance in CNS glia. Further 
support of this hypothesis is the finding that Kir7.1 is co-expressed on the glial cell 
membrane with the known glial inward rectifier Kir4.1 and Na+-K+-ATPase. 
 
The question remains as to the possible function of Kir7.1 in oligodendrocytes, 
although with the exception of the optic nerve, expression was more heterogeneous 
than in astrocytes, suggesting it may have a more important function in the optic nerve 
than elsewhere in the CNS. The function of oligodendrocytes is myelination, and so it is 
reasonable to assume that Kir7.1 are involved in this function, as has been shown for 
Kir4.1 (Neusch et al., 2000). Oligodendrocyte maturation and myelination are 
dependent on the development of a strongly negative RMP, which is related to a loss 
of Kv and upregulation of Kir (Knutson et al., 1997; Neusch et al., 2003). The results of 
this chapter indicate Kir7.1 may be an important aspect of these changes. Moreover, 
oligodendrocytes are exposed to large shifts in ions and water during axonal action 
potential propagation (Kettenman et al., 1990; Berger et al., 1991; Menichella et al., 
2006), so it seems likely Kir7.1 play a similar role in ion and water homeostasis in 
oligodendrocytes as hypothesised for astrocytes. 
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 4.3.3. Neuronal expression of Kir7.1 in the murine CNS in situ and in vitro 
The staining pattern for Kir7.1 in hippocampal and cerebellar neurones observed in 
this study is consistent with the findings of Krapivinsky et al. (1998), although my 
results disprove their conclusion that Kir7.1 is a purely neuronal channel. More 
specifically, in their paper, Krapivinsky et al. show labelling of the pyramidal cell layer 
in the rat hippocampus as well as less intense labelling in the dentate gyrus, stratum 
oriens, and stratum radiatum. Due to the lack of double staining for glial and neuronal 
markers, it is not possible to decipher from their data whether the less intense staining 
was due to neuronal or glial expression. Nevertheless, my results are in complete 
agreement about the areas of the hippocampus that display Kir7.1 protein expression. 
Moreover, my observation that there is localisation of Kir7.1 equally on neuronal cell 
bodies and their primary dendrites is also in agreement with the data published by 
Krapivinsky et al. Finally, my study confirmed previous findings that Kir7.1 protein is 
expressed in cerebellar Purkinje neurons, with the most intense staining on their large 
cell bodies and still prominent but less intense expression on their elaborate dendritic 
arbor (Krapivinsky et al., 1998). 
The intrinsic electrical properties of neurones are established by and dependent 
on the unique expression of potassium channels on their cell membranes. A key 
feature in neurones is the prominent expression of Kir channels and their function in 
maintaining neuronal excitability, with important roles in stabilising the neuronal 
membrane potential and repolarisation of axons during the action potential which 
determines their excitability (Armstrong and Hille, 1998). The localisation of Kir7.1 on 
the neuronal cell somata and dendrites of pyramidal and Purkinje neurones as well as 
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 the initial segment of their axons, suggests a role for Kir7.1 in the summation of 
electrical signals received by these neurones and axon potential propagation. 
Pyramidal neurons receive and transmit both inhibitory (GABA) and excitatory 
(Glutamate) synaptic inputs. Purkinje neurons are GABAergic neurons and their 
dendrites receive excitatory glutamatergic signals from parallel and climbing fibres as 
well as inhibitory GABAergic signals from stellate cells, while basket cells provide 
further inhibitory (GABAergic) inputs on the purkinje neuron axon initial segment (Ito, 
2012). In their paper, Krapivinsky et al. (1998) mention the expression of Kir7.1 in both 
GABAergic and non-GABAergic neurons and the results shown here suggest that Kir7.1 
may have a role in the regulation of postsynaptic excitability of specific populations of 
neurones in the brain. The GIRK/Kir3.x subfamily has been shown to be most widely 
and prominently expressed in the postsynaptic membrane of CNS neurones (Inanobe 
et al., 1999; Koyrakh et al., 2005), and to be intimately involved in the modulation of 
neuronal excitability by coupling to GABAb receptors in CA1 hippocampal and 
substantia nigra neurones (Koyrakh et al., 2005). Expression of the Kir2.x subfamily has 
also been studied and found to be expressed mainly on the cell somata and dendrites 
of neurones which receive excitatory signals in the olfactory bulb (Inanobe et al., 
2002). Moreover, Kir channels are hypothesized to be powerful modulators of 
excitatory postsynaptic potentials (EPSPs) due to their maintenance of the dendritic 
RMP (John and Manchanda, 2011). It would be interesting to investigate potential 
coupling of Kir7.1 with GABA and NMDA receptors using pharmacology and 
electrophysiology in order to determine whether the same receptor interactions apply 
as with GIRK and classical Kir channels. Patch clamping of pyramidal and Purkinje 
neurons using hippocampal and cerebellar slices respectively could provide answers 
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 about the functional implications of the postsynaptic expression of Kir7.1 channels in 
these cells. 
The partnering of Kir7.1 channels with the Na+/K+-ATPase in the RPE, kidney, 
choroid plexus and thyroid epithelia is indicative of a possible role of Kir7.1 in 
regulating potassium and sodium movements in neurones. The basal intracellular Na+ 
concentration ([Na+]i) in rat hippocampal neurones is around 8 mM and the function of 
Na+/K+-ATPase is to quickly remove Na+ ions from the cytoplasm following an action 
potential, which induces only small increases in the [Na+]i. However, upon inhibiting 
the Na+/K+-ATPase with ouabain, the activity of ion channels and transporters of the 
neuron may increase [Na+]i levels up to 50 mM within minutes (Yu and Salter, 1998). 
Thus, it becomes clear that failure of the Na+/K+-ATPase to maintain the Na+ and K+ 
gradients can lead to loss of neuronal excitability as well as a reduction of the driving 
force for a variety of Na+ coupled transport mechanisms, including the 
Na+/H+ exchange and Na+/Ca2+ exchange, resulting in intracellular acidification and Ca2+ 
overload. This sequence of events has been implicated in the pathogenesis of 
neurodegenerative diseases (Brines et al., 1995; Ellis et al., 2003; Wang et al., 2003; 
Dobretsov and Stimers, 2005). Specific localisation patterns of Kir channels and their 
coupling to selective apparatus serve in regulating particular cell functions and in 
neurones they play a role in unidirectional transport of K+ and in the organization of 
signal transduction. 
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 4.4. Summary and Conclusions 
The key finding of this chapter is that astrocytes and oligodendrocytes express 
Kir7.1 channels. In addition, the results provide new information on the pattern of 
Kir7.1 expression in neurones, with a novel finding being the expression in cortical 
pyramidal neurones. The highest expression of Kir7.1 was observed in the choroid 
plexus epithelium, ependymal lining of the ventricles and in Purkinje neurones of the 
cerebellum. On the whole, astrocytes exhibited immunopositivity for Kir7.1 similar to 
neurones and greater than oligodendrocytes in most of the brain. Oligodendroglial 
expression of Kir7.1 was heterogeneous throughout the brain, although they appeared 
to be the main cells expressing the channel in the optic nerve. Astrocytes expressed 
Kir7.1 ion their cell somata and processes, with high expression in astrocytic 
perivascular end-feet, consistent with a role in K+ and water transport at blood vessels. 
The physiological function of Kir7.1 in neurones and glia is unknown, but its pattern of 
cellular localisation supports a potential role in neuronal excitability and K+ and water 
homeostasis in both neurones and glia. Future electrophysiological studies utilising the 
recently discovered Kir7.1 blocker VU590 will be invaluable in determining the function 
of these channels in neurones and glia. 
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Chapter 5 - Role of Kir7.1 in Ischaemia 
Mediated Disruption of Optic Nerve 
Glia 
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 5.1. Introduction and Aims 
Glial cells express a variety of Kir subtypes with multiple functions (Kalsi and Butt, 
2006). In sections 3 and 4, I demonstrated for the first time that Kir7.1 is prominently 
expressed by astrocytes and oligodendrocytes in the optic nerve, as well as elsewhere 
throughout the CNS. Although their precise functions in glia are unknown, Kir7.1 
channels have been previously shown to be particularly sensitive to acidification, 
suggesting Kir7.1 channels could be important during glial ischaemia and hypoxia (Yuan 
et al., 2003; Hughes and Swaminathan, 2008).  Oligodendrocytes are highly susceptible 
to hypoxic/ischaemic damage (Fern and Möller, 2000), and a recent study in our lab 
provided evidence that potassium channels contribute to oligodendrocyte damage in 
hypoxia (Hawkins and Butt, 2013). The high expression of Kir7.1 in oligodendrocytes 
may therefore be pivotal to their susceptibility to hypoxic injury (Back et al., 2007; 
Dewar et al., 2003). Therefore, the aim of this chapter was to investigate the effects of 
Kir7.1 pharmacological blockade on oligodendrocytes in hypoxic/ischaemic conditions, 
using the small-molecule Kir7.1 channel blocker 7,13-bis(4-nitrobenzyl)-1,4,10-trioxa-
7,13-diazacyclopentadecane (VU590) (Lewis et al., 2009). Although VU590 also inhibits 
Kir1.1 (Bhave et al., 2011), these channels are not present in the optic nerve (Section 
3.2.3), whereas Kir4.1 and Kir2.1 are prominent in the optic nerve (Section 3.2.3), but 
are not affected by VU590 at micromolar concentrations (Lewis et al., 2009). 
 
 
 
139 
 
 5.2. Results 
The potential function of Kir7.1 during hypoxia/ischaemia was examined using the 
oxygen and glucose deprivation (OGD) model (Salter and Fern, 2005; Hawkins and 
Butt, 2013). In brief, P12-P14 SOX10-eGFP and GFAP-eGFP reporter mice were killed 
humanely and the optic nerve rapidly isolated intact and immediately placed in normal 
aCSF to stabilise for 30 min at 37°C in a normoxic incubator (95% O2/5% CO2). Optic 
nerves were then incubated for a further 1 h at 37°C in normal oxygen and glucose 
(OGN; 95%O2/5%CO2) or in zero O2 and glucose (OGD; 95%N/5%CO2). Ion channel 
blockers VU590 or BaCl2 were added directly to the aCSF to a final concentration of 
100 µM. At the end of the incubation period, optic nerves were immersion fixed in 4% 
PFA for 1 hr at RT and following washes were whole-mounted on microscope slides in 
Fluoromount G. Cells expressing the GFAP-eGFP or SOX10-eGFP reporters were 
visualised at 488 nm using an argon laser and images captures on a Zeiss LSM 710 
metaconfocal microscope, using a x40 oil immersion lens with high numerical aperture 
(1.3 nm). Images were captured maintaining the acquisition parameters constant 
between samples. In each nerve, the total number of cells was counted in five FOV 
along the length of the optic nerve. The FOV comprised a constant volume of 20 x 20 
µm in the x-y-plane and 15x1 µm optical sections in the z-plane, commencing 15 µm 
below the pial surface. Cell counts are expressed as mean number of cells per FOV + 
SEM (n>5, where ‘n’ represents the number of nerves), and significance was 
determined by ANOVA and Newman–Keuls multiple comparison post-hoc analysis, 
using GraphPad Prism5.0. 
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 The function of Kir7.1 in maintaining glial integrity was examined using the Kir7.1 
blocker VU590, compared to the general Kir blocker BaCl2, and the Kir1.1 blocker 
VU591. Full concentration curves were not practical, since this would have required a 
very large number of reporter mice, which were not available within the time-frame. 
Hence, I selected a concentration of 100 µM for the inhibitors based on the literature 
and the following reasons. Studies in our lab have shown that bath application of 
100µM BaCl2 results in near complete inhibition of Kir4.1, the primary glial Kir channel 
in the optic nerve (Bay and Butt, 2012), whereas other Kir subtypes, including Kir7.1 and 
Kir2.1, have been shown to require >2mM BaCl2 for effective blockade in HEK cell 
cultures (Lewis et al., 2009). Similarly, complete inhibition of Kir7.1 by VU590 in HEK 
cell cultures has been shown to require 10 µM in one study (Lewis et al., 2009) and 100 
µM in another (Rouhier et al., 2009), whilst Kir4.1 and Kir2.1 were unaffected at a 
concentration 10 µM in HEK cell cultures (Lewis et al., 2009). Similarly, VU591 has been 
shown to specifically inhibit Kir1.1 and have no effect on Kir7.1 at concentrations up to 
100 µM in C1 cell cultures (Bhave et al., 2011). Furthermore, the pial surface of the 
nerve acts as a permeability barrier and in order to overcome this restriction and affect 
cells within the nerve parenchyma, numerous studies in our lab have shown that 
agents need to be applied at 10-fold the concentration used in single cell cultures 
(Bolton and Butt, 2005; Hamilton et al., 2008; Azim and Butt, 2011; Bay and Butt, 
2012). On this basis, a concentration of 100 µM of BaCl2, VU590 and VU591 was 
selected to specifically inhibit Kir4.1, Kir7.1 and Kir1.1, respectively. 
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 5.2.1. Blockade of Kir7.1 induces loss of oligodendrocytes in OGN and OGD 
The function of Kir in maintaining oligodendrocyte integrity was examined using 
100 µM VU590 to block Kir7.1 (Lewis et al., 2009; Rouhier et al., 2009). Compared to 
control nerves incubated in O2 and glucose (Figure 5.1A), OGD resulted in a marked 
loss of Sox10-eGFP positive oligodendrocytes (Figure 5.1B), which was statistically 
significant (Figure 5.1E; p<0.001, ANOVA and Newman-Keuls post-hoc tests). Notably, 
blockade of Kir7.1 resulted in a significant loss of oligodendrocytes in nerves incubated 
in normal O2 and glucose, OGN (Figure 5.1C, E; p<0.05, ANOVA followed by Newman–
Keuls multiple comparisons test), and a marked loss of oligodendrocytes in OGD 
(Figure 5.1D, E; p<0.001, ANOVA followed by Newman–Keuls multiple comparisons 
test).The number of oligodendrocytes was reduced by half in OGD+VU590 compared 
to OGN, and by one-third compared to OGD in the absence of VU590 (Figure 5.1E). 
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Figure 5.1: Kir7.1 inhibition induces loss of oligodendrocytes. Optic nerves from P12-P14 Sox10-eGFP 
reporter mice were exposed to 1 h OGD in the absence and presence of the Kir7.1 blocker VU590 (100 
µM) and compared to controls incubated in normal aCSF with O2 and glucose (OGN) . (A–D) 
Representative images of optic nerves from SOX10-eGFP reporter mice, which identifies 
oligodendrocytes, incubated in OGN (A), OGD (B), OGN plus VU590 (C), or OGD plus VU590 (E). 
Quantification of the number of SOX10 –eGFP positive cells (mean ± SEM; n ≥ 5 nerves per experimental 
group in all cases) shows a significant loss of oligodendrocytes during OGD, compared to OGN, and cell, 
loss was significantly greater following treatment with VU590 in both OGN and OGD (ANOVA with 
Newman–Keuls multiple comparison post-hoc analysis; *p<0.05, **p<0.01, ***p<0.001).  
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 5.2.2. Blockade of Kir4.1 induces loss of oligodendrocytes in OGN and OGD 
To test whether the effects on oligodendrocyte integrity are specific to Kir7.1 
blockade, optic nerves were treated with 100 µM BaCl2 to block Kir4.1 in OGN and OGD 
conditions, to serve as a positive control, since Kir4.1 are the primary potassium 
channels in optic nerve glia (Butt and Kalsi, 2006; Bay and Butt, 2012; Section 3.2.3). In 
addition, the effects of the Kir1.1 inhibitor VU591 were examined in OGD to serve as a 
negative control, since Kir1.1 were not detected in the optic nerve (Section 3.2.3) and 
VU591 does not inhibit Kir7.1 or Kir4.1 (Bhave et al., 2011). As observed above for 
Kir7.1, blockade of Kir4.1 resulted in a significant loss of oligodendrocytes in OGN 
(Figure 5.2A, C, E; p<0.001, ANOVA followed by Newman–Keuls multiple comparisons 
test), and to a lesser extent aggravated the loss of oligodendrocytes in OGD (Figure 
5.2B, D, E; p<0.05, ANOVA followed by Newman–Keuls multiple comparisons test). In 
contrast, the Kir1.1 blocker VU591 had no significant effect on the loss of 
oligodendrocytes in OGD (inset Figure 5D and Figure 5E; p>0.05, ANOVA followed by 
Newman–Keuls multiple comparisons test). Although VU590 inhibits both Kir7.1 and 
Kir1.1, the lack of effect of VU591 confirms the effect of VU590 on oligodendrocyte 
integrity is mediated by Kir7.1, and the similar action as BaCl2 in OGN and OGD suggests 
Kir7.1 are as important as Kir4.1 in maintaining oligodendrocyte integrity. 
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Figure 5.2: Kir4.1 inhibition induces loss of oligodendrocytes. Optic nerves from P12-P14 Sox10-eGFP 
reporter mice were exposed to 1 h OGD in the absence and presence of the Kir4.1 blocker BaCl2 (100 
µM) or Kir1.1 blocker VU591 (100 µM), and compared to controls incubated in normal aCSF with O2 and 
glucose (OGN) . (A–D) Representative images of optic nerves from SOX10-eGFP reporter mice, which 
identifies oligodendrocytes, incubated in OGN (A), OGD (B), OGN plus BaCl2 (C), OGD plus BaCl2 (D) or 
OGD plus VU591 (inset F). Quantification of the number of SOX10 –eGFP positive cells (mean ± SEM; n ≥ 
4 nerves per experimental group in all cases) shows a significant loss of oligodendrocytes during OGD, 
compared to OGN, and cell, loss was significantly greater following treatment with BaCl2 in both OGN 
and OGD, whereas VU591 had no effect on oligodendrocyte number in OGD (ANOVA with Newman–
Keuls multiple comparison post-hoc analysis; *p<0.05, **p<0.01, ***p<0.001). 
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 5.2.3. Blockade of Kir7.1 does not induce the loss of astrocytes 
Compared to oligodendrocytes and neurons, astrocytes are generally considered 
to be less sensitive to ischaemic injury, which results in reactive astrogliosis (Ridet et 
al., 1997; Davies et al., 1998), although irreversible ischaemic damage eventually leads 
to astrocyte cell death (Bondarenko and Chesler, 2001; Thomas et al., 2004; Giffard 
and Swanson, 2005). Astrocytes may be more sensitive in developing white matter 
during the period of myelination (Salter and Fern, 2008). Astrocytes in the developing 
mouse optic nerve during myelination (P10) have been shown to be sensitive to OGD 
(Shannon et al., 2007; Salter and Fern, 2008). We therefore examined the effects of 
Kir7.1 blockade and OGD in P12-14 nerves from GFAP-eGFP mice. The results indicated 
that compared to OGN (Figure 5.3A), the number of astrocytes was not decreased in 
OGD (Figure 5.3B), and blockade of Kir7.1 with VU590 had no effect on astrocyte 
numbers in OGN (Figure 5.3C) or OGD (Figure 5.3D), confirmed by statistical analysis of 
cell counts (Figure 5.3E; p>0.05, ANOVA). However, qualitative examination indicated a 
marked decrease in the overall density of astrocyte processes following incubation in 
VU590, in both OGN (Figure 5.3C) and OGD (Figure 5.3D). Previous studies have shown 
a loss of processes from astrocytes under ischaemic conditions (Davies et al., 1998; 
Hulse et al., 2001; Kraig and Chesler, 1990; Thomas et al., 2004; Salter and Fern, 2008), 
and the present results indicate that blockade of Kir7.1 has an equivalent effect in 
normoxic and ischaemic conditions. 
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Figure 5.3: Kir7.1 inhibition does not induce loss of astrocytes. Optic nerves from P12-14 GFAP-eGFP 
reporter mice were exposed to 1 h OGD in the absence and presence of the Kir7.1 blocker VU590 (100 
µM) and compared to controls incubated in normal aCSF with O2 and glucose (OGN). (A–D) 
Representative images of optic nerves from GFAP-eGFP reporter mice, which identifies astrocytes, 
incubated in OGN (A), OGD (B), OGN plus VU590 (C), or OGD plus VU590 (D). (E) Quantification of the 
number of GFAP–eGFP positive cells shows no significant difference in astrocyte numbers between the 
treatment groups (data are mean ± SEM; n ≥ 5 nerves per experimental group; tested for significance by 
ANOVA with Newman–Keuls multiple comparison post-hoc analysis; *p<0.05, **p<0.01, ***p<0.001). 
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 5.2.4. Blockade of Kir4.1 does not induce the loss of astrocytes 
Kir4.1 is the predominant ion channel in optic nerve astrocytes and is essential for 
maintaining their RMP (Bay and Butt, 2012). It was therefore pertinent to examine the 
effects of 100 µM BaCl2 on astrocytes, which has been shown to almost completely 
inhibit inward currents in optic nerve astrocytes (Bay and Butt, 2012). Blockade of 
Kir4.1 had no significant effect on astrocyte cell numbers or processes in OGN or OGD 
(Figure 5.4; p>0.05, ANOVA). The results indicate Kir7.1 blockade specifically results in 
the loss of astrocyte processes, and that the effects of OGD and Kir4.1 or Kir7.1 
blockade on cell number is specific to oligodendrocytes, consistent with their being 
more sensitive to ischaemic injury than astrocytes. 
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Figure 5.4: Kir4.1 inhibition does not induce loss of astrocytes. Optic nerves from P12-14 GFAP-eGFP 
reporter mice were exposed to 1 h OGD in the absence and presence of the Kir4.1 blocker BaCl2 (100 
µM) and compared to controls incubated in normal aCSF with O2 and glucose (OGN). (A–D) 
Representative images of optic nerves from GFAP-eGFP reporter mice, which identifies astrocytes, 
incubated in OGN (A), OGD (B), OGN plus BaCl2 (C), or OGD plus BaCl2 (D). (E) Quantification of the 
number of GFAP–eGFP positive cells shows no significant difference in astrocyte numbers between the 
treatment groups (data are mean ± SEM; n ≥ 5 nerves per experimental group; tested for significance by 
ANOVA, p>0.05). 
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 5.2.5. Kir7.1 blockade activates cell death pathways 
The results above show that Kir7.1 blockade results in the loss of oligodendrocytes 
in normoxic conditions, indicative of cell death. To examine this further, I investigated 
by qRT-PCR the mRNA expression levels of key genes that are important for the central 
mechanisms of cellular death (apoptosis, autophagy, and necrosis), using the Cell 
Death Pathway Finder RT2 profiler PCR array (Sabiosciences, Qiagen). Ct values of the 
genes of interest were normalised to two reference genes, a combination of Actb and 
Gapdh (variation value 0.005) (Figure 5.5), which is more accurate than using a single 
reference gene (Gimeno et al., 2014). Relative quantification was performed (2-∆Ct 
Method) followed by calculation of the fold change in gene expression (∆∆Ct Method).  
 
Figure 5.5: Estimation of stability of candidate reference genes using NormFinder. Genes are ranked 
according to their expression stability across all samples. The arrow indicates the most stable 
combination of reference genes. 
 
 
qRT-PCR identified a number of genes in the Cell Death Pathway array that are 
significantly altered by the Kir7.1 blocker VU590 in nerves under normoxic conditions 
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 (Table 5.1). Ccdc103, Bcl2 and Ifng were the three most regulated genes in VU590, 
Ccdc103 and Bcl2 being upregulated and Ifng being downregulated. Mutations in 
Ccdc103 are a diagnostic marker for Primary Ciliary Dyskinesia (PCD) (Zariwala et al., 
2007 and 2013) and the protein serves as an anchoring factor for dynein, a motor 
protein that uses ATP energy to move cell cilia (Panizzi et al., 2012). Ccdc103 has no 
reported function in the brain or in glia, but astrocytes express primary cilia and these 
regulate their survival under stressed conditions (Yoshimura et al., 2011). Hence, the 
10.8 FC upregulation of Ccdc103 in VU590 suggests they may be important in the 
survival of astrocytes and their changes in morphology following blockade of Kir7.1. 
Similarly, Bcl2 is a major anti-apoptotic factor (Rossé et al., 1998) and was upregulated 
7.031 fold in VU590. Also upregulated were the apoptosome complex gene Apaf1 
(FC1.402), which binds with cytochrome C and is responsible for caspase activation and 
the initiation of apoptotic cell death in the nervous system (Yuan and Yankner, 2000), 
and caspase 3 (FC 1.231), a pro-apoptotic regulator in oligodendrocytes (Prineas 
and Parratt, 2012). Interestingly, caspase 3 is also responsible for cleavage of 
Huntingtin (Goldberg et al., 1996), which was significantly upregulated in VU590 (FC 
1.341) and indirectly activates caspase 8, another pro-apoptosis factor (Gervais et al., 
2002). In addition, Abl1 was upregulated in VU590 (FC 1.799) and encodes the 
ubiquitously expressed nonreceptor tyrosine kinase ABL, which is activated in oxidative 
stress and can stimulate cell survival or death (Li, 2005; Wang, 2014), although it has 
no reported function in glia or the brain.  
The top genes in the Cell Death Pathway array that were significantly (p<0.05, 
unrelated t-tests) downregulated in VU590 treated nerves under normoxic conditions 
include Ifng (IFN-γ), which is pro-inflammatory in for glia (Neumann, 2001), and the 
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 poliovirus receptor (PVR), which is a transmembrane glycoprotein belonging to the IgG 
superfamily, and mediates cell attachment to the ECM molecule vitronectin, which 
regulates glial growth and activation (Bouslama-Oueghlani et al., 2012; Milner et al., 
2007). The remaining downregulated genes were related to cell survival and 
autophagy and have no reported functions in glia. Autophagy functions as a cell death 
mechanism or as a stress response, mediating prominent cytoprotective effects 
(Salminen et al., 2013; Cecconi and Levine, 2008), and so the downregulation of key 
autophagy related genes ATG5 and Becn1 (Beclin 1) in VU590 indicates these are 
important in the effects of Kir7.1 blockade on glial responses in the optic nerve. 
Moreover, the Bcl2 family can interact with Beclin1 to inhibit autophagy (Salminen et 
al., 2013), and so there would be potentially opposing effects of upregulation of Bcl2 
(see above) and downregulation of Bcl2a1 (bcl-2 related a1) in VU590. Bcl2a1 is also 
known as Bfl1 and is a highly regulated NF-κB target gene that exerts important pro-
survival functions (Vogler, 2012). The remaining gene regulated by VU590 was the cell 
cycle regulator and tumour suppressor gene TP53 (Table 5.1).  
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 Table 5.1: Effects of Kir7.1 blockade on cell death related genes expressed during OGN, determined by 
qRT-PCR using the Cell Death Pathway Finder RT2 profiler PCR array (Sabiosciences, Qiagen). Data are 
fold-change (FC) determined in nerves incubated for 1h in normal O2 and glucose conditions (OGN), 
comparing nerves in the absence or presence of the Kir7.1 blocker VU590 (n≥6 optic nerves per 
treatment group, sun in triplicate). Statistical analysis was performed by volcano plot (unrelated t-test 
p<0.05; FC>1.0). 
Symbol Fold Change Location Type 
Ccdc103 ↑ 10.805 Cytoplasm Other 
Bcl2 ↑ 7.031 Cytoplasm Transporter 
Abl1 ↑ 1.799 Nucleus Kinase 
Apaf1 ↑ 1.402 Cytoplasm Other 
HTT ↑ 1.341 Cytoplasm Transcription Regulator 
Caspase 3 ↑ 1.231 Cytoplasm Peptidase 
Ifng ↓ -3.775 
Extracellular 
Space 
Cytokine 
Bfl1 (Bcl2a1) ↓ -1.670 Cytoplasm Other 
Pvr ↓ -1.092 
Plasma 
Membrane 
Other 
Atg5 ↓ -1.062 Cytoplasm Other 
TP53 ↓ -1.033 Nucleus Transcription Regulator 
Becn1 ↓ -1.021 Cytoplasm Other 
 
 
Thus, it is evident that multiple genes related to cell death are significantly altered 
by the Kir7.1 blocker VU590 in nerves under normoxic conditions. Given this, data was 
further analysed using IPA pathway analysis (Ingenuity Systems), which predicted the 
activation of caspase-dependent apoptotic signalling (Figure 5.6). The results 
presented here indicate that the blockade of Kir7.1 with the blocker VU590 induces 
significant oligodendrocytic cell death via caspase-dependent apoptotic pathways.  
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Figure 5.6: Apoptosis signalling genes in the optic nerve altered by VU590 under normoxic conditions. 
A complement system pathway generated by IPA. Proteins with increased expression are marked in red 
proteins with decreased expression are marked in green. 
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 5.3. Discussion 
The aim of this chapter was to examine the possible functional role of the novel 
Kir7.1 subtype in optic nerve glial physiology. In the previous chapters, evidence was 
provided for the high expression of Kir7.1 in optic nerve glia on both the transcriptome 
and protein levels. The effects of Kir7.1 blockade on glial cell survival in the myelinating 
mouse optic nerve during normal (OGN) as well as oxygen and glucose deprivation 
(OGD) conditions were investigated using the OGD model in combination with 
pharmacology. Results showed that Kir7.1 inhibition caused significant 
oligodendrocytic cell death in normal conditions and exacerbated cell death in OGD 
conditions. In contrast to oligodendrocytes, astrocytes were not as sensitive to hypoxic 
cell death and Kir7.1 inhibition did not adversely affect their survival in either OGN or 
OGD. In order to determine the type of cell death that is induced in oligodendrocytes 
when treated with the specific Kir7.1 blocker VU590, RNA was extracted from optic 
nerves incubated for 30mins in a normal incubator or for a further 1 hr in OGN 
conditions with and without VU590 and qRT-PCR was performed using the Cell Death 
Pathway Finder RT2 Array. Pathway analysis of the cell death related genes that were 
significantly regulated in the VU590 treated groups highlighted a caspase-dependent 
apoptotic pathway.  
 
5.3.1. Kir7.1 blockade induces oligodendrocytic cell death 
Oligodendrocytes are responsible for the myelination of neuronal axons; loss of 
myelination and, as a consequence axonal functional degeneration, is involved in the 
pathogenesis of a variety of conditions such as cerebral palsy, stroke, multiple sclerosis 
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 and Alzheimer's disease. Oligodendrocyte lineage cells, like neurons but not 
astrocytes, are very vulnerable to ischaemic/hypoxic injury and the investigation of the 
cellular mechanisms that are responsible for this high sensitivity has been central in 
scientific studies for many years (Salter and Fern, 2005). Here, the Oxygen and Glucose 
Deprivation (OGD) model of the optic nerve was selected in order to study the 
potential involvement of Kir7.1 in glial cell survival during hypoxic conditions. 
Incubation time of 60 mins was deemed the most appropriate, since this time period 
has been shown to be sufficient for the observation of significant oligodendrocytic 
process damage and oligodendrocyte cell death in previously published studies (Salter 
and Fern, 2005; Hawkins and Butt, 2013). Cell counts of optic nerve oligodendrocytes 
in normal oxygen and glucose (OGN) versus OGD conditions confirmed that within 60 
mins, a significant reduction of oligodendrocyte lineage cells occurred in the model 
and I also showed that blockade of Kir7.1 with the specific blocker VU590 resulted in 
significantly increased oligodendrocyte cell death after 60mins in OGD conditions. 
Moreover, it was observed that incubation of optic nerves with VU590 caused 
oligodendrocyte cell death even in OGN conditions, which indicates an important 
function of Kir7.1 in oligodendrocyte physiology. The pharmacological blocker VU590 
has been shown to effectively block Kir7.1 at micromolar concentrations, whereas it 
has no effect on Kir4.1 and Kir2.1 (Lewis et al., 2009). 
Ischaemic/hypoxic injury is mediated by a combination of mechanisms; the 
disruption of ionic homeostasis due to energy depletion and the accumulation of 
excessive glutamate are both important factors leading to white matter cell death 
(Stys, 2004; Tekkök et al., 2007). The significant sensitivity of differentiating 
oligodendrocytes to ischaemia/hypoxia and oxidative stress has been linked to their 
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 limited anti-oxidative defences (Back et al., 2002; Fern and Möller, 2000) along with 
their expression of Ca2+ permeable ionotropic glutamate receptors and more 
specifically N-Methyl-D-Aspartate (NMDA) receptors (Káradóttir et al., 2005; Back et 
al., 2007). Moreover, the depolarisation of the resting membrane potential as a result 
of inhibition of oxidative phosphorylation, reduction of ATP levels and subsequent 
failure of the Na+/K+ pump is one of the perpetrators of ischaemic neuronal cell death 
(Clarke and Sokoloff, 1994; Lipton, 1999). Since oligodendrocytes have a highly 
negative resting membrane potential, which is maintained principally via the 
expression of Kir channels (Kalsi and Butt, 2006), it is possible that blockade of Kir 
would result in exacerbation of ischaemic injury cascades. In addition, blockade of the 
Na+/Ca2+ exchanger (NCX) during anoxia of the rat optic nerve was found to have a 
protective effect as it was shown that a reversal of its function was responsible for the 
large Ca2+ influx that led to white matter cell death (Stys et al., 1991; Fern et al., 1993). 
Nitric Oxide (NO) production by microglia and [Na+]o increase during hypoxia has been 
shown to be linked with the reversal of NCX from efflux to influx of Ca2+ but the exact 
mechanisms have not been elucidated (Boscia et al., 2013; Stys et al., 1992).  
Finally, the acid-sensing ion channels (ASICs), which are highly permeable to Ca2+, 
could also be acting as excitotoxicity mediators in ischaemic/hypoxic conditions since 
under these conditions extracellular pH becomes acidic enough for these channels to 
be activated (Barber et al., 2003; Krishtal, 2003). Expression of ASIC at the 
transcriptome level in optic nerve glia and especially Asic1 was demonstrated in 
chapter 3 and their expression at protein level has been shown in previous studies in 
OPCs (Feldman et al., 2008; Lin et al., 2010). The mechanism of Ca2+ -induced 
excitotoxicity is glutamate-independent and can trigger both necrotic and apoptotic 
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 cell death (Stys et al., 1992) and removal of extracellular calcium resulted in greater 
recovery of young adult white matter following OGD but not aging white matter 
(Tekkök et al., 2007; Baltan et al., 2008). 
Barium (Ba2+) is a known nonspecific blocker of Kir channels; therefore, treatment 
of optic nerves with barium chloride (BaCl2) in OGN and OGD was used as a positive 
control for oligodendrocyte Kir blockade. The Kir4.1 subtype, which sets the resting 
membrane potential in oligodendrocytes, is very sensitive to Ba2+ blockade, but at the 
concentration used here, it might also partially block other Kir channels in the mouse 
optic nerve such as Kir2.x or Kir3.x (Bolton et al., 2006; Bay and Butt, 2012). However, 
Kir7.1, are not blocked by Ba2+ at this concentration (Krapivinsky et al., 1998). In fact, 
the Kir7.1 subtype displays several unique features compared to the rest of the Kir 
channels such as its very low single channel conductance (approximately 50 fS), its 
independence on internal block by Mg2+ as well as its low sensitivity to block by 
external Ba2+ and Cs+. The sensitivity of Kir7.1 to Ba2+ and Cs+, common blockers of Kir 
channels, is very low with IC50 values of 1 mM and ~10 mM, respectively, which are 
~10 times higher than the IC50 values for other Kir channels (Partiseti et al., 1998) 
therefore the barium concentration used in this study (100 µM) should only block non-
Kir7.1 inward rectifier channels, and mainly Kir4.1. Another important biophysical 
characteristic of Kir7.1 is that its inward rectification is independent of [K+]o. It is 
possible therefore, that the extracellular K+ accumulation that occurs during hypoxia, 
renders Kir7.1 as the main inward rectifier that maintains the resting membrane 
potential in oligodendrocytes. 
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 This hypothesis is further supported by the finding that while both Ba2+ and VU590 
cause oligodendrocyte cell death in normal oxygen and glucose conditions, the effect 
of Ba2+ and therefore inhibition of Kir4.1, was more detrimental than the inhibition of 
Kir7.1. However, the opposite was noted for oxygen and glucose deprivation 
conditions, during which Kir7.1 blockade had a more significantly damaging effect to 
oligodendrocytes than Kir4.1 inhibition. Due to its biophysical properties it was 
hypothesised that Kir7.1 could help set the membrane potential in cells in which it is 
expressed (Krapivinsky et al., 1998). As it has been previously established that the 
most important contributor to setting the very negative glial resting membrane 
potential (RMP) is Kir4.1 (Butt and Kalsi, 2006), it is unlikely that Kir7.1 plays a major 
role in normal conditions. A conditional CNS knockout of Kir7.1 would answer this 
question and in combination with OGD it could help elucidate on the role of Kir7.1 in 
oligodendrocytic survival during hypoxic conditions. It is important to note that 
incubation of mouse optic nerves with 100 µM BaCl2 in OGN conditions for 1hr caused 
significant oligodendrocyte cell death but since we did not perform a time course we 
are unable to say with certainty how long after the introduction of BaCl2 the cells 
started to die. 
In contrast to the dramatic effect that VU590 had on oligodendrocytes, astrocytic 
cell death was not exacerbated in OGN or OGD. Moreover, no significant 
ischaemic/hypoxic astrocytic death was observed after incubation of optic nerves in 
OGD conditions. Astrocytes are generally more resilient than oligodendrocytes and 
neurons and they can survive longer in oxygen and glucose deprivation. Even in the 
absence of oxygen, astrocytes can still produce ATP (anaerobic metabolism) which 
allows them to maintain intracellular ionic homeostasis as well as continue the 
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 clearance of [K+]o that is increased in ischaemic/hypoxic conditions thus protecting the 
brain. Astrocytes are protective against ischaemic damage in other ways as well, by 
clearing excess glutamate and Reactive Oxygen Scavengers (ROS) from the 
extracellular space, sustaining neurons by producing lactate, by releasing 
neuroprotective factors such as vascular endothelial growth factor (VEGF) and by 
forming the glial scar thus isolating damaged areas (Verkhratsky and Butt, 2013). 
However, there is a likelihood that Kir blockade could compromise astrocytic functions 
such as [K+]o clearance and consequently resulting in an exacerbation of the effects of 
OGD on oligodendrocytes. 
Finally, application of VU591 did not have any effect in glial cell death in the 
mouse optic nerve during OGD. VU591 was identified by Bhave et al as a Kir1.1 
inhibitor that is more specific than VU590 as it does not block Kir7.1 at concentrations 
up to 10 µM (Bhave et al., 2011). The potential effects of VU591 on Kir7.1 at the 
concentration used here (100 µM) were not examined electrophysiologically, therefore 
it is possible that some blockade occurred, however it was not high enough that it 
caused an effect on cell survival during OGD. 
 
5.3.2. Cell Death Pathways 
Cell death can happen in any of the three different forms; apoptosis, autophagy or 
necrosis (Lipton, 1999). Here, the Cell Death Pathway Finder qRT-PCR Array (Qiagen) 
was used in order to investigate the involvement of key molecules from all three cell 
death modes that may participate in the observed oligodendrocytic cell death after 
incubation with VU590, which blocks Kir7.1. Volcano plot analysis identified the 
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 upregulation Bcl2, Abl1, Apaf1 and Caspase 3, which are key players in the initiation of 
caspase dependent apoptotic cell death. The family of caspases contains at least 14 
members in mammalian cells, where they are present as inactive pro-caspases and are 
proteolytically processed into active caspases. They are activated either through 
engagement of cell surface receptors such as the tumour necrosis factor alpha 
receptor (TNFa) and Fas or by the release of cytochrome c from mitochondria 
(Kroemer et al., 1998). Release of cytochrome c from the mitochondria depends on the 
integrity of the mitochondrial outer membrane and more specifically on the 
permeability of the mitochondrial voltage dependent anion channel (VDAC) which is 
regulated by the Bcl-2 family of proteins (Shimizu et al., 1999). Mitochondria can also 
be induced to release cytochrome c through various weak stress signals emanating 
from the interior of the cell such as DNA damage, premature mitotic arrest or unfolded 
protein response (Green and Reed, 1998; Zamzami and Kroemer, 2001). The 
redistribution of cytochrome c into the cytosol results in the formation of the 
apoptosome with Apaf1, which in turn activates caspase-9 in the presence of dATP (Li 
et al, 1997; Du et al, 2000). Caspase-9 then activates the effector caspase-3 that is 
responsible for many of the morphological and biochemical features of apoptosis (Los 
et al., 1999; Salvesen and Dixit, 1997). It is important to note that the family of Bcl-2 
contains both pro- and anti-apoptotic molecules that can either directly affect the 
integrity of the outer mitochondrial membrane (protein-membrane interaction) or 
heteromerise with each other (protein to protein interaction). Moreover, it has been 
hypothesised that the fate of a cell will ultimately depend on the relative balance of 
pro- and anti-apoptotic signals, but the exact mechanisms and interactions of Bcl-2 
family proteins are still being studied. Multiple models have been hypothesised over 
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 the last 3 decades to describe the regulation of mitochondrial apoptosis by Bcl-2 
proteins and it appears that the specific functions of each member depend on the 
specific combination of BH regions (Bcl-2 Homology regions), as cleavage of specific 
regions and alternative splicing can determine whether a Bcl-2 related protein will 
protect or condemn a cell, and all these mechanisms comprise of multiple stages (Chi 
et al., 2014).  
Besides the well-established role of mitochondria in the induction of cell death, 
the disruption of the function of endoplasmic reticulum has also been implicated in the 
pathophysiology of various diseases involving cell death (Kim et al., 2006; Hetz et al., 
2013). Moreover, membrane contact sites (MCSs) have been discovered between the 
ER and mitochondria, with important implications about the involvement of ER in 
mitochondria -induced apoptosis (Kornmann, 2013). The ER extends all through the 
cytoplasm and it is primarily involved in protein production and transportation, Ca2+ 
homeostasis as well as lipid and membrane biosynthesis. Importantly, it also serves as 
the initiating locus for autophagy and is able to initiate signals that regulate cell 
survival (Szegezdi et al., 2006; Martinez et al., 2010). The autophagy related gene 
Beclin1 (Becn1) is located on the ER membrane as well as other Bcl-2 related proteins 
(Sinha et al., 2008) and the cell death signals initiated from the ER and transmitted to 
the mitochondria are aimed at both the transcriptional and post-transcriptional level 
(Puthalakath et al., 2007) as well as the regulation of Ca2+ via trans-ER-membrane 
channels including IP3 receptors (Wang et al., 2011).  
An interesting finding was that the Ccd3c103 transcript was significantly 
upregulated in the VU590 treated optic nerves. Generally very little is known about the 
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 possible expression and distribution of Ccdc103; mRNA was found to be highly 
expressed in all cilia bearing cells of the zebrafish and protein expression was shown in 
the cytoplasm and the axonemes (cytoskeleton) of cilia as well as in human respiratory 
epithelium (Panizzi et al., 2012) but it is not known whether it is expressed 
physiologically in the CNS. Ccdc103 transcription is regulated by the Foxj1a 
transcription factor which in turn is a target of Hedgehog signalling in the floor plate 
(FP) of both mouse and chick embryos (Yu et al., 2008; Cruz et al., 2010). Expression of 
Foxj1 has been previously found in mouse respiratory and reproductive epithelium, T-
cells, as well as pancreatic b-cells but it has never been investigated in the CNS 
(Hackett et al., 1995; Park et al., 2007; Lin et al., 2004; Kang et al., 2009). Interestingly, 
T-cell populations from Foxj1–/– chimeras were found to produce up to 7fold more 
interferon-γ (IFN-γ) than their Foxj1+/+ counterparts (Lin et al., 2004) whereas 
expression of Ccdc103 was negative in foxj1a-deficient embryos (Panizzi et al., 2012). 
IFN-γ is a cytokine that belongs to the family of interferons and it is known to activate 
the JAK-STAT system which is a major signalling alternative to the second messenger 
system that involves IP3 and Ca2+ among others (Holla et al., 2014). Here, Ccdc103 
transcript expression was greatly upregulated (11fold) and IFN-γ almost 4fold 
downregulated in VU590 treated optic nerves when compared to the untreated. This is 
very interesting since astrocytes and neural stem cells express primary cilia and these 
regulate their survival under stress conditions (Yoshimura et al., 2011). Further 
investigations into the physiological function of Ccdc103 in CNS astrocytes would 
possibly provide information about its potential significance in astrocytic/neural stem 
cell motility and astrocytic activation for the formation of glial scar.  
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 The expression and function of Fas/Fasl in glial cells has been investigated in 
several studies in vitro and the association of Fas activation with apoptosis is 
controversial for astrocytes. IFN-γ significantly upregulates microglial Fas/Fasl 
expression whereas cytokine treatment has been shown to have no effect on 
astrocytic Fas/Fasl in mice (Lee et al., 2000). However, treatment with IFN-γ 
upregulated Fas/Fasl in human embryonic astrocytes (Choi et al., 1999) and Fas 
upregulation promoted apoptosis in astrocytic cell lines (Saas et al., 1999). Fas induced 
apoptosis and Bcl2 downregulation that is enhanced by INF-γ treatment has been also 
shown in cultured microglia (Spanaus et al., 1998). In oligodendrocytes, Fas dependent 
cell death was demonstrated in MS that was described as atypical apoptosis (Thilenius 
et al., 1999) and a more recent study showed that IFN-γ and Fas induced 
oligodendrocytic cell death was mediated by Caspase 11 (Hisahara et al., 2001). 
Additionally, studies have shown that Fas/Fasl activation is associated with decreased 
levels of mitochondrial anti-apoptotic proteins such as Bcl2 and Bcl2a1a (Li et al., 1998; 
Werner et al., 2002). IFN-γ is also involved in the process of reactive astrogliosis 
(Balasingam et al., 1994). Microglial cytotoxicity against oligodendrocytes can be 
enhanced by treatment with IFN-γ (Peck et al., 1989). Fasl is a member of the Tumour 
Necrosis Factor (TNF) family and can be either a transmembrane protein or be 
produced by cells and exist in the extracellular space and is an inducer of apoptosis by 
interacting with the Fas receptor (Kearns et al., 2014). Interestingly, studies have 
shown that Fas/Fasl activation is associated with decreased levels of mitochondrial 
anti-apoptotic proteins such as Bcl2a1a (Li et al., 1998; Werner et al., 2002).  
From the above, it can be hypothesized that in my study of the optic nerve, IFN-γ 
production by microglia may play a role in the oligodendrocyte cell death observed 
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 after application of VU590. These results are also consistent with oligodendrocyte 
lineage cells being vulnerable to oxidative stress which can trigger mitochondrial 
apoptosis (Sánchez-Gómez et al, 2003), and the analysis of VU590 treated optic nerves 
may have identified early changes in these cells. As described in section 5.2.1, 
significant oligodendrocytic cell death has already occurred after 1hr of incubation 
with VU590. It can be therefore assumed that the mRNA transcript levels that indicate 
there is ongoing caspase-dependent apoptosis are a reflection of the intracellular 
signalling in the remaining oligodendrocytes that have not yet perished. A time course 
of VU590 incubation of 30 mins, 90 mins and 120 mins incubation with the blocker 
could provide additional information about the cell death relevant genes altered that 
might aid in the formulation of a more complete cell death model for oligodendrocytic 
lineage cells.   
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 5.4. Summary and Conclusions 
The results provide novel evidence that Kir7.1 are important for the survival of 
oligodendrocytes and this is greater when they are under hypoxic stress. The 
equivalent effect of VU590 and Ba2+ indicates Kir7.1 are as important as Kir4.1, an 
essential channel for the survival of oligodendrocytes and their primary function of 
myelination (Neusch et al., 2000). In addition, the results suggest a unifying 
mechanism by which blockade of Kir4.1 and Kir7.1 and consequent oligodendrocyte 
depolarization compromises their integrity, via caspase-dependent pathways.  
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Chapter 6 - Kir7.1 effects on glial 
calcium: a role for store operated 
calcium entry  
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 6.1. Introduction and Aims 
In Chapter 5, I provided evidence that Kir7.1 are cytoprotective for 
oligodendrocytes. Furthermore, their blockade resulted in oligodendrocyte death in 
normoxic conditions and abrogated their loss in ischaemia. In contrast, blockade of 
Kir7.1 did not induce a loss of astrocytes, but there was evidence of a loss of their 
processes, which has been reported in ischaemia and may be an early indication of 
astroglial injury response (Salter and Fern, 2008). Calcium is a key mechanism 
mediating oligodendrocyte cell death in ischaemia (Fern et al., 2014) and in regulation 
of astrocyte plasticity and reactive astrogliosis (DeBock et al., 2014). Furthermore, cell 
death pathway analysis in Chapter 5 revealed that cell integrity maybe compromised 
via caspase-dependent pathways, which have been shown to mediate oligodendrocyte 
cell death as a result of Ca2+ dyshomeostasis (Alberdi et al., 2005). Kir have been shown 
to be critical for establishing the RMP of optic nerve glia (Bolton and Butt, 2006; Bolton 
et al., 2006; Bay and Butt, 2012), providing a potential mechanism by which Kir7.1  
blockade could cause sustained depolarization and therefore unregulated Ca2+ influx 
through plasmalemmal voltage-operated Ca2+ channels (Cav channels). In addition, 
recent studies have identified that store operated calcium entry (SOCE) may play a key 
role in Ca2+ movements in astrocytes via TRPC1 channels (Verkhratsky and Parpura, 
2014), although it is not known whether this is a widely expressed mechanism in the 
CNS. Oligodendrocytes have not been studied in this context, but SOCE has been 
demonstrated in OPCs via TRPC1 (Paez et al., 2011). The molecular identity of glial 
SOCE has not been identified unequivocally, but the balance of evidence indicates Orai 
is predominantly expressed in microglia, whereas astrocytes and oligodendrocytes rely 
more on TRP channels (Verkhratsky and Parpura, 2014). Studies in our lab have shown 
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 that optic nerve glia display ‘calcium excitability’ involving a range of G-protein 
coupled receptors (GPCR) (Hamilton et al., 2008, 2010), and indicated that SOCE is an 
important mechanism for replenishment of intracellular stores following IP3-mediated 
rises in [Ca2+]i (James and Butt, 2001). The aims of this section are to determine 
whether blockade of Kir7.1 triggers a rise in glial [Ca2+]i and examine the potential 
mechanisms mediating plasmalemmal Ca2+ fluxes in optic nerve glia, using calcium 
imaging and qRT-PCR. 
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 6.2. Results 
6.2.1. Calcium imaging of glia in isolated intact optic nerves 
Chapter 5 shows that blockade of Kir7.1 channels has pathological implications for 
glia. Calcium dyshomeostasis is a primary physiological mechanism in glial pathology 
(Fern et al., 2014; DeBock et al., 2014), suggesting that the effects of Kir7.1 blockade 
may be mediated by a rise in glial [Ca2+]i, which is normally tightly regulated at 
nanomolar levels. We therefore examined the potential role of Kir7.1 in Ca2+ fluxes in 
optic nerve glia using Fluo4 calcium imaging, as described previously (Hamilton et al., 
2008, 2010). In brief, P10-P14 nerves were isolated intact and loaded with Fluo-4/AM, 
a green-fluorescent Ca2+ dye that in its AM (acetoxymethylester) form is membrane 
permeable and, once taken up by the cell, cytosolic esterases remove the ester group 
and the dye is rendered membrane impermeable and thus remains intracellular 
(Garaschuk et al., 2006). Fluo4-loaded nerves were placed in a perfusion chamber 
under a Zeiss LSM5 Pascal Axioskop 2 confocal microscope and nerves imaged using a 
20x/0.50 WPh2 Achroplan water immersion lens. Fluo4 was visualised by excitation at 
488 nm and optical z-sections were obtained, typically 7-8 sections at 2–3 µm 
intervals. Changes in Fluo4 fluorescence were measured using the Zeiss LSM Image 
Examiner software (Zeiss, Germany) in glial cell bodies, selected as regions of interest 
(ROI). Figure 6.1 illustrates an experiment on a P14 optic nerve, where PLP-DsRed-
positive oligodendrocytes are identified in z-stacks by excitation at 543 nm (Figure 
6.1A), Fluo4 loading is detected at 488 nm (Figure 6.1B), and the overlay identifies 
Fluo4-loaded PLP-DsRed-positive oligodendrocytes and PLP-DsRed-negative cells 
(Figure 6.1C). Oligodendrocytes comprised 52% of Fluo4-loaded cells (n=250 cells from 
170 
 
 12 optic nerves), and the bulk of the remaining 48% were astrocytes, based on their 
large cell bodies (Figure 6.1D), although a minor population of small diameter cells are 
likely to be OPCs and possibly microglia (Hamilton et al.,  2008, 2009), but we did not 
attempt to analyse these separately. Subsequent continuous recordings of Fluo4 were 
performed using excitation at 488 nm alone, to increase the rate of image acquisition, 
and analysed using a grayscale (Figure 6.1B). It was not possible to perform equivalent 
experiments in GFAP-eGFP reporter mice to unequivocally identify astrocytes, because 
eGFP is detected at the same wavelength as Fluo4, and experiments using alternative 
red calcium dyes have not been successful in our hands.  Furthermore, it was not 
possible to perform all experiments on PLP1-DsRed nerves, because of insufficient 
numbers, and so most experiments were performed on wild-type mice, unless 
otherwise stated. 
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Figure 6.1: Identification of oligodendrocytes for calcium imaging. Live cell confocal imaging of isolated 
intact optic nerves from P10-P14 PLP1-DsRed mice loaded with the calcium dye Fluo4. Images are stacks 
of 8x2µm z-sections and illustrate PLP1-DsRed positive oligodendrocytes detected at 543 nm (A, C) and 
Fluo-4 positive cells detected at 488 nm (B, C), in greyscale with representative examples of the ROIs (B) 
and in green in an overlay of 488 nm and 543 nm channels (C). Examples of Fluo4-loaded 
oligodendrocytes are indicated by arrowheads, while asterisks indicate PLP-DsRed-negative cells, which 
from their large somata are identified as astrocytes. (D) Mean percentage of oligodendrocyte ROIs 
(52.26%) versus astrocyte ROIs (47.74%); n=250 cells from 12 optic nerves. 
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 6.2.2. Kir7.1 blockade induces [Ca2+]i fluctuations in optic nerve glia 
A typical experiment is illustrated in Figure 6.2. The nerve was continuously 
bathed in aCSF via a multitap system that allowed rapid turnover to solutions 
containing the agents of interest, such as ATP or VU590, as illustrated (Figure 6.2A, B). 
Fluo4 is extremely sensitive to changes in [Ca2+]i, but as a single wavelength dye it is 
not possible to measure the absolute [Ca2+]i and it has a number of limitations 
compared to dual wavelength dyes, such as: cells take up the dye to a variable extent, 
and so generally it is not possible to compare absolute values of fluorescence between 
cells and between nerves; moreover, fluorescence may decline with time due to 
bleaching. In order to compensate for these limitations, in each nerve a ‘positive 
control’ was performed, whereby a 60s pulse of 100 µM ATP was administered at the 
beginning and the end of the experiment. In any given cell, the response to 100 µM 
ATP provides a measure of the maximal rise of glial [Ca2+]i, irrespective of the level of 
Fluo4 loading (Hamilton et al., 2008). Thus, quantification of the change in glial [Ca2+]i 
can be measured as the change in fluorescence from baseline (ΔF/F), and data 
expressed relative to the ATP response in the same cell, so that comparison can be 
made between treatments, independent of dye-concentration and absolute level of 
fluorescence. Furthermore, an ATP response is tested at the end of the experiment, to 
ensure the responsiveness and viability of the cell. 
 
Hence, in a typical experiment for the analysis of VU590 illustrated in Figure 6.2: 
(1) fluorescence was measured continuously for >60s to provide a baseline and then 
100 µM ATP was applied for 60s, followed by a recovery period of 10 min in aCSF, 
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 during which fluorescence was measured for the first 120s and, to minimise the 
exposure of the nerve to the lasers, excitation and recording was paused 
(indicated by // in the figures); 
(2) after 10 min recovery in aCSF, fluorescence recording was recommenced to 
provide a baseline in aCSF and then the agent of interest, in this case the Kir7.1 
blocker VU590 (100 µM), was applied for >120s to completely replace the solution 
in the chamber; depending on the duration of exposure to the agent, perfusion 
and recording may be stopped, as in the example illustrated, where the optic 
nerve was incubated in VU590 for 60 min, during which time fluorescence was 
recorded intermittently, to minimise the exposure of the nerve to the lasers;   
(3) at the end of the test period; there was a 10 min recovery in aCSF (indicated by // 
in the figures), and a final 60s pulse of ATP was applied to confirm the viability of 
the cells. 
 
Notably, VU590 evoked fluctuations in glial [Ca2+]i that are generally termed 
‘calcium oscillations’ and appeared as spontaneous and transient rises in [Ca2+]i 
(Volterra et al., 2014) (Figure 6.2A). In some cases, cell death was observed, which was 
often associated with an initial rise in [Ca2+]i followed by a decay in fluorescence before 
the cell fluorescence disappeared (Figure 6.2B). However, not all cells responded to 
VU590 and to analyse this, 30 cells that displayed a robust response to ATP were 
randomly selected in a constant field of view (FOV) in each nerve (unless otherwise 
stated, this method of analysis was used throughout). During exposure to VU590 for 
60mins, an analysis of n=140 cells from 5 nerves revealed that 23.5+3.1% of cells 
displayed oscillations while76.5+3.1% did not display a clear-cut response(Figure 6.2C).  
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Figure 6.2: Calcium responses in optic nerve glia in 
response to Kir7.1 blockade. (A, B) Confocal images of 
Fluo4 fluorescence intensity (illustrated in rainbow false 
colour) and representative traces of individual glial cells 
illustrate the changes in fluorescence in response to 100 
µM ATP (60s) and 100 µM VU590 (60 min). During 
exposure to VU590, glial cells exhibited oscillations in 
[Ca2+]I (A), and in some cases cell death (B). (C) Histogram 
of the mean (+SEM) percentage of cells displaying calcium 
oscillations in response to VU590 (n=140 cells from 5 
nerves). 
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 6.2.3. Temporal effects of Kir7.1 blockade on glial [Ca2+]i fluctuations 
In order to assess whether the effect of VU590 on optic nerve glia required long 
term administration, VU590 was applied for 10 min and the results compare to 60 min 
exposure (Figure 6.3). VU590 for 10 min evoked [Ca2+]i oscillations in 36.7+3.4% of cells 
(n=30 cells from 2 nerves; Figure 6.3A), greater but not significantly different to 
23.5+3.1% of cells during 60 min exposure (n=140 cells from 5 nerves; Figure 6.3B; 
unpaired t-test). Administration of VU590 for 10 min did not result in cell death, 
indicating the detrimental effects of Kir7.1 block occurs over longer periods. From this 
point on, VU590 was routinely administered for 10 min to examine the mechanisms of 
the calcium oscillations. 
 
 
Figure 6.3: Temporal effects of Kir7.1 blockade on glial [Ca
2+]i. (A) Representative trace illustrating 
calcium oscillations during 10 min exposure to VU590. (B) Histogram of the mean (+SEM) percentage of 
cells displaying calcium oscillations during exposure to VU590 for 10min (n=30 cells from 2 nerves) or 60 
min (n=140 cells from 5 nerves). p>0.05, unpaired t-test. 
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 6.2.4. Comparison of effects on glial [Ca2+]i of VU590 and other Kir blockers 
The primary glial Kir subtype Kir4.1 is rapidly blocked by Ba2+ ions(100 µM BaCl2) in 
an irreversible or very slowly reversible manner, resulting in depolarization of 
astrocytes and oligodendrocytes in the optic nerve (Bolton and Butt, 2006; Bolton et 
al., 2006; Bay and Butt, 2012).  In contrast, Kir7.1 channels are insensitive to 100 µM 
BaCl2 and are blocked by VU590, which does not act on Kir4.1 (Lewis et al., 2009). 
VU590 also inhibits Kir1.1, and this was tested for using the specific Kir1.1 blocker 
VU591 (Bhave et al., 2011). Application of 100 µM BaCl2 for 10 min had no effect on 
glial [Ca2+]i (Figure 6.4A, B; n=73 cells from 5 nerves). Similarly, in the vast majority of 
cells (~90%) VU591 had no effect on glial [Ca2+]i (Figure 6.4B), but [Ca2+]i oscillations 
were observed in a small number of cells during administration of VU591 (Figure 6.4C). 
The proportion of cells responding to VU591 was 6.6+3.6%, significantly less than 
36.7+3.4% of cells that exhibited [Ca2+]i oscillations in VU590 (Figure 6.4D; unpaired t-
test). Transcripts for Kir1.1 were not detected in the optic nerve (Chapter 3) and VU591 
did not affect glial integrity (Chapter 5), hence the significance of the calcium response 
in VU591 is unclear, but its infrequency suggests it could reflect low levels of Kir1.1 
expression in a subset of glia or a non-specific effect of VU591 on Kir channels (Bhave 
et al., 2011). Overall, the lack of effect of barium and minor effect of VU591 indicate 
the [Ca2+]i fluctuations evoked by VU590 are a specific effect of Kir7.1 blockade.  
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Figure 6.4: Comparison of effects of Kir blockers on glial [Ca
2+]i. Fluo4 fluorescence was measured 
during administration of BaCl2 to block Kir4.1 and VU591 to block Kir1.1. (A) BaCl2 did not evoke a change 
in glial [Ca2+]i (n=73 cells from 5 nerves). (B, C) In most cases, VU591 did not evoke a change in glial 
[Ca2+]I (B), although a subset displayed [Ca
2+]i oscillations in response to VU591 (C). (D) Histogram of the 
mean (±SEM) percentage of cells displaying calcium oscillations in VU590 and VU591; **p<0.01, 
unpaired t-test. 
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 6.2.5. Effects of Kir7.1 blockade on glial [Ca2+]i are independent of extracellular 
Ca2+ 
Removal of extracellular Ca2+(ZERO-[Ca2+]o) for 10 min prior to application of 
VU590 is illustrated in Figure 6.5. Perfusion of the optic nerve with ZERO-[Ca2+]o 
resulted in a slow decline in [Ca2+]i in all cells analysed, to a new stable baseline, and 
did not completely block the VU590-evoked oscillations in glial [Ca2+]i (Figure 6.5A), but 
the number of cells displaying VU590-evoked oscillations was significantly decreased 
(p<0.05, unpaired t-test) from 36.7±3.4% of cells in aCSF to 13.1±3.5% of cells in ZERO-
[Ca2+]o (n=75 cells from 5 nerves, Figure 6.5B). The results indicate that the response of 
glial cells to VU590 is largely dependent on extracellular Ca2+. 
 
 
Figure 6.5: Effects of extracellular Ca2+ removal on VU590-evoked changes in glial [Ca2+]i. (A) 
Representative trace showing ZERO-[Ca2+]o resulted in a gradual decline in glial [Ca
2+]i, but this did not 
block VU590-evoked oscillations in all cells. (B) Histogram of the mean (+SEM) percentage of cells 
displaying calcium oscillations in VU590 in aCSF and VU590 in ZERO-[Ca2+]o; *p<0.05, unpaired t-test. 
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 6.2.6. Role of Cav channels in mediating glial [Ca2+]i fluctuations 
There is evidence that L-type Cav channels may participate in astroglial [Ca2+]i 
oscillations (Parri and Crunelli, 2003). To examine this in the optic nerve, the effects of 
the potent L-type Cav channel activator BayK 8644 and blocker Verapamil were 
examined (Figure 6.6). BayK did not elicit a [Ca2+]i response in cells that displayed 
responses to ATP, when applied at 10 µM or 100 µM (n=50 cells from 2 nerves), 
indicating activation of Cav channels alone does not induce Ca2+ oscillations (Figure 
6.6A). In the presence of the L-type Cav channel blocker verapamil (100 µM), most cells 
did not display VU590-evoked [Ca2+]i oscillations (Figure 6.6B), although they persisted 
in a small proportion of cells (Figure 6.6C). Overall, verapamil resulted in a decrease in 
the percentage of cells displaying VU590-evoked [Ca2+]I oscillations from 36.7+3.4% in 
aCSF to 8.5+7.2% in verapamil (n=70 cells from 4 nerves), but this was not statistically 
significant (Figure 6.6D; p>0.05, unpaired t-test). The results suggest Cav channels 
participate in [Ca2+]i oscillations evoked in response to Kir7.1 blockade, but they were 
not abolished in verapamil, indicating other mechanisms are involved, such as release 
from intracellular stores and SOCE.  
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Figure 6.6: Role for Cav channels in mediating glial [Ca
2+]i fluctuations. (A) The potent L-type Cav 
channel activator BayK did not elicit a rise in glial [Ca2+]i when applied at 10 µM or 100 µM. (B, C) 
Administration of the L-type Cav channel blocker verapamil decreased the number of cells displaying 
oscillations in response to VU590 (B), although oscillations were still prominent in some cells (C). (D) 
Histogram of the mean (+SEM) percentage of cells displaying calcium oscillations in VU590 in aCSF and 
VU590 plus verapamil; p<0.05, unpaired t-test). 
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 6.2.7. Evidence of SOCE in optic nerve glia 
SOCE was activated using the SERCA pump blocker thapsigargin to induce 
depletion of intracellular Ca2+ stores (ER-Ca2+-depletion), as previously reported in 
astroglia (Singaravelu et al., 2006; Moreno et al., 2012). Figure 6.7A shows a trace of 
the mean (+SEM) change in Fluo4 fluorescence (ΔF/F) in response to thapsigargin, 
normalized to the ATP-response in the same cells (n=37 cells from 3 nerves).  
Administration of thapsigargin caused an initial rise in [Ca2+]i, due to SOCE in response 
to SERCA blockade (Figure 6.7A, arrow). In ZERO-[Ca2+]o, there is depletion of [Ca2+]i, 
largely reflecting uptake of Ca2+ into intracellular stores in the absence of 
replenishment from the extracellular milieu (Figure 6.7A,B), and this [Ca2+]i–depletion 
was significantly reduced following blockade of uptake into ER by thapsigargin (Figure 
6.7A,B; p<0.01, unpaired t-test with Welch's correction). When the solution bathing 
the nerve is returned to 2.24mM-[Ca2+]o, there is a rapid replenishment of [Ca2+]i due 
to SOCE, which overshoots the baseline and is significantly greater in thapsigargin 
(Figure 6.7A,C, indicated by red arrow; p<0.05, unpaired t-test). The SOCE inhibitor 2-
aminoethoxydiphenylborane (2APB, 50 µM) (Singaravelu et al., 2006; Abdullaev et al., 
2008) is shown to completely abolish the initial thapsigargin-induced rise in [Ca2+]I in 
optic nerve glia (Figure 6.8A, arrow). In addition, 2APB significantly blocked the 
thapsigargin-induced reduction in [Ca2+]i-depletion in ZERO-[Ca2+]o (Figure 6.8B; 
p<0.001, unpaired t-test with Welch's correction) and [Ca2+]i-replenishment was 
significantly less on return to 2mM-[Ca2+]o (Figure6.8C;p<0.001, unpaired t-test with 
Welch's correction). Even though 50 µM 2APB effectively inhibits SOCE, it has been 
shown to stimulate SOCE at lower concentrations (Salmon and Ahluwalia, 2010), and 
administration of 10 µM 2APB in normal 2mM-[Ca2+]o aCSF evoked a transient rise in 
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 [Ca2+]i (Figure 6.9A; arrow). Moreover, the transient [Ca2+]i increase induced by 10 µM 
2APB was not significantly different to that caused by 10 µM Thapsigargin (Figure 6.9B; 
p>0.05, unpaired t-test with Welch's correction).  
Together, these results provide evidence of SOCE in optic nerve glia (Singaravelu 
et al., 2006; Moreno et al., 2012). 
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Figure 6.7: SOCE after Ca2+ store depletion by thapsigargin. (A) Trace of the response to thapsigargin 
(2µM), each point and error bars representing the mean Fluo4 fluorescence + SEM (n=37 cells from 3 
nerves for thapsigargin and n=81 cells from 5 nerves for aCSF). Blockade of uptake into ER by 
thapsigargin causes an initial small accumulation of [Ca2+]i (black arrow), followed by [Ca
2+]i–depletion in 
ZERO-[Ca2+]o in the absence of replenishment from the extracellular milieu. On return to 2mM-[Ca
2+]o 
there is a rapid replenishment of [Ca2+]i due to SOCE (red arrow). (B, C) Histograms of mean (+SEM) 
[Ca2+]i-depletion and [Ca
2+]i–replenishment in the presence and absence of thapsigargin (*p<0.05; 
**p<0.01, unpaired t-test with Welch's correction).   
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Figure 6.8: SOCE is blocked by 50 µM 2APB.SOCE induced by the SERCA blocker Thapsigargin (black) and 
in the presence of the SOCE blocker 2APB (red). (A) 2APB (50 µM) abolished the Thapsigargin-induced 
transient rise in [Ca2+]i (black arrow). (B) [Ca
2+]i-depletion in ZERO-[Ca
2+]o was significantly greater in 
2APB (***p<0.001, unpaired t-test with Welch's correction). (C) [Ca2+]i -replenishment on return to 
2mM-[Ca2+]o was significantly decreased in 2APB and [Ca
2+]i did not recover to the original baseline. 
(***p<0.001, unpaired t-test with Welch's correction). 
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Figure 6.9: SOCE is stimulated by 10 µM 2APB. (A) Application of 10 µM 2APB induced a transient [Ca2+]i 
increase (arrow) (n=65 ROIs from 5 nerves). (B) The transient [Ca2+]i increase induced by 10 µM 2APB 
was not significantly different from the one caused by 10 µM Thapsigargin (p>0.05, unpaired t-test with 
Welch's correction). 
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 6.2.8. Evidence of SOCE in the VU590-evoked glial [Ca2+]i oscillations 
The effects of thapsigargin (10 µM) and 2APB (50 µM) on the VU590 (100 µM) 
response is illustrated in Figure 6.10. The VU590 -evoked oscillations were inhibited in 
a significant number of cells (65.3+9.2%) in the presence of thapsigargin (p<0.05, 
unpaired t-test; n=116 cells from 5 nerves) (Figure 6.10Ai, Aii;), and thapsigargin also 
significantly decreased the response to ATP (Figure 6.10Aiii; p<0.001, paired t-test). 
Inhibition of SOCE with 50 µM 2APB (Figure 6Bi, red line and symbols) also inhibited 
the VU590 -evoked oscillations in a significant number of cells (77.0+6.3%; p<0.001, 
unpaired t-test) (Figure 6.10Bi inset and Figure 6.10Bii). Moreover, 50 µM 2APB 
significantly decreased the [Ca2+]i  increase in response to ATP (Figure 6.10Biii, 
p<0.001, paired t-test; n=83 cells from 5 nerves). Notably, the glial response to ATP is 
primarily mediated by P2Y1 GPCR (James and Butt, 2000) and it was significantly 
decreased by 2APB (Figure 6.9), supporting a role for SOCE in the IP3-mediated rise in 
[Ca2+]i and indicating it is irreversibly or only slowly reversibly inhibited by 2APB. Taken 
together, the results provide further evidence to indicate a significant role for SOCE in 
glial response to ATP and [Ca2+]i oscillations evoked in response to Kir7.1 blockade. 
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Figure 6.10: Activation of SOCE by Kir7.1 blockade.(A) Thapsigargin (10 µM) significantly decreased the 
VU590 induced oscillations (inset Ai and mean data in Aii) and the ATP response (Aiii); n=116 cells from 
5 optic nerves, ***p<0.001, unpaired t-test in Aii and paired t-test in Aiii). (B) Blockade of SOCE with 
50µM 2APB (red trace) significantly decreased the VU590 induced oscillations (inset Bi, mean data in 
Bii); n = 83 cells from 5 optic nerves, ***p<0.001, unpaired t-test with Welch's Correction). (Biii) 50 µM 
2APB significantly decreased the response to ATP (***p<0.001, paired t-test). 
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 6.2.9. qRT-PCR identification of Cav channels in the mouse optic nerve 
Taken together, the effects of verapamil above provide functional evidence of Cav 
channels in optic nerve glia. To inform on their possible molecular identity, I performed 
qRT-PCR, using the Mouse Neuronal Ion Channels RT2 Profiler™ qPCR array and a 
custom RT² Profiler™ qPCR arrays (Sabiosciences, Qiagen). For technical reasons, and 
for efficient Fluo4 loading, the calcium imaging experiments were performed on P9-12 
optic nerves. However, there is evidence that glial cells may lose calcium channels 
during maturation (Verkhratsky and Butt, 2013), which raises the question of whether 
studies in the postnatal tissue can be extrapolated to the adult. Therefore, 
developmental changes in the calcium channel profile was analysed in mice aged P9 
(pre-myelination), P12 (active myelination) and P35 (post-myelination/mature), as 
described in Chapter 3. Results are expressed as relative gene expression using the      
2-ΔΔCT method, normalised to Gapdh. Cav channels are grouped functionally into the 
High Voltage Activated (HVA), including the N-type, P/Q-type and L-type channels, and 
Low Voltage Activated (LVA) T-type channels, all of which have been reported in glia 
(Verkhratsky and Butt, 2013). Cav channels are structurally and functionally diverse due 
to their multimeric composition; the α1 subunit that forms the ion conducting pore, 
and associated subunits (α2δ, β1-4, and γ), which modulate channel activity, gating 
and cellular localisation (Simms and Zamponi, 2014). Table 6.1 displays various Cav 
channel subunits, the mRNA level of which was investigated in the optic nerve for the 
purposes of this project, providing both the gene and protein names, and the results 
are illustrated in Figure 6.11. 
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 Table 6.1: Voltage Gated Ca2+ Channels. 
α1 Subunits 
Voltage Type Gene Name (Protein Name) 
High Voltage Activated (HVA) 
P/Q Type Cacna1a (Cav2.1) 
N Type Cacna1b (Cav2.2) 
L Type Cacna1c (Cav1.2), Cacna1d (Cav1.3) 
Low Voltage Activated (LVA) T Type Cacna1g (Cav3.1), Cacna1h (Cav3.2), Cacna1i 
(Cav3.3) 
β Subunits – Gene Name(Protein Name) 
Cacnb1 (Cavβ1), Cacnb2 (Cavβ2), Cacnb3 (Cavβ3) 
γ Subunits – Gene Name(Protein Name) 
Cacng2 ((Cavγ2 - Stargazin), Cacng4 (Cavγ4) 
 
The Cav channel transcripts with the most abundant expression levels in the mouse 
optic nerve are illustrated in Figure 6.11. Prominent expression of Cavβ1 and Cavγ4 was 
observed, together with a wide range of α subunits, most prominently the P/Q-Type 
Cav2.1, L-Type Cav1.2 and T-Type Cav3.1 (Figure 6.11); other subunits were expressed 
to a lesser extent and the T-Type LVA Cav3.2 and Cav3.3 were not detected. Generally, 
mature glial cells do not exhibit measurable Cav currents, although Cav1.2, Cav2.1 and 
Cav3.1 are detected in OPCs and cultured astrocytes (Verkhratsky and Steinhäuser, 
2000; Paez et al., 2009). This is consistent with findings in the optic nerve, where there 
was a general developmental downregulation of Cav, most markedly for Cavβ3 and 
Cavγ4 (Figure 6.11; p<0.01 and p<0.001 respectively, ANOVA, followed by Bonferroni's 
Multiple Comparison test). 
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Figure 6.11: Expression of voltage-gated Ca2+channels (Cav) in mouse optic nerve. Tested for significance by ANOVA and post hoc Bonferroni's tests (*p<0.05, **p<0.01, 
***p<0.001). 
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 6.2.10. qRT-PCR identification of Orai/Stim 
The calcium imaging results indicated glial ‘Ca2+ signalling’ involves Ca2+ release 
from the ER stores by activation of IP3R, and replenishment via store-operated calcium 
channels (SOCC). The best characterised SOCC are the Ca2+ release activated Ca2+ 
channels (CRAC) in which the Stromal Interaction Molecule (STIM) acts as the Ca2+ 
sensor in the ER, which upon Ca2+ depletion activates Ca2+ influx through the Orai 
proteins, which form the plasmalemmal CRAC channel pore (Frischauf et al., 2008). 
Table 6.2 displays the SOCC channels, the mRNA level of which was investigated in the 
optic nerve by qRT-PCR, using a custom RT² Profiler™ qPCR array (Sabiosciences, 
Qiagen), and expressed as relative gene expression normalised to Gapdh; gene and 
protein names are given and the results are illustrated in Figure 6.12. 
 
Table 6.2: Channels involved in Ca2+ release from intracellular ER stores. 
Type Gene Name (*gene and protein name the same) 
IP3 Receptors Itpr1 (IP3R1), Itpr2 (IP3R2) 
Calcium Release-Activated 
Channels (CRAC)/Store 
Operated Ca2+ Channels (SOCC) 
Orai1*, Orai2*, Orai3* 
Stim1*, Stim2* 
 
IP3-mediated Ca2+ signalling is very prominent in the mouse optic nerve (Butt, 
2006, 2012), and this is supported by high expression of IP3R2 mRNA and to a lesser 
extent IP3R1 (Figure 6.12). Notably, Orai1 and Stim1/2 were robustly expressed and 
similar results were obtained in the cortex and cerebellum, although IP3R1 was more 
strongly expressed than IP3R2, and Orai1, Orai2 and Orai3 were expressed at similar 
levels (not illustrated). Interestingly, in the optic nerve Orai2 and Orai3 appeared to 
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 increase and decrease with age, respectively, although these changes were not 
statistically significant (p>0.05, ANOVA). Orai1 however, was significantly 
downregulated between P9 and P35 (Figure 6.12; p<0.05, ANOVA, followed by 
Bonferroni's Multiple Comparison test). Orai1 and Stim1 have been detected in cortical 
astrocytes (Moreno et al., 2012), whereas microglia mostly express Orai3 (Ohana et al., 
2009), but otherwise little is known about CRAC in glia. The results indicate Orai and 
Stim may be important for CRAC in the optic nerve. 
 
Figure 6.12: Expression of channel protein transcripts involved in Ca2+ release from intracellular ER 
stores in mouse optic nerve. Tested for significance by ANOVA and post hoc Bonferroni's tests 
(*p<0.05). 
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 6.2.11. qRT-PCR identification of TRP channels in the mouse optic nerve 
The calcium imaging results indicated an important role for SOCE in optic nerve 
glia. TRP channels are the primary mechanisms of SOCE in astrocytes, and these were 
analysed by qRT-PCR, using the Mouse Neuronal Ion Channels RT2Profiler™ qPCR array 
and a custom RT² Profiler™ qPCR array (Sabiosciences, Qiagen), and results are 
expressed as relative gene expression normalised to Gapdh. The superfamily of TRP 
channels are non-selective cation channels that are expressed in many cell types and 
can be activated by various intra- and extracellular signals (Venkatachalam and 
Montell, 2007). TRP allow both Na+ and Ca2+ ions to enter the cell in both excitable and 
non-excitable tissues (Ramsey et al., 2006). TRP channels constitute at least seven 
subfamilies, TRPA (TRP-ankyrin), TRPC (TRP-canonical), TRPM (TRP-melastatin), TRPV 
(TRP-vanilloid), TRPP (TRP-polycystin), TRPML (TRP-mucolipin) and TRPN (TRP-NOMPC) 
which is not found in mammals. Table 6.3 displays the TRP channels, the mRNA level of 
which was investigated in the optic nerve for the purposes of this project and the 
results are illustrated in Figure 6.13. 
 
 
Table 6.3: Transient Receptor Potential (TRP) Channels. 
Sub-Family Gene Name (same as protein name) 
TRPA (Ankyrin) Trpa1 
TRPC (Canonical) Trpc1, Trpc2, Trpc3, Trpc6 
TRPM (Melastatin) Trpm1, Trpm2, Trpm3, Trpm4, Trpm6, Trpm7, Trpm8 
TRPV (Vanilloid) Trpv1, Trpv2, Trpv3, Trpv4 
194 
 
  
The most abundant mRNA transcripts in the mouse optic nerve were TRPM3, 
TRPM7 and the ‘canonical’ TRPC1 (Figure 6.14), which is the prominent TRP channel in 
astrocytes and OPCs/oligodendrocytes (Malarkey et al., 2008; Paez et al., 2011). In 
rank order, TRPM3 > TRPM7 >TRPC1 >TRPV2> TRPC3 > TRPM6, whereas the known 
astrocytic ‘Ankyrin’ TRPA1 was present, but less highly expressed, as were TRPV3, 
TRPV4, TRPC6 and TRPM2, whereas TRPV1 and TRPM8 were not detected. 
Developmentally, TRPV3 was barely detected in the P9 optic nerve and was 
significantly increased at P35 (p<0.05, ANOVA, followed by Bonferroni's Multiple 
Comparison tests); there were significant changes in TRPA1, but this channel was 
barely detectable at any age. 
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Figure 6.13: Expression of TRP channel transcripts in mouse optic nerve. Tested for significance by ANOVA and post hoc Bonferroni's tests (*p<0.05). 
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 6.2.12. Key developmental changes in optic nerve calcium channels  
Volcano plot analysis (Sabiosciences Rt2 Array Data Analysis) was used to identify 
significant changes in SOCE mechanisms (unrelated t-test, p<0.05) developmentally 
regulated greater than 2-fold between P12 and P35 (Table 6.5). The results indicate 
the overall trend was for a developmental upregulation of SOCE.  
 
Table 6.4: Developmentally regulated Ca2+ channel transcripts in the mouse optic nerve. Data was 
obtained by qRT-PCR analysis of 3 biological replicates (n=10 optic nerves per group) of acutely isolated 
optic nerves from mice aged P12 compared to P35. Statistical analysis was performed by volcano plot 
(Sabiosciences Rt2 Array Data Analysis) (unrelated t-test p<0.05; FC>2.0). 
Age Gene Regulation p-value  Molecule Regulation p-value 
P12 to P35 
ORAI2 ↑8.093 0.150512  Cavβ3 ↓ -2.9982 0.003032 
STIM2 ↑ 6.2046 0.122685  TRPC6 ↓ -2.4074 0.227988 
TRPV3 ↑ 5.4992 0.029817     
TRPM3 ↑ 5.11 0.127108     
TRPM7 ↑ 3.0035 0.042005     
STIM1 ↑ 2.555 0.894069     
IP3R2 ↑ 2.1785 0.437526     
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 6.3. Discussion 
Calcium is a key molecule in glial cell physiology and pathology, including 
ischaemia. In Chapter 5, I showed that blockade of Kir7.1 with VU590 induced 
pathological changes in optic nerve glia, most notably oligodendrocyte death. Here, I 
show that blockade of Kir7.1 evokes [Ca2+]i fluctuations and cell death in optic nerve 
glia, using calcium imaging of Fluo4 -loaded isolated intact optic nerves. In addition, I 
provide pharmacological evidence that Kir7.1 blockade triggered Ca2+ influx involving 
plasmalemmal SOCE and possibly Cav channels. qRT-PCR identified Orai/Stim 
transcripts at high levels and hence likely underlying the primary molecular basis of 
SOCE in optic nerve glia, together with TRP channels, with prominent expression of 
TRPM3, which is expressed by oligodendrocytes (Hoffmann et al., 2010), TRPC1, which 
have a demonstrated role in astrocyte SOCE (Parpura et al., 2011), and TRPM7, which 
has only been reported in microglia and was highly expressed in the optic nerve (Jiang 
et al., 2003). Expression of functional Cav channels in mature glial cells is contradictory, 
but the qRT-PCR analysis of optic nerves reinforced calcium imaging evidence that 
optic nerve glia express L-type Cav1.2 (James and Butt, 2000; Hamilton et al., 2008), in 
addition to P/Q-Type Cav2.1 and T-Type Cav3.1. Thus, the results of this chapter 
identify a novel function for Kir7.1 in Ca2+ homeostasis in glial cells and provide SOCE as 
the potential molecular basis of Ca2+ fluxes that mediate the pathological effects of 
Kir7.1 blockade (Table 1). Notably, CRAC and TRP channels are developmentally 
upregulated, indicating a persistent role for SOCE in the adult. 
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 Table 6.5: Main calcium ion channels expressed by optic nerve glia. 
------------Astrocytes/Oligodendrocytes----------------/------ OPC/Microglia--------Developmental Change 
Cav Cavβ3  > Cavγ4  >> Cav3.1  > Cavβ1 > Cav2.1> Cav1.2 Downregulated 
TRP TRPM3> TRPM7> TRPC1 > TRPV2> TRPC3> TRPM6 
TRPC1 and TRPM6 
upregulated; TRPC3 
downregulated 
CRAC ORAI1 =  STIM1  > STIM2> ORAI2   
  
Not regulated 
 
 
 
Figure 6.14: Key developmental changes in optic nerve calcium ion channels. Data are presented as 
collective relative expression of the different ion channel families, to illustrate the proportional change 
in gene expression from P9 to adulthood. 
 
6.3.1. Identification of cell types in calcium imaging experiments 
A major limitation of the calcium imaging experiments in the isolated intact optic 
nerve is that it was not possible to identify the specific glial cell types from which 
recordings were made. Unfortunately, both the GFAP-eGFP and the SOX10-eGFP 
strains emit at 488 nm and could not be used with Fluo4, and loading of calcium dyes 
that emit in the red wavelength was not successful. Furthermore, although Fluo4 
recordings were possible with PLP-DsRed reporter mouse, there were insufficient mice 
available during the course of the project. Nonetheless, analysis of Fluo4 loading in 
PLP1-DsRed reporter mice indicated that the dye was taken up into astrocytes and 
oligodendrocytes in equal proportions; therefore calcium imaging measurements will 
include both cell types. However, analysis of the calcium response to VU590 was 
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 heterogeneous, with one-third of cells responding by Ca2+ oscillations, approximately 
one-third dying, and the remainder not displaying a clear response; the viability of the 
non-responders was confirmed by demonstrating a robust response to ATP. The cells 
that die in response to VU590 are oligodendrocytes (Chapter 5), and the identity of the 
oscillating-cells versus non-responders may reflect a difference between Kir7.1 and 
SOCC expression in oligodendrocytes and astrocytes. Immunolabelling for Kir7.1 was 
strongest in oligodendrocytes (Chapter 4) and TRPM3, which is the most highly 
expressed TRP channel transcript in the optic nerve, has not been reported in 
astrocytes but mediates Ca2+ influx in oligodendrocytes (Hoffmann et al., 2010). 
Indeed, blockade of Kir7.1 induced greatest changes in oligodendrocytes (Chapter 5). 
Further studies are required to resolve the cellular identity and the precise 
mechanisms of action of VU590, but overall the results are consistent with 
deregulation of Ca2+ involving TRPM3 being a primary mechanism in the loss of 
oligodendrocyte integrity following Kir7.1 blockade. 
 
6.3.2. VU590 induced deregulation of glial [Ca2+]i: specificity of action on Kir7.1 
The results provide clear evidence that application of VU590 induces Ca2+ 
oscillations and cell death in a large proportion of cells. Notably, Kir4.1 blockade did not 
affect glial [Ca2+]i, whilst blockade of both Kir4.1 and Kir7.1 caused a loss of 
oligodendrocytes, indicating they have different physiological functions and induce 
oligodendrocyte cell death by different mechanisms. Barium has been shown to 
depolarise optic nerve astrocytes and oligodendrocytes (Bolton et al., 2006; Bolton and 
Butt, 2006; Bay and Butt, 2012), and blockade of Kir7.1 may have the same effect, but 
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 only VU590 induced glial [Ca2+]i -oscillations, indicating that depolarisation is not the 
primary cause. It is notable that the Kir1.1 blocker VU591 also induced Ca2+-oscillations 
in a very small population of glial cells. Although transcripts for Kir1.1 were not 
detected in the optic nerve, splice variants of Kir1.1 (also known as the renal outer 
medullary K+, ROMK, channel) have been described in the kidney and ROMK2 and is 
localized to the apical tips of a glial cells in mouse taste buds (Dvoryanchikov et al., 
2009). Hence, it cannot be excluded at present that a small population of optic nerve 
glia may express Kir1.1, but they have never been described in CNS glia, and it seems 
more likely that at 100 µM VU591 partially inhibits Kir7.1. In addition, VU591 may 
partially inhibit Kv at high micromolar concentrations, by <10% (Bhave et al., 2011). The 
possible off-target effects of VU590 and VU591 on Kv1.1 channels, which were the 
most highly expressed transcript in the optic nerve, warrants further investigation, 
using blockers such as tetraethylammonium ions (TEA) and agitoxin-2. Nevertheless, it 
seems unlikely that partial blockade of Kv1.1 compared to complete blockade of Kir7.1 
is the mechanism of VU590-evoked glial [Ca2+]i -oscillations. Overall, the effects of 
ZERO-[Ca2+]o, thapsigargin and 2APB indicate VU590 acts on Kir7.1 to deregulate glial 
[Ca2+]i homeostasis involving Ca2+ release from intracellular stores and SOCE.  
 
6.3.3. A major role for SOCE in glial [Ca2+]i homeostasis 
A striking finding of this chapter was the dependence of glial Ca2+homeostasis on 
an apparent continuous Ca2+ influx from the extracellular milieu, since removal of 
[Ca2+]o resulted in a rapid and marked depletion of [Ca2+]i within minutes. The effects of 
thapsigargin and 2APB indicate this is largely dependent on SOCE and uptake into ER 
stores via SERCA pumps, as summarised in Figure 6.16. Moreover, blockade of SOCE 
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 with 2APB resulted in an irreversible deregulation of [Ca2+]i, and future experiments 
should determine whether this effects glial integrity. 
 
The mechanisms of SOCE have been most extensively studied in astrocytes than 
other types of glia (Kirischuk et al., 1996; Golovina, 2005; Malarkey et al., 2008; 
Pivneva et al., 2008; Lo et al., 2002; Singaravelu et al., 2006). Stim1 and Orai1 
expression and function has been demonstrated in rat cortical astrocytes in vitro 
(Moreno et al., 2012), and a role for TRP channels and especially TRPC1 and TRPC3 in 
SOCE has also been substantiated (Pizzo et al., 2001; Grimaldi et al., 2003). In contrast, 
the only experimental evidence of oligodendroglial SOCE is for TRPM3 (Hoffmann et 
al., 2010) and association of the Golli protein with Stim1 and TRPC1 in OPCs (Paez et 
al., 2007; Walsh et al., 2010). The evidence provided here in the optic nerve indicates 
functional expression of SOCE has a widespread importance in astrocytes and 
oligodendrocytes. 
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Figure 6.15: Diagram summarising the data showing a key role for SOCE in glial [Ca2+]i homeostasis. 
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 My finding that thapsigargin induced an increase of [Ca2+]i in optic nerve glia is in 
agreement with literature reports that the blockade of SERCA results in ER Ca2+ store 
depletion which causes an influx of Ca2+ into the cytosol. Furthermore, I showed that 
the [Ca2+]i increase caused by thapsigargin was abolished by 50 µM 2APB, which is a 
potent inhibitor of ORAI/STIM CRAC and TRPC channels (Prakriya and Lewis, 2001; 
Trebak et al., 2002; Peinelt et al., 2008), all of which I show are expressed in the optic 
nerve. In addition, 2APB has been found to cause inhibition of IP3R and inhibit Ca2+ 
efflux from the ER lumen into the cytoplasm (DeHaven et al., 2005). My finding that 
2APB caused a more significant depletion of [Ca2+]i in combination with thapsigargin is 
in agreement with previous experiments performed in rat parotid acinar cells (Soltoff 
and Lannon, 2013). Soltoff and Lannon also demonstrated that after the initial [Ca2+]i 
increase that followed re-introduction of Ca2+ to the extracellular solution, inhibitory 
concentrations of 2APB induced an immediate decrease of [Ca2+]i, whereas in the cells 
that were only treated with 2 µM of thapsigargin, [Ca2+]i levels returned to baseline but 
decreased no further. My results demonstrated the same action for 2APB in optic 
nerve glia. In contrast, <10 µM 2APB has been shown to rapidly activate CRAC channels 
(DeHaven et al., 2005). Moreover, Salmon and Ahluwalia (2010) demonstrated that 
10µM 2APB consistently stimulated Ca2+ influx which was even more significant in 
combination with thapsigargin. In agreement with their findings, my data 
demonstrated a transient increase of [Ca2+]i following the application of 10 µM 2APB, 
thus indicating that at this concentration Ca2+ influx into the cytosol is induced via 
activation of SOCE. 
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 In addition to SOCE and uptake into ER via SERCA pumps, calcium homeostasis 
involves multiple mechanisms, including Ca2+ extrusion by Na+/Ca2+-exchangers (NCX) 
and ATP-dependent plasma membrane Ca2+ pumps (PMCA), uptake by mitochondria, 
mainly via the mitochondrial Ca2+ uniporter (MCU) and mitochondrial NCX 
(Verkhratsky and Butt,2013). PCMAs may be main contributors to glial [Ca2+]i 
homeostasis (Nett and Deitmer, 1998) and have been described in astrocytes (Fresu et 
al., 1999) and oligodendrocytes (Kirischuk et al., 1995). Plasmalemmal NCX are 
regarded as main contributors to clearing large increases in [Ca2+]i, such as occur 
following receptor-mediated transients (Deitmer et al., 1998), and their expression and 
function has been clearly defined in glial cells (Goldman et al., 1994; Alberdi et al., 
2002 and 2005). In astrocytes, NCX are also up-regulated in hypoxic conditions 
(Takuma et al., 2013), while oligodendrocytic NCX are believed to be involved in cell 
differentiation and myelin production (Boscia et al., 2013). 
 
Block of Kir7.1 may also cause glial depolarisation, but as discussed above this is 
unlikely to be a mechanism of action of VU590, since barium is known to massively 
depolarise optic nerve glia and did not cause Ca2+ influx. Another example of the 
Kir/[Ca2+]i relationship was demonstrated when over-expression of Kir channels 
resulted in reduced calcium spikes in neurons of the developing nervous system 
(Rosenberg and Spitzer 2011). In addition, Kir4.1 channels can be permeable to Ca2+ 
(Härtel et al., 2007) and if the same is true for Kir7.1, then the decrease in Ca2+ influx 
following their blockade would trigger Ca2+ release from intracellular stores and 
activate SOCE to maintain [Ca2+]i. Interestingly, Kir7.1 blockade did cause a decrease in 
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 [Ca2+]i in some cells (not illustrated), which paradoxically caused Ca2+ overload and 
death, termed the “Ca2+ paradox” of ischaemia-reperfusion (Wei et al., 2007). In 
addition, verapamil depressed VU590-evoked [Ca2+]i oscillations in optic nerve glia, 
consistent with a role for L-type Cav channels (Hoehn et al., 1993). However, verapamil 
also blocks T-type Cav channels at micromolar concentrations (Begson et al., 2011), 
implicating both L-type and T-type Cav channels in the VU590-evoked [Ca2+]i 
oscillations, likely to be Cav2.1 and Cav3.1 based on the qRT-PCR. Interestingly, Cav3.1 
are open at more negative membrane potentials and it would be interesting to further 
investigate their involvement in glial oscillations.  
 
6.3.4. qRT-PCR analysis of Cav in optic nerve glia 
The correlation between qRT-PCR and calcium imaging data provides evidence for 
functional expression of Cav channels, CRAC and TRP channels in astrocytes and 
oligodendrocytes.  Moreover, our arrays included all of the main Cav channels, TRP 
channels and CRAC shown to be expressed by glia (Verkhratsky and Butt, 2013). On 
this basis, the relative expression levels identify the key channels expressed by optic 
nerve astrocytes and oligodendrocytes, and the low expression of some transcripts 
suggests either low expression in macroglia (e.g. Cav2.1), or possibly significant 
expression in minor populations of OPC and microglia, such as Cav1.2 which is 
constitutively expressed by OPCs (Table 6.6). In addition, the results indicate a general 
developmental downregulation of Cav channels, whereas CRAC and TRP channels are 
developmentally upregulated, supporting a key role for these channels in mediating 
Ca2+ fluxes in mature glia (Figure 6.15). 
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 The Cavβ3 and Cavβ4 subunits were strongly expressed in the optic nerve, 
although the α subunits were expressed at lower levels, with a rank order of Cav3.1 > 
Cav2.1> Cav1.2. Astrocytes are not considered to express Cav channels in situ (Parpura 
et al., 2011), and although oligodendrocytes express Cav channels during myelination 
(Paez et al., 2009), there is little evidence for functional Cav channels in differentiated 
oligodendrocytes. Taken together with the calcium imaging data, the low transcript 
levels of Cav and their marked developmental downregulation are suggestive of OPCs. 
Cav channels currents have been demonstrated in OPCs in vitro and in situ (Paez et al., 
2009a), and they regulate important developmental processes in OPCs, such as cell 
migration and proliferation (Paez et al., 2010; Fulton et al., 2010). Nonetheless, Cav 
channels currents and protein expression for Cav2.1 (P/Q Type), Cav2.2 (N-Type) and 
Cav1.2 (L-Type) have been reported in astrocytes and oligodendrocytes (Parri and 
Crunelli, 2003; Fern, 1998; Akopian et al., 1996; Paez et al., 2009), and their expression 
in optic nerve astrocytes and oligodendrocytes is supported by the effect of verapamil 
in our calcium imaging experiments. Cav channels may be highly localized to process 
terminals, and therefore difficult to detect unless they are activated by mechanisms 
such as Kir7.1 inhibition.  
 
In addition, Cavγ subunits, including Cavγ4, which was detected in the optic nerve, 
are type I transmembrane AMPA receptor (AMPA-R) regulatory proteins (TARPs) and 
regulate trafficking and gating of AMPA-R (Körber et al., 2007). Interestingly, 
astrocytes, oligodendrocytes and OPCs express all four types of AMPA-R subunits 
(GluA1-4) and their activation causes raised intracellular Ca2+ (Hamilton et al., 2008, 
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 2009), and makes OPCs and oligodendrocytes vulnerable to hypoxic-ischaemic damage 
(Salter and Fern, 2005; Zonouzi et al., 2011). The relatively high expression of Cavγ4 in 
the postnatal nerve and its subsequent downregulation may be related to changes in 
glial AMPA-R expression. Furthermore, optic nerve axons have been shown to express 
Cav channels and these are able to support axonal conduction in premyelinated axons, 
involving L-type Cav prior to P5 and P/Q-type Cav up to P12 (Alix et al., 2008). In my 
study, L-Type channels (Cav1.2 and Cav1.3) were downregulated only after P12, and 
P/Q-type channels (Cav2.1) was not significantly downregulated, supporting the 
conclusion that they predominantly reflect glial expression rather than axonal. 
 
6.3.5. qRT-PCR evidence of CRAC in optic nerve glia 
In physiological conditions, SOCE play important roles in the sustained phase of 
the [Ca2+]i signal observed following stimulation of GPCR in glial cells (Verkhratsky and 
Parpura, 2014). The results of this chapter demonstrate a role for SOCE in ATP-
mediated calcium signalling in optic nerve glia, which has previously been shown to be 
primarily from IP3-mediated release of Ca2+ from intracellular ER stores (James and 
Butt, 2001; Hamilton et al., 2008). Replenishment of ER stores depends on SOCE 
involving CRAC comprising ORAI, which form the plasmalemmal Ca2+ channels, and 
STIM proteins, which act as the sensors of Ca2+ depletion (Soboloff et al., 2012). More 
recently, the canonical sub-family of TRP channels (TRPC) is reported to be implicated 
in the construction and function of SOC channels (Huang et al., 2006; Cahalan, 2009). In 
this chapter, the qRT-PCR identified predominance of IP3R2, Orai1/2, Stim1/2 and a 
wide range of TRP channels in the mouse optic nerve, and the calcium imaging 
supports a role for these channels in regulating Ca2+ fluxes in astrocytes and 
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 oligodendrocytes. The high relative expression of IP3R2 is consistent with it being the 
predominant astrocytic IP3R involved in calcium signalling in response to GPCR 
activation (Fiacco and McCarthy, 2006; Kanno and Nishizaki, 2012; Zhao et al., 2000). 
IP3-mediated Ca2+ signalling is also present in OPC, oligodendrocytes and microglia, 
although the IP3R involved are unresolved (Butt, 2006; Kettenmann et al., 2011). ORAI 
are most associated with microglia (Verkhratsky and Parpura, 2014), and the main 
microglial ORAI is Orai3 (Ohana et al., 2009), transcript levels for which were the 
lowest ranked in the optic nerve. Expression has also been demonstrated in astrocytes 
(Akita and Okada, 2011; Motiani et al., 2013), where Orai1/Stim1 may predominate 
(Moreno et al., 2012). The levels of Orai1/2 and Stim1/2 mRNAs detected in the mouse 
optic nerve are comparable to those for IP3R, and together with the calcium imaging 
data demonstrate a previously unrecognised important role of CRAC in optic nerve 
astrocytes and oligodendrocytes. It is possible that OPCs also express CRAC, since Golli, 
a member of the MBP family of proteins, has been shown to regulate SOCE in OPCs 
(Paez et al., 2007) and to bind Orai1/Stim1 complexes to negatively regulate SOCE 
(Walsh et al., 2010). 
 
6.3.6. qRT-PCR evidence of TRP channels in optic nerve glia 
TRP channels are non-selective cation channels and important routes of Ca2+ and 
Na+ influx (Bon and Beech, 2013). In astrocytes, TRPC1 channels appear to primarily 
mediate SOCE (Golovina, 2005), which is consistent with the calcium imaging data of 
this chapter and the qRT-PCR showing TRPC1 transcript being highly expressed in the 
adult nerve. The transcript level of TRPV2 was also high, supporting a recent study 
showing TRPV2 functional expression in cerebellar astrocytes (Shibasaki et al., 2013). 
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 In addition, TRPM3 was the highest transcript detected and is of interest because in 
the brain they are specifically localised to oligodendrocytes (Hoffmann et al., 2010), 
indicating that TRPM3 function as a Ca2+-permeable channel in optic nerve 
oligodendrocytes. TRPM7 was the second highest transcript level and, to our 
knowledge, has not been described in astrocytes or oligodendrocytes and has only 
been reported in microglia (Jiang et al., 2003). However, the level of expression of 
TRPM7 seems unlikely to reflect the minor population of microglia, hence future 
experiments should determine whether it is also expressed in astrocytes and 
oligodendrocytes. In hippocampal neurons, TRPM7 channels detect decreases in 
[Ca2+]o that paradoxically causes Ca2+ overload and death, termed the “Ca2+ paradox” 
of ischaemia-reperfusion (Wei et al., 2007). A similar function for TRPM7 in 
oligodendrocytes may be important in their loss in OGD and following blockade of 
Kir7.1.  
 
The other main TRP channels detected were TRPM6 and TRPC3, which were 
respectively up- and downregulated with development. Previous studies have shown 
extremely low expression of TRPM6 in various CNS regions, but did not include the 
optic nerve (Lee et al., 2012).  Notably, TRPM6 is central to Mg2+ homeostasis (Runnels, 
2011), and Mg2+ deficiency results in hypomyelination in the optic nerve (Gong et al., 
2003). Our finding that TRPM6 mRNA is prominent in the optic nerve and 
developmentally upregulated is therefore of some interest, since it suggests 
oligodendroglial TRPM6 may have a previously unrecognised Mg2+ regulatory function 
during myelination, which requires further investigation. In the case of TRPC3, positive 
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 mRNA and protein expression for TRPC3 has been shown in cultured mouse astrocytes 
(Akita and Okada, 2011), but immunolabelling for TRPC3 in the brain was specific to 
oligodendrocytes and labelling intensity decreased with age (Fusco et al., 2004). This is 
consistent with my findings, and suggests a developmental role for TRPC3 in optic 
nerve oligodendrocytes. 
 
Although TRP channels are prominent in microglia and play an important role in 
SOCE (Verkhratsky and Parpura, 2014), of the main TRP channels reported in microglia, 
only TRPM7 was detected at significant levels in the optic nerve, and TRPV1, which is 
reported to be found solely in microglia and no other glia, was barely detectable in the 
optic nerve. TRPV2 has also been shown to increase phagocytic activity in microglia, 
but may be less important in resting microglia (Hassan et al., 2014). 
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 6.4. Summary and Conclusions 
The overall aim of this section was to examine the possibility that Kir7.1 have a role 
in glial calcium homeostasis. The results of calcium imaging and qRT-PCR indicate 
blockade of Kir7.1 induces SOCE involving ORAI1/STIM1 CRAC and TRP channels, 
principally TRPM3 in oligodendrocytes and TRPC1 in astrocytes (Figure 6.16). In 
addition, high expression of TRPM7 suggests a major role in microglia or unresolved in 
optic nerve macroglia. The results also indicate a lesser functional role for Cav, 
comprising predominantly Cav3.1/β3/γ4 subunits that may be developmentally 
downregulated.  
 
Figure 6.16: Profile of the major calcium ion channels expressed by optic nerve glia and their role in 
deregulation of [Ca2+]i and oligodendrocyte cell death induced by Kir7.1 blockade. 
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Chapter 7 - General Discussion 
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 7.1. Summary of Key Findings 
The overall aim of this thesis was to provide an insight into the ion channel 
expression and function in optic nerve glia, with a focus on the inward rectifier subtype 
Kir7.1. The optic nerve is widely used as a model of white matter tissue for studying 
glial cell development and function, because it comprises mainly astrocytes and 
oligodendrocytes, whose functions are to support and myelinate the axons of retinal 
ganglion cells (Butt et al., 2004). The key findings of the optic nerve ion channel profile 
are summarised in Figure 7.1. It is evident from the results in Chapter 3 that potassium 
channels are abundantly expressed in glia and the data indicated that optic nerve 
astrocytes and oligodendrocytes are dominated by Kv1.1, Kir4.1 and Kir7.1. A key novel 
finding was the high expression of Kir7.1 and Chapter 4 demonstrated this is major 
feature of oligodendrocytes in the optic nerve, and astrocytes throughout the brain. 
The physiological function of Kir7.1 in glia is unresolved, but Chapter 5 identified Kir7.1 
as critical for maintaining the integrity of oligodendrocytes in the optic nerve and their 
blockade results in pathological loss of oligodendrocytes under normal conditions and 
in ischaemia models/hypoxia. Chapter 6 identified SOCE as a potential mechanism for 
the pathological effect of Kir7.1 blockade by causing deregulation of calcium 
homeostasis in optic nerve glia. In addition, Chapter 6 identified important functions 
for CRAC and TRP channels in mediating SOCE and what has been termed ‘calcium 
excitability’ in optic nerve glia. This study has provided a new insight into the ion 
channel expression profile and function in optic nerve glia, which is relevant to 
fundamental functioning of the CNS and to its pathology, including ischaemia, stroke 
and demyelination. 
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Figure 7.1: Profile of the major ion channels expressed by optic nerve glia. 
 
7.2. Antibodies and VU590 as tools for studying Kir7.1 
Kir7.1 expression and function were examined using commercially available 
antibodies and the small molecule inhibitor of Kir7.1, VU590. A Kir7.1 knock out animal 
model would be invaluable for validating the aKir7.1 antibody and VU590, and 
elucidating the significance of Kir7.1 in neuronal and glial function and integrity. 
Notwithstanding this, these tools have been validated in homologous cell systems, 
using transfection gain- and loss-of-function techniques (Lewis et al., 2009; Bhave et 
al., 2011; McCloskey et al., 2014). Hence, it is reasonable to conclude that the results 
of this thesis represented an accurate measurement of Kir7.1 expression and function. 
Nonetheless, the specificity of VU590 for Kir7.1 remains an important consideration. At 
concentrations of 10 µM in vitro, VU590 inhibits Kir7.1 and Kir1.1, but not other Kir 
subtypes, and is largely ineffective on Kv (Lewis et al., 2009). Here however, VU590 was 
used at 100 µM, on the basis that the pial surface of the nerve acts as a permeability 
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 barrier and to be effective in the intact optic nerve, pharmacological agonists and 
antagonists are applied at 10-times the concentration used in vitro (Bolton and Butt, 
2005), and this concentration has been shown to fully block Kir7.1 (Rouhier et al., 
2014). Potential off-target effects of VU590 would most likely be due to Kir4.1 and 
Kv1.1, the most highly expressed ion channels in glia alongside Kir7.1. It seems likely 
that the marked effects of VU590 on optic nerve glia reflect its complete block of 
Kir7.1, rather than partial inhibition of Kir4.1 or Kv1.1. This conclusion is supported by 
the differences in action of 100 µM Ba2+ (BaCl2), which completely blocks Kir4.1, but at 
this concentration does not inhibit Kir7.1 channels. Together with electrophysiological 
studies performed by various groups (Lewis et al., 2009; McCloskey et al., 2014), the 
results of this thesis provide novel evidence of functional expression of Kir7.1 in 
astrocytes and oligodendrocytes. 
 
7.3. Glia ion channel toolbox in the mouse optic nerve  
 An important feature of glial cells is that their ion channel expression is regionally 
diverse and developmentally regulated (Verkhratsky and Butt, 2013). The results here 
demonstrated that optic nerve glia express diverse ion channels, with a developmental 
trend of increased K+ channel expression and a decrease in Na+ and Ca2+ channels 
(Figure 7.2). Developmental analysis of the ion channels, grouped according to class, 
provides further insight into the primary functional importance of delayed rectifier Kv 
and inward rectifier Kir channels, the mRNA levels of which together comprise >50% of 
the transcripts in the adult optic nerve (Figure 7.3). This study identified highest 
expression levels of mRNA encoding for Kv1.1, followed by Kir4.1 and Kir7.1, which 
indicates these channels are the molecular basis of the strongly negative RMP that 
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 underpins glial physiological functions. The expression of Kir7.1 protein was confirmed 
in astrocytes and oligodendrocytes, and immunolabelling with Na+/K+-ATPase 
supported plasmalemmal expression of Kir7.1 with Kir4.1. Together with evidence that 
Kir7.1 is potentially as important for oligodendrocyte integrity as Kir4.1, this thesis 
demonstrates a previously unrecognised important function of Kir7.1 in glia, in 
particular oligodendrocytes. Moreover, the combined qRT-PCR and calcium imaging 
approach identified CRAC and TRP channels that mediate SOCE in glial Ca2+ signalling, 
and demonstrated that they persist in the adult nerve. These results have important 
implications for glial physiology and pathology. 
 
 
Figure 7.2: Key developmental changes in optic nerve ion channels. Data are presented as collective 
relative expression of the different ion channel families, to illustrate the proportional change in gene 
expression from P9 to adulthood. 
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Figure 7.3: Developmental expression (percentile) of ion channels in the optic nerve grouped by class.  
Data are presented as collective relative expression of the different ion channel classes, to illustrate the 
proportional expression within the ages studied. 
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 7.4. Kir7.1 expression and function in glia 
The main novel finding of this thesis was the high expression levels of Kir7.1 
detected in glia. These channels have been mainly studied in epithelial cells of the RPE 
and kidney (Pattnaik et al., 2013; Suzuki et al., 2003), and in the brain were considered 
to be restricted to the choroid plexus, Purkinje neurones of the cerebellum and 
pyramidal neurons of the hippocampus (Krapivinsky et al., 1998; Döring et al., 1998). 
The highest glial expression of Kir7.1 was found in optic nerve oligodendrocytes. 
Oligodendroglial expression was variable in the rest of the mouse brain, while 
astrocytes showed a fairly uniform and ubiquitous expression, notably in their 
perivascular endfeet. The specific localisation of Kir7.1 on perivascular astrocytic 
endfeet is consistent with a function in ion and water homeostasis. The co-expression 
of Kir7.1 with Kir4.1 on the cell membrane is interesting, since it implies that they have 
different roles in K+ transport, as they do in epithelial cells where they are also co-
expressed, such as in the kidney (Zhang et al., 2008). Kir4.1 is known to have a major 
function in setting the glial RMP and K+ spatial buffering, which is the movement of K+ 
away from areas of high neuronal activity to areas of low activity, such as blood vessels 
(Kalsi and Butt, 2004). At physiological [K+]o, Kir7.1 have an almost linear I-V 
relationship between -100 and 0 mV, indicating they are particularly well-suited to 
mediate K+ efflux. Notably, a recent study in our lab showed that in optic nerve, glial K+ 
spatial buffering via Ba2+-sensitive Kir4.1 was only significant during large shifts in [K+]o 
in response to intense neuronal activity and pathology (Bay and Butt, 2012). In 
contrast, K+ uptake during physiological neuronal activity and subsequent K+ efflux for 
redistribution to axons was largely insensitive to Ba2+, suggestive of Kir7.1. Moreover, 
Kir7.1 are essential for K+ recycling to maintain the activity of the Na+/K+-pumps, which 
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 are a primary mechanism for K+ uptake during neuronal activity (Bay and Butt, 2012; 
Ransom et al., 2000). In addition, the Na+/K+-pumps establish and maintain the Na+ 
concentration gradient across the cell membrane that drives multiple plasmalemmal 
transport mechanisms in glia, most notably glutamate uptake, which is a primary 
function of astrocytes and is essential for glutamatergic neuronal activity (Verkhratsky 
and Butt, 2013). Notably, astroglial glutamate uptake protects oligodendrocytes from 
glutamate-mediated cytotoxicity, and the results of Chapter 5 implied a protective role 
for Kir7.1 in oligodendrocytes (see below). These studies indicated Kir4.1 and Kir7.1 play 
distinct functional roles in glia that are essential for maintaining white matter function 
and integrity. 
 
Figure 7.4:  Scheme of mechanisms contributing to K+ transport in glia. Adapted from studies in the 
proximal kidney tubule (Derst et al., 2001). 
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 7.5. Kir7.1 expression and function in neurones 
The identification of Kir7.1 in cortical neurones is novel. The localisation of Kir7.1 
on the primary dendrites of cortical neurones and the dendritic tree of Purkinje 
neurones, as well as the somatal expression in these cell types, implicates the channel 
in the regulation of postsynaptic excitability. The "classical" Kir2.x channels are also 
mainly found in neuronal cell somata and dendrites and their blockade resulted in 
membrane depolarisation and action potential initiation in cortical neurones, as well 
as enhancement of dendritic excitability in striatopallidal neurones (Day et al., 2005; 
Shen et al., 2007). It is interesting though that no obvious neuronal abnormalities are 
reported in Kir2.1 and Kir2.2 knockout mice (Zaritsky et al., 2000), which was postulated 
to be due to compensation by other Kir channels in these mutant mice (Prüss et al., 
2005), which my results show includes Kir7.1. 
 
7.6. Kir7.1 and Kir4.1 are essential for maintaining oligodendrocyte 
integrity 
Based on the hypothesis that Kir7.1 is involved in the maintenance of ion 
homeostasis in glial cells, which is essential for glial integrity under normal 
physiological conditions and in particular during stress (Stys, 2004; Tekkök et al., 2007), 
the next step was to examine the effects of Kir7.1 inhibition on optic nerve glial survival 
by treating the nerves with the specific Kir7.1 blocker VU590. Kir7.1 blockade induced 
oligodendrocytic cell death in control conditions via activation of caspase-dependent 
apoptotic pathways, and it severely exacerbated cell death in OGD. Moreover, 
inhibition of Kir4.1 with Ba2+ was also detrimental for oligodendroglial survival during 
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 hypoxic stress, although the effect was less pronounced than with VU590. These 
results demonstrated that both Kir4.1 and Kir7.1 sustain oligodendrocyte integrity. 
Kir4.1 is essential for maintaining the RMP of oligodendrocytes (Bolton and Butt, 2006; 
Neusch et al., 2000), and Kir7.1 may have a similar function. Hence, severe 
depolarisation may be the mechanism of oligodendrocyte demise following the block 
of these channels, which could be tested using high [K+]o to directly depolarise glia. Cell 
death was observed during live cell calcium imaging, and the qRT-PCR results provided 
evidence of functional expression of Cav channels; the above are consistent with 
membrane depolarisation being involved in the loss of oligodendrocytes during OGN, 
which could be tested using verapamil and other Cav channel blockers. In addition, a 
classical picture of calcium-mediated caspase activation and excitotoxic cell death is 
illustrated in Figure 7.5, which involves astroglial depolarisation causing a reversal of 
glutamate uptake (see above), with a concomitant glutamate build up in the 
extracellular space activating oligodendroglial AMPA-R and NMDA-R, resulting in a 
cytotoxic rise in [Ca2+]i (Benerroch, Neurology 2009, 1779-1785). This could be 
examined using AMPA-R and NMDA-R inhibitors to protect oligodendrocytes from 
VU590-induced death. Other mechanisms of oligodendroglial demise include reversal 
of NCX, which normally extrudes Ca2+ from the cell, but a rise in [Na+]i induced by 
depolarisation and run-down of Na+/K+-pumps causes reversal of NCX and a cytotoxic 
influx of Ca2+, which could be tested in future experiments using ouabain to block 
Na+/K+-pumps and NCX inhibitors, such as KB-R7943 and SEA0400 (Akabas, 2004). 
Further experiments are required to investigate these multiple potential effects of 
Kir4.1 and Kir7.1 blockade, which due to time limitations were outside the scope of my 
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 project, which focused on the mechanisms of Ca2+-oscillations evoked by Kir7.1 
blockade. 
 
 
Figure 7.5: Classical model of glutamate-mediated cytotoxicity and Ca2+-dependent activation of 
caspase-mediated mechanisms of oligodendrocyte cell demise. (Adapted from Benerroch, 2009).   
 
7.7. Kir7.1 blockade results in glial [Ca2+]i deregulation 
This study has provided clear evidence that application of VU590 induced Ca2+ 
oscillations and cell death in a large proportion of cells. Notably, Ba2+ did not affect glial 
[Ca2+]i, indicating differences in the functions of Kir4.1 and Kir7.1 in glia. Calcium 
imaging studies revealed that Kir7.1 blockade induced glial [Ca2+]i oscillations that are 
dependent on SOCE, mediated most likely via both Orai1/Stim1 and Trpm3/Trpc1 
channels. There was evidence that Cav channels may also be involved in glial [Ca2+]i 
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 oscillations, but since blockade of Kir4.1 with Ba2+ is known to cause glial depolarisation 
but did not induce glial [Ca2+]i oscillations, they are unlikely to be dependent on Cav 
channels. Overall, the results suggest a specific role for Kir7.1 in SOCE, which provides a 
potential mechanism by which a pathological rise in [Ca2+]i results in caspase-
dependent cell death in oligodendrocytes, although as noted above this is unlikely to 
be the sole mechanism and further experiments are required to demonstrate a causal 
link between these events (Figure 7.5). 
 
Figure 7.6: Potential mechanism of effect of Kir7.1 blockade on deregulation of [Ca
2+]i and 
oligodendrocyte cell death. 
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 7.8. Clinical implications of findings 
The results of this thesis indicate a protective role for Kir7.1 in ischaemic/hypoxic 
conditions, since their blockade aggravated oligodendrocyte cell loss. The high 
expression of Kir7.1 in neurones and glia supports a potential role in membrane 
depolarisation, which is one of the causes of neuronal and glial stress during a 
hypoxic/ischaemic event that eventually leads to cell demise. Moreover, transient 
ischaemia resulted in a marked decrease in glial Kir4.1 (Iandiev et al., 2006), and it 
would be of interest to investigate whether changes in Kir7.1 expression are involved in 
the sensitivity of neurones and oligodendrocytes to ischaemia/hypoxia. In addition, 
acidification increased Kir7.1 conductance, which could be important in helping to 
maintain the neuron/glial RMP in oxidative stress (Hughes and Swaminathan, 2008). 
Furthermore, Kir4.1 mutations are associated with increased seizure activity, such as 
SESAME/EAST Syndrome (Williams et al., 2010), and a similar function for Kir7.1 is 
likely, since KCNJ13, the gene encoding for Kir7.1, is one of the genes associated with 
epileptogenicity in a functional genomics study on chronic epilepsy (Winden et al., 
2011). 
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 7.9. Summary and Conclusions 
The results presented in this thesis have shed some light on the expression and 
function of Kir7.1 in glia. However, these experiments created more questions on the 
functions of Kir7.1 in glia and neurones, as might be expected in the study of a novel 
ion channel. My findings lead to many further potential avenues of research that may 
be of interest and importance. Moreover, high expression of mRNA for Kv1.1 and the 
Kvβ1 and Kvβ2 subunits is of particular interest, because Kvβ subunits provide a direct 
mechanistic link between cell membrane functionality, and thus ionic flux, and cellular 
metabolic status in their role as aldo-ketoreductases linked to membrane voltage-
gated potassium channel subunits, and are known to be closely associated in neurones 
and axons (Rhodes et al., 1997; Poliak et al., 2003; Jukkola et al., 2012), but have not 
been demonstrated in glia. The high expression of these transcripts in the optic nerve 
are not consistent with axonal expression and implies a major role in mature glia, 
which is completely novel; immunolabelling and electrophysiology experiments would 
be invaluable in order to determine its function, e.g. with pharmacological modulators 
such as κ-Dendrotoxin, a selective blocker of homomeric and heteromeric Kv1.1 
channels (Hatton et al., 2010; Hao et al., 2013). In conclusion, this study has 
demonstrated that glia express a remarkable variety of ion channels, equivalent to 
neurones, and elucidating their precise functions in physiological and pathological 
processes is an immense task, but will provide a solid foundation for future 
development of strategies to combat the deleterious consequences of glial cell 
pathology. 
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